Annual Report and 31 May 2024
Financial Statements
## Baillie Gifford
## US Growth
## Trust plc
Investor disclosure document
The UK Alternative Investment Fund Managers
Regulations requires certain information to be
made available to investors prior to their making an
investment in the Company. The Company’s Investor
Disclosure Document is available for viewing at
bgusgrowthtrust.com.
Notes
None of the views expressed in this document If you are in any doubt as to the action you should
should be construed as advice to buy or sell a take you should consult your stockbroker, bank
particular investment. manager, solicitor, accountant or other Independent
Financial Adviser authorised under the Financial
Investment trusts are UK public listed companies
Services and Markets Act 2000 if you are in the
and as such comply with the requirements of the
United Kingdom or, if not, from another appropriately
Financial Conduct Authority. They are not authorised
authorised financial adviser.
or regulated by the Financial Conduct Authority.
If you have sold or otherwise transferred all of your
Baillie Gifford US Growth Trust plc (the ‘Company’)
ordinary shares in Baillie Gifford US Growth Trust
currently conducts its affairs, and intends to continue
plc, please forward this document, together with any
to conduct its affairs, so that the Company’s ordinary
accompanying documents, but not your personalised
shares can qualify to be considered as a mainstream
Form of Proxy, as soon as possible to the purchaser
investment product and can be recommended
or transferee, or to the stockbroker, bank or other
by Independent Financial Advisers to ordinary
agent through whom the sale or transfer was or
retail investors in accordance with the rules of
is being effected for delivery to the purchaser or
the Financial Conduct Authority in relation to
transferee.
non-mainstream investment products.
This document is important and requires your
immediate attention.
Baillie Gifford US Growth Trust plc
Financial highlights 02
## Contents Purpose and investment principles 04
Strategic report
Chair's statement 07
Managers' review 09
Baillie Gifford's stewardship principles 14
Baillie Gifford proxy voting 15
Baillie Gifford environmental, social and governance engagement 16
One year summary 20
Five year summary 22
Summary of results since inception 24
Review of investments 26
Portfolio executive summary 30
Baillie Gifford – valuing private companies 34
List of investments 41
Business review 45
Governance report
Directors and management 58
Directors’ report 61
Corporate governance report 66
Audit Committee report 73
Directors’ remuneration report 76
Statement of Directors’ responsibilities 80
Financial report
Independent Auditor’s report 83
Income statement 90
Balance sheet 91
Statement of changes in equity 92
Cash flow statement 93
Notes to the Financial Statements 94
Shareholder information
Notice of Annual General Meeting 113
Further shareholder information 118
Third party data provider disclaimer 120
Sustainable Finance Disclosure Regulation 121
Communicating with shareholders 122
Glossary of terms and alternative performance measures 124
Company information 129
01
Introduction
## Baillie Gifford US Growth:
## The American Dream made real
Financial highlights
Year to 31 May 2024
Total returns *
# †
Share price NAV Comparative index
## 32.9% 16.2% 24.8%
Share price, NAV and comparative index total return* Discount*
(figures rebased to 100 at 31 May 2023) (figures plotted at month end dates)
140
130 (15 %)
120
110 %)
100

|  | 90 |  |  |  | %) |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  | MAMFJDNOSAJJM |  |  | MAMFJDNOSAJJM |
|  |  | 2023 |  |  |  | 2023 |  |
|  |  | # | † |  |  |  |  |
| 150 (10%) |  |  |  |  |  |  |  |

* Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.
† The comparative index is the S&P 500 Index total return (in sterling terms).
# Net asset value per share (‘NAV’) with borrowings at fair value. At 31 May 2024 the NAV with borrowings at fair value was the same as the NAV with
(20 borrowings at book value. For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
Source: LSEG/Baillie Gifford and relevant underlying index providers. See disclaimer on page 120.
Past performance is not a guide to future performance.

| (25 |  | 02 | Annual Report and Financial Statements 2024 |  |
| --- | --- | --- | --- | --- |
|  |  |  |  | 2024 2024 |
|  | Discount NAV |  | Share price Comparative index |  |

Baillie Gifford US Growth Trust plc
03
Introduction
## Purpose and
## investment principles
Our purpose
## Baillie Gifford US Growth
Baillie Gifford US Growth aims to find, own and
## aims to deliver above
support the most exceptional public and private
growth companies in America.
## average long-term returns
We believe that our investment approach of
## for shareholders by
long termism, embracing asymmetry, and global
## keeping fees and costs perspective gives us an advantage in uncovering
exceptional growth companies. Our opportunity set
## low and harnessing the is wide given the Company’s structure means we can
invest in exceptional growth companies regardless of
## long-term growth potential
their listed status.
## of companies.
Exceptional growth companies address huge market
opportunities at an early stage, possess a sustainable
competitive edge and enjoy powerful and effective
cultures that enable them to realise their long-term
potential. We believe such companies contribute to
productive innovation in society and, over the full
course of time, these companies will develop deep
competitive moats and generate abnormal profits
and unusually high shareholder returns.
We endeavour to generate returns for our
shareholders by helping in the creation and
improvement of such useful enterprises. If we are
successful in identifying these companies, we believe
that we can multiply our shareholders’ wealth over
the long term.
04 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Our investment principles far more in a company if we are right than lose
if we are wrong, tells us that the costliest of
Managing shareholders’ money is a huge privilege
mistakes is excessive risk aversion.
and not one we take lightly. It is a relationship,
not a transaction. Relationships can only be built on
ș We do not believe that the index is the right
a foundation of trust and understanding. With this in
starting point for portfolio construction. The index
mind, we seek to lay out the fundamental principles
allocates capital based on size. We believe that
by which we will manage your money and the
capital should be allocated based on marginal
framework for how we make decisions so that you,
return and the ability to grow at those rates
our shareholders, can decide whether it aligns with
of return. Big companies are not immune to
your investment philosophy.
disruption. We do not manage the portfolio to
an active share target, but we expect the active
ș We believe the fundamental measure of our
share of the Company to be high.
success will be the value we create for our
shareholders over the long term. It is only
ș We are largely indifferent to a company’s private
over periods of five years or more that the
or public status. We will conduct diligent analysis
characteristics we look for in businesses
and allocate capital to where the highest returns
become apparent. Our turnover has been low,
are likely to be.
consistent with our time horizon. We ask that
ș We believe our duty is to maximise the long-term
our shareholders measure our performance over
wealth of our shareholders, and that placing
similar periods.
emphasis on short-term performance serves our
ș Short-term volatility is an inevitable feature of
shareholders poorly.
the market, and we will not manage the portfolio
ș We will endeavour to operate in the most
to reduce volatility at the expense of long-term
efficient, honest and economical way possible.
gain. Many managers are risk-averse and fear
That means keeping our ongoing costs
loss more than they value gain. Therefore, they
including management fees low. We recognise
accept smaller, more predictable risks rather
that even modest amounts, when allowed to
than the larger and less predictable ones.
compound over long periods of time, add up to
We believe that this is harmful to long-term
staggering sums, and we do not wish to dilute the
returns, and we will not shy away from making
compounding of returns with the compounding
investments that are perceived to be risky if we
of costs.
believe that the potential payoffs are worthwhile.
This means that our performance may be lumpy With this foundation, we aim to build Baillie Gifford
over the short term. US Growth Trust into a world-class savings vehicle.
We are grateful that you have joined us on this
ș We believe, and academic work has shown,
journey, and we look forward to a long and hopefully
that long-term equity returns are dominated by
prosperous relationship with you.
a small handful of exceptional growth companies
that deliver outsized returns. Most stocks do
not matter for long-term equity returns, and
investors will be poorly served by owning them.
In our search for exceptional growth companies,
we will make mistakes. But the asymmetry
inherent in equity markets, where we can make
05
## Strategic
## report
The Strategic report, which
includes pages 7 to 56 and
incorporates the Chair’s statement
has been prepared in accordance
with the Companies Act 2006.
Baillie Gifford US Growth Trust plc
## Chair’s
## statement
I am pleased to report an improvement in
performance during the financial year to
31 May 2024. The Company’s share price and net
asset value, calculated by deducting borrowings
at fair value, total returns were 32.9% and 16.2%
respectively. This compares with a total return of

|  | 24.8% for the S&P 500 Index |  | * (in sterling terms). |
| --- | --- | --- | --- |
| Tom Burnet | Over the period from 23 March 2018 (launch date |  |  |
| Chair | and first trade date), the Company’s share price and |  |  |
| Appointed | net asset value, calculated by deducting borrowings |  |  |
| Director and Chair | at fair value, returned 91.4% and 121.2% respectively |  |  |
| 5 March 2018 | compared to a total return of 152.0% for the |  |  |
|  | S&P 500 Index | * (in sterling terms). |  |

Further information about the Company’s portfolio
performance is covered by our portfolio managers,
Gary Robinson and Kirsty Gibson, in their
Managers’ review.
Share issuance and buy-backs
The Company’s shares moved from a discount of
22.4% at the start of the financial year to a discount
of 11.2% at 31 May 2024 as sentiment towards the
Company’s growth investing style and the investment
trust sector more generally improved. During the
financial year the Company deployed its buy-back
powers and 7,925,000 shares were bought back,
representing 2.6% of the Company’s issued share
capital at the start of the year. The Board recognises
the importance of the Company’s liquidity policy and
regularly discusses this topic at Board meetings.
As at 31 May 2024, the Company had authority,
which was granted at the 2023 Annual General
Meeting, to issue a further 30,515,370 shares and
to buy-back a further 45,742,539 shares. These
authorities expire in September 2024. The Company
will be seeking to renew both the issuance and
buyback authorities at the forthcoming Annual
General Meeting.
* Source: LSEG and relevant underlying index providers. See disclaimer on page 120.
For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
Past performance is not a guide to future performance.
07
Strategic report

## Gearing

The Company has two loan facilities in place. The US$25 million five-year revolving credit facility with ING Bank N.V., London Branch, which matured on 31 July 2023, was refinanced with a US$25 million three-year revolving credit facility from ING Bank N.V., London Branch on 26 July 2023. The US$25 million three-year fixed rate facility with ING Bank N.V., London Branch matured on 23 October 2023 and was refinanced with a US$25 million three-year revolving credit facility from The Royal Bank of Scotland International Limited on 18 October 2023. The facilities are available to be used to fund purchases of securities as and when suitable opportunities arise. As at 31 May 2024, the facilities had been drawn down in full (31 May 2023 – US$50 million). Net gearing fell from 6% to 5% over the course of the year.

## Earnings and dividend

The Company's priority is to generate capital growth over the long term. The Company therefore has no dividend target and will not seek to provide shareholders with a particular level of dividend. The net revenue return per share for the year to 31 May 2024 was a negative 2.07p (period to 31 May 2023, a negative 1.55p). As the revenue reserve is again running at a deficit, the Board is recommending that no final dividend be paid. Should the level of underlying income increase in future years, the Board will seek to distribute the minimum permissible to maintain investment trust status by way of a final dividend.

## Private company investments

As at the Company's year end, the portfolio weighting in private company investments stood at 34.1% of total assets, invested in 24 companies (2023 – 34.5% invested in 25 companies). There was one new purchase in the year, Human Interest, and Oddity listed during the period (the Convoy holdings were written off during the period subsequent to the company ceasing operations). There is commentary on the new and existing holdings in the Managers' review and the review of investments on pages 9 to 12 and 26 to 29. Your portfolio managers remain alert to further special and high potential opportunities not widely accessible through public markets.

## Environmental, Social and Governance (ESG) matters

The Company's Managers believe that sustainability is inextricably linked to being a long-term investor, and their thoughts on this topic are set out in more detail on page 14. The Managers' pursuit of long-term growth opportunities typically involves investment in entrepreneurial, disruptive and technology-driven businesses. These companies are often capital-light with a low carbon footprint.

## Annual General Meeting

The Annual General Meeting of the Company has been scheduled to be held at the offices of Herbert Smith Freehills in London (Exchange House, Primrose Street, London, EC2A 2EG) at 9.00am on Friday, 27 September 2024. All shareholders are invited to attend, and the Board looks forward to welcoming you. The meeting will be followed by a presentation from the Managers. I encourage shareholders to submit their votes by proxy before the applicable deadline ahead of the meeting and to submit any questions for the Board or Managers in advance by email to trustenquiries@bailliegifford.com or by calling 0800 917 2112 (Baillie Gifford may record your call).

## Outlook

In our last report I allowed myself to imagine that peaking interest rates might see valuations begin to recover during 2024. Clearly the Board is delighted that we have seen an improvement in our share price and a narrowing of our discount over the intervening period. Perhaps more importantly though, we continue to believe that the seismic changes in technology that underpin many of the companies we are invested in will continue and accelerate. We are at an inflexion point where many verticals, from transportation to drug discovery to communications and many others, are all ripe for disruption and we firmly believe that the portfolio of businesses we own includes many that will deliver outsize returns to long-term investors.

Tom Burnet  
Chairman  
21 August 2024

08 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Managers’
## review
In recent years, we have observed a marked shift
in emphasis among the companies in your portfolio.
There has been a pivot from prioritising growth
alone to embracing a more balanced approach that
incorporates both growth and profitability. In our
previous interim report, we characterised 2022
as the ‘year of reorientation’ and 2023 as the
Gary Robinson ‘year of execution’. We are now witnessing the
Portfolio manager
tangible benefits of this strategic shift, as evidenced
by the improved financial metrics across your
portfolio companies.
As of the end of March, 67% of the portfolio was
generating positive cash flow or positive earnings
per share (‘EPS’), a notable increase from 48% in
March 2023. Crucially, growth has remained robust
during this period of improving profitability. The
median revenue growth rate exceeded 18% over
the year to March 2024, significantly outpacing the
S&P 500 Index. This dual achievement – maintaining
Kirsty Gibson
strong growth while enhancing profitability – is a
Portfolio manager
testament to the quality and adaptability of our
chosen companies.
It is our view that many of your holdings are
emerging from the challenging post-Covid period
in a stronger position than when they entered it.
These businesses have not only addressed cost
bases that had become inflated during the pandemic
but have also evolved their strategies, organisational
structures and processes. Companies that were
buffeted by pandemic-induced demand fluctuations
have become leaner and more agile, positioning
themselves for higher profitability.
09
Strategic report
We see parallels between the current situation and The launch of ChatGPT at the end of 2022 brought
the period following the Global Financial Crisis. AI into the spotlight, and we believe this attention
Then, as now, many businesses faced unexpectedly is warranted. Indeed, recent advancements in AI
weak demand, with cyclical companies in the represent some of the most important technological
consumer discretionary and industrial sectors developments in a century. The internet and
particularly affected. However, we observed that mobile drove near universal access to computing
the most adaptable of these businesses emerged power. AI is rendering computers intelligent. It
from that period stronger. For instance, the is outperforming humans in certain tasks and is
multi-industrial business United Technologies improving at a remarkable rate. It has the potential to
Group, which we held in our American Fund, make large swathes of the economy more efficient.
achieved higher margins in 2011 than in 2008,
Our decision to reinvest in Meta (previously
despite sales not having fully recovered. The market
Facebook) last year was partly driven by our view
underestimated this recovery, leading to strong
that the company is uniquely placed to leverage AI.
share performance.
AI requires substantial financial resources and data,
A similar pattern is now unfolding with internet- both of which Meta possesses in abundance. The
focused companies. Consider Shopify, the company also boasts a strong engineering culture
ecommerce tools platform. Its free cash flow margin and appears well-positioned to attract top talent.
turned negative post-Covid as lockdown-driven
We see numerous parallels between Shopify’s
demand waned. However, following a period of
strategic shift and Meta’s ‘year of efficiency’. Both
reorientation, margins have recovered to prior peak
companies, compelled by necessity, streamlined
levels and could potentially surpass them this year.
their teams to address the complexities bred from
What drove Shopify to pursue such a rapid growth and to position themselves for the new
turnaround? While there was some pressure to cut AI paradigm. Mark Zuckerberg optimised Meta
costs given the shift in stock market sentiment, by trimming managerial layers, thus accelerating
the company was motivated by a more pressing decision-making. Like Shopify, he made the company
concern. Chief executive Tobi Lütke recognised that leaner by cancelling lower priority projects – the
artificial intelligence (‘AI’) would be key to Shopify’s aforementioned ‘side quests’. Zuckerberg shares
future, and he wanted to ensure the company was Lütke’s view that side quests can slow a company
well-positioned to capitalise on this opportunity. down. For instance, side quests require IT and HR
This required Shopify to become leaner to move support and, as these functions grow, they can
faster. Lütke insightfully noted that companies often become less responsive to the main mission.
become sluggish not due to their size, but because A leaner organisation, perhaps counterintuitively,
of an accumulation of ‘side quests’ – projects often executes faster.
adjacent to the main mission that don’t directly serve
AI is already beginning to impact Meta’s business.
it. While these may be manageable during stable
It was Meta’s use of AI that enabled it to successfully
economic times, they can hinder agility when the
navigate Apple’s ad-targeting rule changes a few
market landscape shifts.
years ago. Meta is also using AI to refine its content
In response, Shopify streamlined its operations, recommendation algorithm and has already seen
divesting its logistics business to focus on AI. The improvements in user engagement as a result.
company also eliminated unnecessary meetings and
Investments in AI are not inexpensive. Both Meta
cut bureaucracy, resulting in a one-third increase in
and Amazon have revised their capital expenditure
engineer productivity. Customer service efficiency
budgets upward due to their AI spending plans.
has also improved, with AI already assisting in over
However, this expenditure remains manageable in
half of customer service inquiries in the January
the context of their prodigious cash flows. Indeed,
– March quarter. Shopify is optimistic that AI will
Amazon’s margins are on an upward trend and, like
help contain costs while maintaining robust top-line
Shopify’s, are poised to exceed their prior peak
growth. The newly streamlined Shopify is emerging
levels in the coming years.
better positioned to exploit the product and cost
opportunities afforded by generative AI.
10 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
NVIDIA, another holding in your portfolio, has been cohorts from which Insulet and Inspire derive most
a key beneficiary of this AI spending boom. Its of their revenues are unlikely to be significantly
revenues grew by a remarkable 125% last year and impacted by GLP-1s. We had been following both
the shares responded accordingly. We reduced our businesses for some time and used this weakness
position earlier this year to reflect the change in as an opportunity to initiate positions.
risk-reward profile.
Other notable new holdings in the period include:
As mentioned, we believe Shopify and Meta have Guardant Health, a provider of molecular diagnostic
emerged from their periods of reorientation stronger tests for cancer; YETI, a consumer branded goods
and better positioned for the future. Block has company renowned for its durable coolers and
undergone a similar transformation over the past drinks containers; Sprout Social, a social media
year, which was one of the key motivations for our management platform; and Samsara, a provider of
recent investment. Block, which owns merchant telematics and safety technology for the trucking
software provider Square and financial app Cash industry.
App, has always been an exceptional product
We also made several complete sales during this
company. However, it historically lacked financial
period. We parted ways with communications
discipline, and this lack of focus had begun to impact
software provider Twilio, which had been
its pace of innovation. This appears to be changing.
underperforming for some time. The catalyst for this
Founder Jack Dorsey is now managing the business
sale was the departure of its founder, Jeff Lawson.
to stringent targets that balance both growth and
We also divested our position in videoconferencing
profitability. Employee numbers have been capped,
software company Zoom, which was struggling to
and he has restructured the company to refocus on
grow amidst fierce competition from Microsoft’s
its core mission. As a result, Block is now more agile
Teams. Other complete sales included Snap,
and seems poised to become significantly more
Chegg, Illumina, MarketAxess, Novocure, Redfin
profitable.
and Warby Parker.
One feature common to Shopify, Meta and Block,
While this may seem like a substantial list of
and indeed many of your other holdings, is the
changes, it’s important to note that your portfolio
presence of a founder-leader. It has long been
turnover remains low at 14%, consistent with our
our contention that founder-led businesses
five to ten-year holding period. This underscores
are more adaptable than average. This is partly
our commitment to long-term investing and our
because founders wield what Ben Horowitz calls
conviction in the companies we hold.
‘moral authority’ – the credibility necessary to
make substantial strategic changes. The rapid On the unlisted front, we made one additional
transformations we have witnessed at Shopify, investment during the year: Human Interest,
Meta and Block in response to changing market which helps small and medium-sized businesses
conditions are rare in non-founder-led businesses. offer retirement plans to their employees.
The IPO market is beginning to show signs of life,
Portfolio changes although volumes remain well below pre-pandemic
While AI has dominated recent headlines, it is levels. As mentioned in our interim report, one of
not the only disruptive force to have emerged in your holdings, online cosmetics company Oddity,
recent years. In the healthcare sector, a new class went public during the year. We anticipate that
of medicines called GLP-1s has created a stir due more of the private businesses in your portfolio will
to their ability to induce weight loss. While we do transition to public markets in the coming years.
not have direct exposure to manufacturers of these
At the end of the reporting period, the Company held
drugs, the excitement surrounding GLP-1s indirectly
24 private companies, which in aggregate comprised
led to the purchase of two new healthcare holdings:
34.1% of total assets. The allocation to private
Insulet, which produces pumps for treating diabetes,
companies is concentrated, with the top five private
and Inspire Medical Systems, which manufactures
companies comprising over half of the allocation,
surgical implants for sleep apnoea. Both stocks
and the top ten comprising over three-quarters.
experienced sell-offs due to fears that GLP-1s would
We have provided a summary of the operational
shrink their addressable markets. While diabetes
progress of the top ten private companies on pages
and sleep apnoea are linked to obesity, making this
38 to 40.
concern understandable, we believe that the patient
11
Strategic report
Outlook
The US remains a fertile hunting ground for
growth investors. Its companies are leading in new
technological paradigms like AI, just as they led
previous innovation waves such as the internet and
mobile. Our aim is to identify the most exceptional
amongst these companies and hold them for the
long term, thereby capturing the unique upside that
such companies offer. In our experience, one of the
key features that unites such firms is adaptability.
To endure and thrive over the long term, businesses
must be able to respond effectively to changing
market circumstances and technological paradigms.
The transformations we have witnessed at holdings
including Shopify, Meta, Block and, indeed, NVIDIA
over the past few years are extremely encouraging
in this context. They have demonstrated their
adaptability and are now better positioned for
the future.
The next cohort of generationally important
companies will share this ability to adapt, innovate
and position themselves for a rapidly evolving future.
It is our conviction that many such companies are
present in your portfolio, across both your public and
private holdings.
Markets have been volatile lately, reflecting
uncertainty about the future. We believe our investee
companies have the qualities necessary to navigate
through this uncertainty. The best companies create
opportunities for themselves, even in challenging
environments. We believe this feature is structurally
underappreciated by markets and exploitable by
patient investors.
As we look ahead, we remain excited about the
prospects for your portfolio and confident in our
ability to continue identifying and investing in the
companies that will shape the future of the global
economy.
US Equity Growth Team
Baillie Gifford & Co
21 August 2024
12 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
13
Strategic report
## Baillie Gifford’s
## stewardship principles
Baillie Gifford’s overarching ethos is that we are
‘Actual’ investors. That means we seek to invest for
the long term. Our role as an engaged owner is core
to our mission to be effective stewards for our clients.
As an active manager, we invest in companies at
different stages of their evolution across many
industries and geographies, and focus on their unique
circumstances and opportunities. Our approach
favours a small number of simple principles rather
than overly prescriptive policies. This helps shape our
interactions with holdings and ensures our investment
teams have the freedom and retain the responsibility
to act in clients’ best interests.
Long-term value creation Governance fit for purpose
We believe that companies that are run for the Corporate governance is a combination of structures
long term are more likely to be better investments and behaviours; a careful balance between systems,
over our clients’ time horizons. We encourage our processes and people. Good governance is the
holdings to be ambitious, focusing on long-term essential foundation for long-term company
value creation and capital deployment for growth. success. We firmly believe that there is no single
We know events will not always run according to governance model that delivers the best long-term
plan. In these instances we expect management outcomes. We therefore strive to push back against
to act deliberately and to provide appropriate one-dimensional global governance principles in
transparency. We think helping management to favour of a deep understanding of each company
resist short-term demands from shareholders often we invest in. We look, very simply, for structures,
protects returns. We regard it as our responsibility to people and processes which we think can maximise
encourage holdings away from destructive financial
the likelihood of long-term success. We expect to
engineering towards activities that create genuine
trust the boards and management teams of the
value over the long run. Our value will often be in
companies we select, but demand accountability
supporting management when others don’t.
if that trust is broken.
Alignment in vision and practice
Sustainable business practices
Alignment is at the heart of our stewardship
A company’s ability to grow and generate value for
approach. We seek the fair and equitable treatment
our clients relies on a network of interdependencies
of all shareholders alongside the interests of
between the company and the economy, society and
management. While assessing alignment with
environment in which it operates. We expect holdings
management often comes down to intangible factors
to consider how their actions impact and rely on these
and an understanding built over time, we look for
relationships. We believe long-term success depends
clear evidence of alignment in everything from
on maintaining a social licence to operate and look
capital allocation decisions in moments of stress
for holdings to work within the spirit and not just the
to the details of executive remuneration plans and
letter of the laws and regulations that govern them.
committed share ownership. We expect companies
Material factors should be addressed at the board
to deepen alignment with us, rather than weaken it,
level as appropriate.
where the opportunity presents itself.
14 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Baillie Gifford
## proxy voting
We believe that ‘active ownership’ of our clients’ Company meeting record
holdings is as important as selecting the right
investments in the first instance. These guidelines
are aligned with our stewardship principles and
describe our approach to proxy voting and company
engagement, the key levers of active ownership,
often described as ‘stewardship’.
While these guidelines are intended to provide an
insight into how we approach voting on our clients’
behalf, it is important to note that we assess every
company individually. In voting, we will always
evaluate proposals on a case-by-case basis, based
on what we believe to be in the best long-term
interests of our clients, rather than rigidly applying
a policy.
Number of meetings voted
100
A broad cross section of our investment staff are with management
involved in our ongoing work on stewardship. In the
Number of meetings with at least
14
same way that our investment approach is based one vote against, withhold or abstain
around empowered and independent teams, our
Meetings not voted –
voting and engagement is led by the individual
investment teams. In keeping with our decentralised
and autonomous culture, our investment teams will,
Voting distribution
on occasion, elect to vote differently on the same
general meeting resolutions. Where this happens, we
report accordingly in the proxy voting disclosure on
our website. We also have clear processes in place
to identify, prevent and manage potential proxy
voting-related conflicts of interest to ensure that in
all cases the firm acts in the clients’ best interest.
Baillie Gifford’s firm-wide conflict of interest
disclosure is available on our website at
bailliegifford.com
Prior to taking any voting action, we usually address
specific ESG concerns by engaging directly with the
company, using voting as an escalation mechanism
if we have not seen sufficient progress. Voting
activity and the reasons for any resolutions voted
Votes for 92.4%
against in the period is disclosed on the Company
Votes against 6.6%
website and can be viewed at bgusgrowthtrust.com
Votes abstained 1.0%
15
Strategic report
## Baillie Gifford environmental,
## social and governance
## engagement
By engaging with companies, we seek to build
constructive relationships with them, to better inform
our investment activities and, where necessary,
effect change within our holdings, ultimately with the
goal of achieving better returns for our shareholders.
The examples on the following pages demonstrate
our stewardship approach through constructive,
ongoing engagement.
Engagements in the year to 31 May 2024 Environmental Social Governance
10X Genomics
Affirm
Alnylam Pharmaceuticals
Amazon
Aurora Innovation
Cloudflare
CoStar Group
Coursera
Guardant Health
HashiCorp
Moderna
Netflix
NVIDIA
Penumbra
Pinterest
Rivian Automotive
Roblox
Roku
Solugen
Shopify
Snowflake
Sprout Social
Sweetgreen
Tesla
The Trade Desk
Watsco
Wayfair
Workday
16 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Guardant Health
Objectives
In March 2024, we met with the co-Founders and
co-CEOs of Guardant Health, Helmy Eltoukhy
and AmirAli Talasaz. We wanted to deepen our
relationship with the founders and further explore
their long-term strategy to grow Guardant’s liquid
biopsy business.
Discussions Outcomes
The discussion was wide ranging. Areas of focus Overall, we gained a greater understanding of
included: how Guardant could grow the therapy Guardant’s market opportunity, the approach of the
selection part of the business to expand across the co-founders, as well as some further insight into
patient journey, rather than the single point it is used the culture they foster at the company. The meeting
at today; the company’s international expansion served to deepen our relationship in what we
plans; and the potential scale and opportunity of its hope to be a multi-year investment and was thesis
screening business, which could be revolutionary supportive.
but is at an early stage. In particular, we explored the
FDA approval pathway for it to become reality.
17
Strategic report
Solugen
Objectives
We spent several days visiting Solugen’s headquarters
in Houston, Texas in September 2023. As mentioned
last year, we have an observer board seat at
Solugen, which helps us gain significant insight
into the company’s progress. The purpose of this
visit was to see how this progress is translating
into action on the ground. We were taken on a tour
of various manufacturing facilities by the chief
technical officer and co-founder, Sean Hunt.
Discussions Outcomes
Sean Hunt showed us much of the original This visit served to enhance our understanding
manufacturing equipment and the control room of Solugen’s processes and potential competitive
for Solugen’s innovative bioforge in Houston. advantages as well as confirm its progress in
The bioforge is a biomanufacturing platform to developing the next generation of sustainable
produce organic acids (used in concrete, cleaning, chemical production. The Houston bioforge is the
agricultural and energy industries) via a novel proof of concept that helped Solugen to recently
technology that leverages enzymes and metal win a contract with the US Department of Energy
catalysts. The highly efficient production process to begin construction of a second, larger bioforge
has significantly lower carbon emissions and higher in Marshall, Minnesota.
yield than existing methods of chemical production.
Solugen’s bioforge in Houston has been operating
since 2021. We also visited the bioforge itself and
were taken through the groundbreaking process the
company has developed.
18 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
CoStar Group
Objectives
CoStar provides information, analytics and online
marketplaces to the commercial real estate industry
in North America and the UK. The objective of our
meeting in August 2023 was to explore aspects
of sustainability most material to CoStar, namely,
human capital, social issues and data privacy.
Discussions Outcomes
CoStar balanced people’s needs and the imperative Through ongoing discussions with company
for growth during our discussion about human leadership, it has become clear that CoStar sees
capital and social issues. They believe the answer to human capital, social and data privacy issues
these concerns can be found in people leadership. as among the most material to the long-term
The board spends a lot of time on strategy sustainability of their businesses. We agree.
alongside acquisitions and integrations, while the
This was another positive conversation. CoStar
head of HR presents to CoStar’s board at least
has been proactive in reaching out to us on many
twice yearly. CoStar also conducted a materiality
topics, and we invited them to continue to do so.
assessment several years ago, identifying attrition
We will follow CoStar’s progress through future
and engagement as concerns. They believe they
engagements.
have addressed some of this as attrition rates have
fallen and engagement scores have subsequently
risen. Data privacy has always been on top of
CoStar’s priority list due to its large dataset,
which is a source of competitive advantage. The
engagement highlighted CoStar’s continued focus
on strengthening its data and cyber security as it
integrates AI further into its business.
19
Strategic report
## One year
## summary
31 May 2024 31 May 2023 % change

| Shareholders’ funds | # |  | £643.9m £568.6m 13.2 |  |
| --- | --- | --- | --- | --- |
| Gearing* |  |  |  | 5% 6% |
| Net asset value per ordinary share |  | ‡ | 216.65p 186.48p 16.2 |  |

Share price 192.40p 144.80p 32.9
Comparative index (in sterling terms) † 24.8
Ongoing charges* 0.70% 0.69%
Discount* 11.2% 22.4%
Active share (relative to S&P 500 Index)* 86% 92%
Number of shares in issue 297,228,700 305,153,700
Market capitalisation £571.9m £441.9m
Year to 31 May 2024 2023
Total returns (%)*
Net asset value 16.2% (2.7%)
Share price 32.9% (13.8%)
Comparative index (in sterling terms) † 24.8% 4.7%
* Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.
† S&P 500 Index total return (in sterling terms). See disclaimer on page 120.
# For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
‡ Net asset value per share (‘NAV’) with borrowings at fair value. At 31 May 2024 the NAV with borrowings at fair value was the same as the NAV with
borrowings at book value. For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
Source: LSEG/Baillie Gifford and relevant underlying index providers. See disclaimer on page 120.
Past performance is not a guide to future performance.
20 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

|  Year to 31 May | 2024 | 2024 | 2023 | 2023  |
| --- | --- | --- | --- | --- |
|  Year's high and low | High | Low | High | Low  |
|  Net asset value per ordinary share‡ | 228.97p | 176.10p | 223.16p | 169.35p  |
|  Share price | 204.00p | 135.6p | 197.00p | 132.80p  |
|  Discount* | 9.6% | 24.5% | 9.7% | 23.7%  |

|   | 2024 | 2023  |
| --- | --- | --- |
|  Net return per ordinary share |  |   |
|  Revenue | (2.07p) | (1.55p)  |
|  Capital | 31.73p | (3.56p)  |
|  **Total** | **29.66p** | **(5.11p)**  |

* Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.

‡ Net asset value per share ('NAV') with borrowings at fair value. At 31 May 2024 the NAV with borrowings at fair value was the same as the NAV with borrowings at book value. For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.

Source: LSEG/Baillie Gifford and relevant underlying index providers. See disclaimer on page 120.

Past performance is not a guide to future performance.

21
Strategic report

# Five year summary

The following charts indicate how an investment in Baillie Gifford US Growth has performed relative to its comparative index and its underlying net asset value over the five year period to 31 May 2024.

**Total return* performance**
(figures rebased to 100 at 31 May 2019)

![img-0.jpeg](img-0.jpeg)

**Premium/(discount)* to net asset value**
(figures plotted on a monthly basis)

![img-1.jpeg](img-1.jpeg)

* Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.

† S&P 500 Index total return (in sterling terms). See disclaimer on page 120.

Source: LSEG/Baillie Gifford and relevant underlying index providers. See disclaimer on page 120.

Past performance is not a guide to future performance.

22 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Annual net asset value and share price total return * Relative annual net asset value and share price
total return *
(after deducting borrowings at fair value)
(relative to the comparative index † total return)
25%
50%
0%
0%

|  | 2020 | 2021 2022 2023 |  | 2024 |  | 2020 | 2021 2022 2023 |  | 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Years to 31 May |  |  |  |  | Years to 31 May |  |
| NAV per share return ● Share price return |  |  |  |  | NAV per share return ● Share price return |  |  |  |  |

Active share * Portfolio turnover *
(compared to the comparative index † ) (plotted on a quarterly basis)
80%
60%
40%
10%
20%

| 0% |  |  |  | 0% |  |  |
| --- | --- | --- | --- | --- | --- | --- |
|  | 2019 | 2020 | 2021 2022 2023 |  | 2019 2020 2021 2022 2023 |  |
|  |  |  | Years to 31 May |  |  | Years to 31 May |
| Active share |  |  |  | Turnover |  |  |

100% 30% 100% 50%
20%
* Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.
(25%)
† S&P 500 Index total return (in sterling terms). See disclaimer on page 120.
Source: LSEG/Baillie Gifford and relevant underlying index providers. See disclaimer on page 120.
(50%)
Past performance is not a guide to future performance.

| (50%) (75%) |  |  |
| --- | --- | --- |
|  | 2024 2024 | 23 |
| ● ● ● ● |  |  |

Strategic report
## Summary of results
## *
## since inception
Capital
Shareholders’
funds/net

|  |  |  |  |  |  |  |  | asset value |  |  | Net asset |  |  |  | Premium/ |  | Premium/ |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Total |  |  | Shareholders’ |  |  | (book) |  | value (fair) |  | Share |  | (discount) |  | (discount) |  |  |
|  |  |  | assets | Borrowings |  |  | funds | per share |  |  | per share | † | price |  | (book) | † |  | (fair) | † |
| At 31 May |  |  | £’000 |  | £’000 |  | £’000 |  |  | p |  | p |  | p |  | % |  |  | % |
| 23 March |  | 169,466 – 169,466 97.96 97.96 100.50 2.6 2.6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| 2018 | # |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

2019 301,830 11,901 289,929 126.17 126.17 129.00 2.2 2.2
2020 490,762 14,560 476,202 181.92 181.92 189.00 3.9 3.9
2021 935,222 26,339 908,883 296.21 296.12 308.00 4.0 4.0
2022 623,860 39,674 584,186 191.44 191.63 168.00 (12.2) (12.3)
2023 608,941 40,342 568,599 186.33 186.48 144.80 (22.3) (22.4)
2024 683,204 39,271 643,933 216.65 216.65 192.40 (11.2) (11.2)
Revenue Gearing ratios
Revenue
earnings

|  |  |  |  | Net return |  | per ordinary |  |  | Ongoing |  |  |  |  | Gross |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Period/year |  | Income |  | after tax |  |  | share |  | charges | † | Gearing | † | gearing |  | † |
| to 31 May |  | £’000 |  |  | £’000 |  |  | p ‡ |  | % |  | % |  |  | % |
| 2019 | ¶ |  | 699 (2,054) (1.09) 0.77 2 4 |  |  |  |  |  |  |  |  |  |  |  |  |

2020 595 (2,555) (1.05) 0.75 (1) 3
2021 648 (5,066) (1.78) 0.68 1 3
2022 568 (5,781) (1.88) 0.62 6 7
2023 850 (4,718) (1.55) 0.69 6 7
2024 603 (6,282) (2.07) 0.70 5 6
* For a definition of terms used see Glossary of terms and alternative performance measures on pages 124 to 127.
† Alternative performance measure. See Glossary of terms and alternative performance measures on pages 124 to 127.
# Close of business on 23 March 2018, launch date and first trade date.
‡ The calculation of revenue earnings per share is based on the revenue from ordinary activities after taxation and the weighted average number of
ordinary shares in issue (see note 7 to the Financial Statements on page 98).
¶ For the period 7 February 2018, date of incorporation of the Company, to 31 May 2019.
Past performance is not a guide to future performance.
24 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Cumulative performance (taking 23 March 2018 as 100)
At 31 May Net asset value (fair) total return † Share price total return † Comparative index total return §
23 March 2018 # 100 100 100
2019 129 128 122
2020 186 188 141
2021 302 306 172
2022 196 167 193
2023 190 144 202
2024 221 191 252
† Alternative performance measure. See Glossary of terms and alternative performance measures on pages 124 to 127.
# Close of business on 23 March 2018, launch date and first trade date.
§ S&P 500 Index total return (in sterling terms). Source: LSEG and relevant underlying index providers. See disclaimer on page 120.
Absolute performance

|  |  | 1 year |  | 3 years |  | 5 years |  | Since inception |  | # |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | % |  | % |  | % |  |  | % |
| Share price |  | 32.9 |  | (37.5) |  |  | 49.1 |  | 91.4 |  |
| NAV | ‡ |  | 16.2 (26.8) 71.7 121.2 |  |  |  |  |  |  |  |

Comparative index* 24.8 46.5 106.2 152.0
All figures are stated on a total return basis † for the period to 31 May 2024.
* Comparative index: S&P 500 Index (total return and in sterling terms).
† Alternative performance measure – see Glossary of terms and alternative performance measures on pages 124 to 127.
# Close of business on 23 March 2018, launch date and first trade date.
‡ Net asset value per share (‘NAV’) with borrowings at fair value. At 31 May 2024 the NAV with borrowings at fair value was the same as the NAV with
borrowings at book value. For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
Source: Baillie Gifford/LSEG and relevant underlying index providers. See disclaimer on page 120.
Past performance is not a guide to future performance.
25
Strategic report
## Review of
## investments
Top ten holdings
A review of the Company’s
ten largest investments and
additions to the private company
investments as at 31 May 2024.
© Copyright (c) 2022 Nor Gal/Shutterstock© SpaceX

| Space Exploration | NVIDIA |
| --- | --- |
| Technologies | NVIDIA designs and manufactures |
| An aerospace and space | graphics processing units for the |
| transportation company that | gaming and professional markets. |
| manufactures advanced rockets, | They are highly specialised |
| like the Falcon 9, and satellites, | semiconductor chips that can be |
| like Starlink, which provides | used for a range of applications, |
| global broadband services. We are | from gaming to artificial intelligence |
| excited by its pursuit of reduced | (‘AI’). After years of investment |
| launch costs, thus opening | into both hardware and software, |
| avenues for growth, such as | NVIDIA is well positioned to benefit |
| tourism and transportation. A clear | from the rise of generative AI, as |
| segment leader, it looks positioned | its chips form the infrastructure |
| to capture an attractive share of | layer to power large language |
| the growing space industry, while | models. NVIDIA is using its scale to |
| Starlink may become the first | further reinvest in its opportunity; |
| globally relevant utility. | designing new hardware to make |

data centres more powerful and
energy efficient, while building
software to help companies adopt
AI more quickly.

| Valuation at | £51,864,000 |  | Valuation at | £44,715,000 |
| --- | --- | --- | --- | --- |
| 31 May 2024 |  |  | 31 May 2024 |  |
| % of total assets* 7.6% |  |  | % of total assets* 6.5% |  |
| Valuation at | £39,220,000 |  | Valuation at | £24,334,000 |
| 31 May 2023 |  |  | 31 May 2023 |  |
| % of total assets* 6.5% |  |  | % of total assets* 4.0% |  |
| Net purchases/(sales) |  | Nil | Net purchases/(sales) | (£1,399,000) |
| in the year |  |  | in the year |  |

Denotes private company investment.
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
26 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
© Stripe

| Amazon |  | The Trade Desk |  | Stripe |  |  |
| --- | --- | --- | --- | --- | --- | --- |
| In retail, Amazon competes on |  | The advertising industry is |  | Stripe is a payments technology |  |  |
| price, selection and convenience |  | undergoing a wholesale shift. In the |  | company. Founded in 2010 by Irish |  |  |
| and is improving all three as |  | past advertising was bought and |  | brothers Patrick and John Collison, |  |  |
| it gets bigger. Amazon’s AWS |  | sold in bundles. In the digital world, |  | the company is in the process of |  |  |
| (Amazon Web Services) division |  | advertising can be transacted on |  | developing a platform for sending |  |  |
| is in a clear position of leadership |  | a one-to-one basis, targeting only |  | money seamlessly and compliantly |  |  |
| in what could turn out to be one |  | the audiences that are relevant. |  | between any two internet- |  |  |
| of the largest and most important |  | The Trade Desk provides the |  | connected nodes in the world. |  |  |
| market shifts of our time. Both |  | technology that enables this |  | The company processes massive |  |  |
| opportunities are outputs of what |  | targeted buying of advertising |  | volumes of payments from a broad |  |  |
| is perhaps most distinctive of all |  | through real-time auctions. |  | customer base, ranging from US |  |  |
| about Amazon – its culture. The |  | This is known as programmatic |  | start-ups to global giants. Stripe’s |  |  |
| company is run with a uniquely |  | advertising. Programmatic |  | long-term ambition is to make |  |  |
| long-term perspective. It is |  | advertising is growing rapidly, |  | entrepreneurship easier and thus |  |  |
| willing to be bold and scale its |  | supported by higher efficacy and |  | significantly increase the amount |  |  |
| experiments (and failures) as it |  | a tangible demonstration of return |  | of business conducted online. |  |  |
| grows. These cultural distinctions |  | on investment. We believe that |  |  |  |  |
| allow Amazon to possess the rare |  | The Trade Desk will emerge as the |  |  |  |  |
| and attractive combination of scale |  | leading buying platform for the |  |  |  |  |
| and immaturity. |  | independent internet. |  |  |  |  |
| Valuation at | £35,710,000 | Valuation at | £34,288,000 | Valuation at | £32,007,000 |  |
| 31 May 2024 |  | 31 May 2024 |  | 31 May 2024 |  |  |
| % of total assets* 5.2% |  | % of total assets* 5.0% |  | % of total assets* 4.6% |  |  |
| Valuation at | £22,361,000 | Valuation at | £32,448,000 | Valuation at | £25,681,000 |  |
| 31 May 2023 |  | 31 May 2023 |  | 31 May 2023 |  |  |
| % of total assets* 3.7% |  | % of total assets* 5.3% |  | % of total assets* 4.2% |  |  |
| Net purchases/(sales) | £3,626,000 | Net purchases/(sales) | (£1,040,000) | Net purchases/(sales) |  | Nil |
| in the year |  | in the year |  | in the year |  |  |

Denotes private company investment.
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
27
Strategic report
© DIEGO AZUBEL/EPA-EFE/Shutterstock© Shutterstock / Melnikov Dmitriy

| Meta Platforms | Moderna | Netflix |
| --- | --- | --- |
| Meta Platforms is the owner | Moderna is a leader in the field | Netflix has the potential to |
| of Facebook, WhatsApp and | of mRNA therapeutics. mRNA is | become the first truly global |
| Instagram. We think that AI could | a foundational technology that | content and distribution media |
| be a significant growth driver. In | theoretically has the potential | brand. Its base of more than |
| the nearer term, it should facilitate | to induce the production of just | 230 million subscribers allows |
| revenue growth as AI systems | about any protein – human or | it to invest in building a strong |
| allow adverts to be targeted | non-human – inside our cells. This | customer proposition through its |
| more effectively despite Apple’s | versatility opens up a wide range | library of exclusive and desirable |
| privacy restrictions. Facebook | of therapeutic opportunities for | content. This in turn attracts more |
| may be unique in having the | mRNA. mRNA is in a sense digital, | subscribers, creating a powerful |
| engineering resources to take | and is therefore programmable. | flywheel that distances itself |
| advantage of this opportunity. The | In moving from one drug to the | from other likely competitors. |
| company addressed its cost base | next, the delivery mechanism | The shift from linear TV to on- |
| last year, leaving it well-placed | and building blocks remain the | demand streaming is still in the |
| to take on this challenge. In the | same. The only thing that changes | early stages, and Netflix is a prime |
| longer term, AI should facilitate | is the code. Because of this, | beneficiary. |
| the monetisation of WhatsApp, a | Moderna’s mRNA platform ought |  |
| platform that enjoys widespread | to be more scalable than past |  |
| usage but has struggled to find a | drug development approaches. |  |
| revenue model. | Moderna may have more in |  |

common with a software company
than a biotech business.

| Valuation at | £25,369,000 |  | Valuation at | £23,506,000 |  | Valuation at | £23,441,000 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 31 May 2024 |  |  | 31 May 2024 |  |  | 31 May 2024 |  |
| % of total assets* 3.7% |  |  | % of total assets* 3.4% |  |  | % of total assets* 3.4% |  |
| Valuation at |  | – | Valuation at | £21,025,000 |  | Valuation at | £17,247,000 |
| 31 May 2023 |  |  | 31 May 2023 |  |  | 31 May 2023 |  |
| % of total assets* – |  |  | % of total assets* 3.5% |  |  | % of total assets* 2.8% |  |
| Net purchases/(sales) | £18,391,000 |  | Net purchases/(sales) |  | £973,000 | Net purchases/(sales) | (£1,588,000) |
| in the year |  |  | in the year |  |  | in the year |  |

* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
28 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Private company new buy
© NetPhotos/Alamy Stock Photo
Shopify Brex Human Interest
Shopify provides software tools Brex is building an all-in-one Human Interest is a digital
which allow merchants to easily set platform for businesses to manage retirement account manager giving
their finances. It started by offering
up and manage their businesses SME employers the ability to offer
a corporate card for venture-
across an increasingly complex employees 401(k) pension and
backed business. It has expanded
and fragmented retail landscape. IRA (individual retirement
into larger businesses and is now
Shopify’s software helps to account) plans. This is a massively
offering a broader suite of products
make merchants more efficient underserved part of the market
including business accounts,
by automating large swathes of – 50% of American households
expense management and bill
their operations (e.g. marketing, have no retirement accounts. The
pay software. Existing options are

| inventory management, payments, | expensive and do not work well | possibilities of real-time payroll |
| --- | --- | --- |
| order processing, shipping) thus | with one another. Brex is aiming to | SaaS (software as a service) |
| allowing them to focus on product | build a fully integrated suite which | integrations enable automated |
| market fit. The company maintains | will act as the financial operating | and therefore very low cost 401(k) |
| a rapid pace of innovation and is | system for growing businesses. Its | administration. Human Interest |

business model and approach have
run by an impressive founder who has become the clear leader in the
demonstrated strong alignment
has built a distinctive merchant space. It has: a large end market;
with its customers, a rarity in
focused culture. a rapidly growing product that has
this sector. This customer focus,
a plausible regulatory tailwind; a
coupled with the strength of the
business model that shows clear
founding team and breadth of their
signs of operating leverage; and
ambition, leave Brex well placed to
a decent argument for business
exploit this opportunity.
model innovation against the
incumbents.

| Valuation at | £21,747,000 | Valuation at | £20,666,000 |  | Valuation at | £4,713,000 |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 31 May 2024 |  | 31 May 2024 |  |  | 31 May 2024 |  |  |
| % of total assets* 3.1% |  | % of total assets* 3.1% |  |  | % of total assets* 0.7% |  |  |
| Valuation at | £33,135,000 | Valuation at | £15,624,000 |  | Valuation at |  | – |
| 31 May 2023 |  | 31 May 2023 |  |  | 31 May 2023 |  |  |
| % of total assets* 5.4% |  | % of total assets* 2.6% |  |  | % of total assets* – |  |  |
| Net purchases/(sales) | (£5,042,000) | Net purchases/(sales) |  | Nil | Net purchases/(sales) | £4,658,000 |  |
| in the year |  | in the year |  |  | in the year |  |  |

Denotes private company investment.
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
29
Strategic report
## Portfolio executive
## summary
Key contributors to and detractors from performance – year to 31 May 2024

|  | Contribution to |  | Absolute |  |  | Contribution to | Absolute |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | absolute performance |  | performance |  |  | absolute performance | performance |  |
| Contributors | % * |  | % | † | Detractors | % * | % | † |
| NVIDIA 6.4 182.7 |  |  |  |  | Convoy (1.3) (100.0) |  |  |  |
| Space |  | 2.0 32.2 |  |  | Novocure (1.0) (80.0) |  |  |  |

Exploration
Denali (0.4) (40.2)
Technologies
Therapeutics
Amazon 1.9 42.4

|  | Indigo | (0.4) (94.5) |
| --- | --- | --- |
| Netflix 1.6 58.0 | Agriculture |  |
| DoorDash 1.4 64.1 | Solugen | (0.4) (19.2) |

* Contribution to absolute performance (in sterling terms) has been calculated to illustrate how an individual stock has contributed to the overall return.
It is influenced by both share price performance and the weighting of the stock in the portfolio, taking account of any purchases or sales over the period.
† Absolute performance (in sterling terms) has been calculated on a total return basis over the period 1 June 2023 to 31 May 2024.
For the definition of total return see Glossary of terms and alternative performance measures on pages 124 to 127. Table ordered by contribution
to performance.
Denotes private company investment.
Source: Revolution.
Distribution of total assets * by sector 2024
Industry 2024 2023
% %
6
1 Information technology 29.9 31.3
1
2 Consumer discretionary 19.0 18.8
5
3 Communication services 15.6 11.7
4 Industrials 12.5 16.2
5 Healthcare 12.1 13.7
4 6 Financials 6.2 3.9
7 Real estate 1.6 0.3
2 8 Materials 1.4 2.3
3 9 Consumer staples 1.0 1.3
10 Net liquid assets 0.7 0.5
Source: Baillie Gifford/LSEG and relevant underlying index providers. See disclaimer on page 120.
* For a definition of terms see Glossary of terms and alternative performance measures on pages 124 to 127.
30 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
New buys Additions
Block Amazon Pinterest
Guardant Health Aurora Innovation Roblox
Human Interest BillionToOne Sana Biotechnology
Inspire Medical Systems Cloudflare Sweetgreen
Insulet Coursera
Meta Platforms Databricks
Samsara Doximity
Sprout Social Honor Technology
YETI Holdings Moderna
ReductionsComplete sales

| Convoy | * | 10X Genomics | HashiCorp | Snowflake |
| --- | --- | --- | --- | --- |
| Chegg |  | Affirm | Lemonade | Tesla |
| Illumina |  | Alnylam Pharmaceuticals | Netflix | The Trade Desk |
| MarketAxess |  | Chewy | NVIDIA | Watsco |
| Novocure |  | CoStar Group | Oddity | Wayfair |
| Redfin |  | Datadog | Penumbra | Workday |
| Snap |  | Denali Therapeutics | Recursion Pharmaceuticals |  |
| Twilio |  | DoorDash | Rivian Automotive |  |
| Warby Parker |  | Duolingo | Roku |  |
| Zoom Video Communications |  | Ginkgo Bioworks | Shopify |  |

Assets highlighted in bold indicate an investment decision.
* The Convoy holdings were written off during the period subsequent to the company ceasing operations.
Denotes private company investment.
Denotes listed investment previously held in the portfolio as a private company investment.
31
Strategic report
Growth drivers 2024
The illustration below groups companies by the long-term growth drivers identified during investment
research. This is a subjective process, but we believe it is more consistent with our view that the real
risk in the portfolio lies in the growth opportunities identified for individual companies not playing out,
rather than how index providers choose to classify companies.
Inspire 10x Genomics
Lyra Health Doximity
Insulet
Rivian Data meets
Devices
Honor
PsiQuantum Nuro Healthcare
3.5%
Zipline
3.4%
Workday Tanium Evolution of Perumbra Capsule
Guardant
Innovation

|  |  |  |  |  | Transportation |  |  |  | BillionToOne |  | Recursion |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  | Healthcare |  | Pharmaceuticals |  |
|  |  |  |  | Samsara |  | 6.3% |  |  |  |  |  |
|  |  |  |  |  |  |  | Convoy | 11.8% |  |  |  |
|  |  | New | Datadog |  |  |  |  |  |  |  |  |
| Databricks | Enterprise |  |  |  |  |  | TeslaAurora |  |  |  |  |
|  |  | 17.2% | Cloudflare |  |  |  |  |  |  |  |  |

Therapies

| Watsco |  |  |  | Snyk |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | HashiCorp |  |  |  |  |  |  |  |  |  | (Development Stage) |  |  |  |  |
| Capital |  |  |  |  | Snowflake |  |  |  |  |  |  |  |  |  |  |  | Alnylam |
|  |  |  |  |  |  |  | Sprout Social |  |  |  |  |  |  | 0.7% |  |  |  |
| Allocators |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Pharmaceuticals |  |
| 2.9% |  |  |  |  |  |  |  |  | Niantic |  |  |  |  | Denali |  |  |  |
|  |  |  | Amazon.com |  |  | NVIDIA |  |  |  |  | Industrialisation |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Therapeutics |  | Therapies |  |
| YETI |  |  |  |  |  |  |  | Roku |  |  |  |  |  |  |  |  |  |
|  | CoStar |  |  |  |  |  |  |  |  |  |  | of Biology |  |  |  |  |  |
|  |  | Away (JRSK) |  |  |  |  |  |  |  | Netflix |  |  |  |  | (Commercial Stage) |  |  |

Roblox
Battle for 1.4% Sana
4.2%
Thumbtack Biotechnology
The Trade Desk
Our Attention Solugen
Moderna
Shopify 16.4% Discord Indigo
Sweetgreen
Pinterest Agriculture
Meta Ginkgo
Future of Epic Games BioWorks
Wayfair Brex
Commerce
Block
22.7% Lemonade
Faire Wholesale
Workrise
Digitisation
of Finance

|  | Oddity |  | Coursera |  |  |
| --- | --- | --- | --- | --- | --- |
| Chewy Airbnb |  | SpaceX |  | 10.8% |  |
|  |  |  | Change in |  | Stripe |

Human Interest

| DoorDash | Commercialisation |  | Education |  |
| --- | --- | --- | --- | --- |
|  |  | of Space | 2.0% | Blockstream |
|  |  | 7.6% | Duolingo |  |

This thematic risk analysis is reflective of the Managers’ views. Companies may appear in more than one circle if they are exposed to the same thematic
risk. Figures represent percentage of total investments excluding cash.
Source: Baillie Gifford.
32 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
33
Strategic report

# Baillie Gifford – valuing private companies

We hold our private company investments at 'fair value' i.e. the price that would be paid in an open-market transaction. Valuations are adjusted both during regular valuation cycles and on an ad hoc basis in response to 'trigger events'. Our valuation process ensures that private companies are valued in both a fair and timely manner.

The valuation process is overseen by a valuations group at Baillie Gifford, which takes advice from an independent third party (S&P Global). The valuations group is independent from the investment team with all voting members being from different operational areas of the firm, and the portfolio managers only receive final notifications once they have been applied.

We revalue the private holdings on a three-month rolling cycle, with one third of the holdings reassessed each month. During stable market conditions, and assuming all else is equal, each investment would be valued four times in a twelve-month period. For investment trusts, the prices are also reviewed twice per year by the respective investment trust boards and are subject to the scrutiny of external auditors in the annual audit process.

Beyond the regular cycle, the valuations team also monitors the portfolio for certain 'trigger events'. These may include: changes in fundamentals; a takeover approach; an intention to carry out an Initial Public Offering ('IPO'); company news which is identified by the valuation team or by the portfolio managers; or meaningful changes to the valuation of comparable public companies. Any ad hoc change to the fair valuation of any holding is implemented swiftly and reflected in the next published net asset value.

The valuations group also monitors relevant market indices on a weekly basis and updates valuations in a manner consistent with our external valuer's (S&P Global) most recent valuation report where appropriate.

Periods of market volatility during the year have meant that valuations continue to be reviewed much more frequently, in some instances resulting in a further valuation movement. The data below quantifies the revaluations carried out during the year to 31 May 2024, but does not reflect the ongoing monitoring of the private investment portfolio that has not resulted in a change in valuation.

## Baillie Gifford US Growth Trust*

|  Instruments held | 56  |
| --- | --- |
|  Number of revaluations | 288  |
|  Percentage of portfolio valued up to 4 times | 30.4%  |
|  Percentage of portfolio valued 5+ times | 69.6%  |

* Data reflecting period 1 June 2023 to 31 May 2024 to align with the Company's reporting period end.

Whilst pockets of heightened volatility remain, the general improvement in market sentiment is reflected in the private company valuations at 31 May 2024. The average movement in company valuations and share prices across the portfolio are shown below.

|   | Average movement in company valuation | Average movement in share price  |
| --- | --- | --- |
|  Baillie Gifford US Growth Trust* | 15.7% | 22.2%  |

* Data reflecting period 1 June 2023 to 31 May 2024 to align with the Company's reporting period end.

34 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

## Private companies summary

### Historical snapshot

Since our first investment in private companies in 2018, Baillie Gifford US Growth has deployed £242.5m of capital in this area.

![img-2.jpeg](img-2.jpeg)

### Transaction value

Showing all transactions prior to 31 May 2024 (£'000).

(Graph plotted in calendar years)

![img-3.jpeg](img-3.jpeg)

### Portfolio activity – year to 31 May 2024

£8.2m of new capital was deployed in private companies during the year.

#### New buys

Human Interest

#### Follow on funding rounds

BillionToOne

Databricks

Honor Technology

Oddity listed during the period. Subsequent to Convoy ceasing operations the holdings in it were written off during the year (see note 9 of the Financial Statements on page 100).

### Concentration

At 31 May 2024 we held 24 private companies which equated to 34.1% of total assets.

- Five companies account for 57.3% of the private company exposure.
- Ten companies account for 78.1% of the private company exposure.

![img-4.jpeg](img-4.jpeg)

All figures stated as percentage of total assets, as at 31 May 2024.

35
Strategic report

|  |  | Private exposure 31 May 2024 |  | 31 May 2023 |  |
| --- | --- | --- | --- | --- | --- |
|  |  |  | % |  | % |
| 1 | 1 Space Exploration Technologies 7. 6 6.5 |  |  |  |  |

2 Stripe 4.6 4.2
3 Brex 3.1 2.6
6
4 Zipline 2.1 2.3
5 Faire Wholesale 1.9 2.2
2
6 Other 14.8 16.7
3
5 4
Performance of listed holdings at 31 May 2024 held previously as private company investments from date of
initial investment of each holding to 31 May 2024
(absolute performance in sterling terms %)
Affirm
Airbnb
Aurora
Ginkgo Bioworks
Oddity
Snowflake
400(100) 0 200100 300
● Absolute performance from initial investment to initial public offering %
● Absolute performance from initial public offering to 31 May 2024 %
● Total absolute performance from initial investment to 31 May 2024 %
Source: Revolution/Baillie Gifford.
Note: Absolute performance returns cannot be added together as they are geometric.
36 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

## Private company investments and listed investments previously held as private company investments as a percentage of total assets*

(plotted quarterly from March 2018)

![img-5.jpeg](img-5.jpeg)

Source: Baillie Gifford.

### Size

Our private company exposure tends to be weighted to the upper end of the maturity curve, focused on late stage private companies which are scaling up and becoming profitable.

|  Cap | Total equity value (USD) | % of total assets* | Number of holdings  |
| --- | --- | --- | --- |
|  Micro | <300m | 0.5 | 3  |
|  Small | 300m–2bn | 5.2 | 7  |
|  Medium | 2bn–10bn | 10.3 | 9  |
|  Large | >10bn | 18.1 | 5  |
|   |  | **34.1** | **24**  |

*Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.

### Valuation movements – year to 31 May 2024

![img-6.jpeg](img-6.jpeg)

Source: Baillie Gifford. Baillie Gifford US Growth private company valuation changes, year to 31 May 2024.

37
Strategic report
Top 10 private companies progress – year to 31 May 2024
Operational highlights Financial highlights
ș World record number of launches in a single year ș In November 2023, Elon Musk confirmed via X
with 96 launches made in 2023. that Starlink had achieved cash flow breakeven.
The company has ample liquidity to fund the
ș Starlink now has 3 million customers in 99
business over the medium term.
countries.
ș Starship flight test 4 took place in June 2024
and both the booster and the upper stage ship
completed a successful splashdown.
ș In 2023, Stripe passed the milestone of $1 ș Tender offer in March 2024 valued the company
trillion in total payment volume (‘TPV’), up 25% at $65 billion.
versus the prior year.
ș At $1 trillion TPV, the output of businesses that
run on Stripe equates to roughly 1% of global
gross domestic product (‘GDP’).

| ș Fintech company Brex has enhanced its |  | ș The changes announced in January 2024 |  |
| --- | --- | --- | --- |
|  | offerings with features like Auto Transfers for |  | are designed to “make Brex more agile and |
|  | business accounts, new card management tools, |  | accelerate our path to profitability, building on |
|  | budget notification options and enhancements |  | the growth we had in 2023. We grew our revenue |
|  | for Brex travel. |  | 35%+ in 2023 while gross profit increased by |

75%. This reduction in force puts us on a clear
ș The company also launched Brex Assistant,
path towards profitability.”
an AI-powered expense management tool,

| and announced a new iteration of the Brex | ș “Brex’s financial plan is to be well above cash |  |
| --- | --- | --- |
| business account with features like AI-powered |  | flow positive with the current cash we have, |
| accounting in 2024. |  | which calls for around 4 years of runway.” |

ș In January 2024, Brex announced it was
laying off about 20% of its staff in an effort to
innovate and streamline its services amidst a
more challenging economic environment.
ș Zipline’s drones have now logged 70 million ș In April 2023, Zipline announced a funding round
miles, making more than 1 million deliveries. raising $330 million at a $4.2 billion post money
valuation – this was a 55% increase from its
ș In early 2023, Zipline unveiled the next
2021 round which valued the company at
generation platform, dubbed Platform 2
$2.7 billion.
or P2 Zip.
ș In September 2023, Zipline obtained
authorisation from the Federal Aviation
Administration (‘FAA’) to operate ‘beyond
the visual line of sight’ flights.
38 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Top 10 private companies progress – year to 31 May 2024 (continued)
Operational highlights Financial highlights

| ș Faire Market, the company’s summer virtual |  | ș The e-commerce platform Shopify invested |  |
| --- | --- | --- | --- |
|  | trade show, was the largest so far. Nearly |  | in Faire in September 2023. Faire is now the |
|  | 53,000 retailers bought stock during the show, |  | recommended wholesale marketplace for Shopify |
|  | with around 290,000 orders placed. There are |  | merchants, bringing a huge customer network to |
|  | over 100,000 brands on Faire’s platform. |  | the brands selling via Faire. |
| ș Faire is building more tools for its brands and |  | ș Faire trimmed its workforce by 20% in November |  |
|  | retailers. It is rolling out analytics tools for its top |  | 2023 to operate with a leaner management |
|  | brands and has improved its ‘Collections’ tool to |  | structure. |

help brands curate their products.

| ș In June 2023, Databricks acquired generative |  | ș In September 2023, Databricks announced the |  |
| --- | --- | --- | --- |
|  | AI company MosaicML for $1.3 billion. |  | closing of its Series I funding round which raised |
|  | The company will help make generative AI |  | over $500 million and valued the company at |
|  | accessible for all organisations enabling it to |  | $43 billion. |

build, own and secure AI models with its own
ș Financials continue to be impressive – at the end
proprietary data.
of July 2023, the company confirmed that it had
ș In March 2024, Databricks and NVIDIA crossed $1.5 billion revenue run rate with over
announced an expanded collaboration 50% year on year growth.
to optimise data and AI workloads on the
Databricks platform (NVIDIA also participated
in the September 2023 funding round).

| ș As at May 2024 Discord had 200 million |  | ș October 2023 saw the company launch an app- |  |
| --- | --- | --- | --- |
|  | monthly active users (from 152 million in |  | store allowing subscribers to purchase digital |
|  | January 2023), rolling out several speed and |  | items for their avatar and accounts. Discord |
|  | feature improvements. |  | plans to open this new revenue stream to non- |

Nitro subscribers.
ș Over 90% of users play games on the platform,
spending a total of 1.5 billion hours gaming ș It will also begin inviting eligible developers in the
each month. UK and Europe to share in company revenue by
building apps on top of the platform and letting
users subscribe to them (this is already available
in the US).
39
Strategic report
Top 10 private companies progress – year to 31 May 2024 (continued)
Operational highlights Financial highlights
ș Over 500,000 people have now received ș Annual recurring revenue has grown to
BillionToOne tests. Its Northstar cancer $125 million, from zero four years ago.
screening tests have been available for
patient use since early 2023.
ș Announced a collaboration with Johnson &
Johnson that will see its UNITY tests used as
part of a Johnson & Johnson clinical trial. This
important validation opens up the opportunity
to support more clinical trials.

| ș As of May 2024, Lyra, the leading provider of |  | ș As of May 2024, Lyra has raised a total of |  |
| --- | --- | --- | --- |
|  | innovative Workforce Mental Health solutions |  | $907 million, with the last funding round being |
|  | for employers, had more than 300 companies |  | a $235 million round in January 2022. |

partnered to offer Lyra’s mental health benefits
to their employees, giving 15 million people
access to this care.
ș In May 2024, a four-year independent study
from AON showed that employers offering
Lyra’s workforce mental health solutions saw an
average annual health care cost reduction of
26%, sustained consistently over four years.

| ș In April 2024, Solugen broke ground on its |  | ș In August 2023 Chakrabati noted its |  |
| --- | --- | --- | --- |
|  | new biomanufacturing facility in Minnesota – |  | 10,000 gallon Bioforge Houston “can |
|  | ‘Bioforge Marshall’. |  | produce the chemicals at enormous |

volumes, and do so profitably.”
ș Solugen’s first commercial production plan

| ‘Bioforge Houston’ opened in 2021 and it | ș Solugen secured a $214 million loan from |  |
| --- | --- | --- |
| has demonstrated an over 80% reduction |  | the Department of Energy to support the |
| in greenhouse gas emissions compared to |  | construction of Bioforge Marshall. |

conventional petroleum-based methods.
Bioforge Marshall will be six times the size
of Bioforge Houston and aims to produce
bio-based chemical products for use in
wastewater treatment, construction,
agriculture and energy sectors.
ș In August 2023 CEO Gaurab Chakrabarti noted
Solugen’s Houston facilities were producing
over 10,000 tons of chemicals per year,
removing more carbon from the environment
than they put in.
40 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## List of investments
as at 31 May 2024

|  |  | 2024 |  | % of | 2023 |
| --- | --- | --- | --- | --- | --- |
|  |  | Value |  | total | Value |
| Name | Business | £’000 | assets* |  | £’000 |
| Space Exploration Technologies | Rocket and spacecraft company 26,502 3.9 20,041 |  |  |  |  |

Series J Preferred
Space Exploration Technologies Rocket and spacecraft company 15,214 2.2 11,505
Series N Preferred
Space Exploration Technologies Rocket and spacecraft company 6,040 0.9 4,568
Series K Preferred
Space Exploration Technologies Rocket and spacecraft company 3,139 0.5 2,374
Class A Common
Space Exploration Technologies Rocket and spacecraft company 969 0.1 732
Class C Common
51,864 7. 6 39,220
NVIDIA Graphics chips 44,715 6.5 24,334
Amazon Online retailer and cloud computing provider 35,710 5.2 22,361
The Trade Desk Advertising technology company 34,288 5.0 32,448

| Stripe Series G Preferred | Online payment platform 13,984 2.0 11,110 |
| --- | --- |
| Stripe Series I Preferred | Online payment platform 13,625 2.0 10,860 |
| Stripe Class B Common | Online payment platform 2,871 0.4 2,281 |
| Stripe Series H Preferred | Online payment platform 1,527 0.2 1,430 |

32,007 4.6 25,681
Meta Platforms Social networking websites 25,369 3.7 –
Moderna Therapeutic messenger RNA 23,506 3.4 21,025
Netflix Subscription service for TV shows and movies 23,441 3.4 17,247
Shopify Cloud-based commerce platform provider 21,747 3.1 33,135
Brex Class B Common Corporate credit cards for start-ups 10,648 1.6 8,050
Brex Series D Preferred Corporate credit cards for start-ups 10,018 1.5 7,574
20,666 3.1 15,624
DoorDash Online local delivery 17,845 2.6 11,482
Tesla Electric cars, autonomous driving and solar energy 17,239 2.4 24,967

| Zipline International Series C Preferred | Drone-based medical delivery 8,910 1.3 8,771 |
| --- | --- |
| Zipline International Series E Preferred | Drone-based medical delivery 5,049 0.7 4,970 |
| Zipline International Series F Preferred | Drone-based medical delivery 820 0.1 807 |

14,779 2.1 14,548
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
Denotes private company investment.
Denotes listed investment previously held in the portfolio as a private company investment.
Past performance is not a guide to future performance.
41
Strategic report

|  |  | 2024 |  | % of | 2023 |
| --- | --- | --- | --- | --- | --- |
|  |  | Value |  | total | Value |
| Name | Business | £’000 | assets* |  | £’000 |

Cloudflare Cloud-based provider of network services 13,357 1.9 12,589

| Faire Wholesale Series F Preferred | Online wholesale marketplace 4,972 0.7 5,114 |
| --- | --- |
| Faire Wholesale | Online wholesale marketplace 4,429 0.6 4,546 |
| Faire Wholesale Series G Preferred | Online wholesale marketplace 3,684 0.6 3,789 |

13,085 1.9 13,449
Workday Enterprise information technology 12,450 1.8 13,548
Pinterest Image sharing and social media company 12,273 1.8 5,698
Databricks Series H Preferred Data and AI platform 11,647 1.7 7,974
Databricks Series I Preferred Data and AI platform 435 0.1 –
12,082 1.8 7,974
CoStar Group Commercial property information provider 10,776 1.6 15,817
Duolingo Mobile learning platform 10,743 1.6 11,944
Watsco Air conditioning, heating and refrigeration 10,611 1.5 11,076
equipment distributor
Discord Series I Preferred Communication software 9,448 1.4 11,006
Sweetgreen Salad fast food chain 9,370 1.4 1,212
BillionToOne Series C Preferred Molecular diagnostics technology platform 3,984 0.6 3,438
BillionToOne Series D Preferred Molecular diagnostics technology platform 2,749 0.4 –
BillionToOne Series C-1 Preferred Molecular diagnostics technology platform 2,533 0.4 –
9,266 1.4 3,438
Lyra Health Series E Preferred Digital mental health platform for enterprises 7,136 1.1 6,688
Lyra Health Series F Preferred Digital mental health platform for enterprises 1,664 0.2 1,591
8,800 1.3 8,279
Datadog IT monitoring and analytics platform 8,768 1.3 8,193
Solugen Series C-1 Preferred Combines enzymes and metal catalysts 5,821 0.9 7,257
to make chemicals
Solugen Series D Preferred Combines enzymes and metal catalysts 2,827 0.4 3,487
to make chemicals
8,648 1.3 10,744
Snyk Series F Preferred Developer security software 5,055 0.8 4,061
Snyk Ordinary Shares Developer security software 3,016 0.4 2,424
8,071 1.2 6,485
Affirm Class B Consumer finance 4,543 0.7 2,373
Affirm Consumer finance 3,477 0.5 2,116
8,020 1.2 4,489
Oddity Online cosmetics and skincare company 7,072 1.0 5,648
Roblox User generated content game company 6,900 1.0 8,115
Epic Games Video game platform and software developer 6,741 1.0 6,060
Wayfair Online furniture and homeware retailer 6,552 0.9 4,831
Block Financial services merchant and mobile 6,127 0.9 –
payment company
Inspire Medical Systems Medical technology company 6,054 0.9 –
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
Denotes private company investment.
Denotes listed investment previously held in the portfolio as a private company investment.
Past performance is not a guide to future performance.
42 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

|  |  | 2024 |  | % of | 2023 |
| --- | --- | --- | --- | --- | --- |
|  |  | Value |  | total | Value |
| Name | Business | £’000 | assets* |  | £’000 |
| Snowflake | Developer of a SaaS-based cloud data warehousing | 5,771 0.8 7,598 |  |  |  |

platform
Insulet Medical device company 5,736 0.8 –
Samsara Connected operations cloud software company 5,430 0.8 –
Alnylam Pharmaceuticals Therapeutic gene silencing 5,248 0.8 11,066
Human Interest Series E Preferred Retirement benefits platform 4,713 0.7 –
Human Interest Warrants for Retirement benefits platform – – –
Series E/E-1
4,713 0.7 –
Guardant Health Biotechnology company 4,645 0.7 –
Tanium Class B Common Online security management 4,548 0.7 3,814
Roku Online media player 4,451 0.7 4,895
Nuro Series C Preferred Self-driving vehicles for local delivery 2,509 0.4 2,040
Nuro Series D Preferred Self-driving vehicles for local delivery 1,939 0.3 1,645
4,448 0.7 3,685
HashiCorp Open source infrastructure software 4,360 0.6 4,709
Workrise Technologies Jobs marketplace for the energy sector 1,975 0.3 2,741
Series E Preferred
Workrise Technologies Jobs marketplace for the energy sector 1,895 0.3 2,662
Series D Preferred
Workrise Technologies Jobs marketplace for the energy sector 421 <0.1 592
Series D-1 Preferred
4,291 0.6 5,995
Chewy Online pet supplies retailer 4,084 0.6 6,168
Thumbtack Class A Common Online directory service for local businesses 2,437 0.4 810
Thumbtack Series I Preferred Online directory service for local businesses 1,293 0.2 1,113
Thumbtack Series A Preferred Online directory service for local businesses 174 <0.1 58
Thumbtack Series C Preferred Online directory service for local businesses 51 <0.1 17
Thumbtack Series B Preferred Online directory service for local businesses 12 <0.1 4
3,967 0.6 2,002
PsiQuantum Silicon photonic quantum computing 3,872 0.6 3,535
Series D Preferred
YETI Holdings Consumer products for the outdoor and recreation 3,726 0.6 –
markets

| Airbnb Class B Common | Online market place for travel accommodation 3,501 0.6 2,725 |
| --- | --- |
| Away (JRSK) Series D Preferred | Travel and lifestyle brand 1,072 0.2 1,698 |
| Away (JRSK) Convertible | Travel and lifestyle brand 1,039 0.2 1,075 |

Promissory Note
Away (JRSK) Convertible Travel and lifestyle brand 1,039 0.2 1,075
Promissory Note 2021
Away (JRSK) Series Seed Preferred Travel and lifestyle brand 234 <0.1 1,165
3,384 0.6 5,013
Denali Therapeutics Clinical stage neurodegeneration company 3,321 0.5 5,803
Penumbra Medical tools to treat vascular diseases 3,178 0.5 5,696
* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
Denotes private company investment.
Denotes listed investment previously held in the portfolio as a private company investment.
Past performance is not a guide to future performance.
43
Strategic report

|  |  | 2024 |  | % of | 2023 |
| --- | --- | --- | --- | --- | --- |
|  |  | Value |  | total | Value |
| Name | Business | £’000 | assets* |  | £’000 |
| Doximity Social network and digital workflow tools for |  | 3,136 0.5 2,680 |  |  |  |

medical professionals

| Niantic Series C Preferred | Augmented reality games 3,026 0.4 2,608 |
| --- | --- |
| Aurora Innovation | Self-driving technology 1,668 0.2 368 |
| Aurora Innovation Class B Common | Self-driving technology 1,317 0.2 785 |

2,985 0.4 1,153
Coursera Online educational services provider 2,842 0.4 4,176
Sprout Social Social media management firm 2,777 0.4 –
Lemonade Insurance company 2,068 0.3 2,335
Recursion Pharmaceuticals Drug discovery platform 1,891 0.3 2,111

| Honor Technology Series D Preferred | Home care provider 1,158 0.2 609 |
| --- | --- |
| Honor Technology Series E Preferred | Home care provider 502 0.1 264 |
| Honor Technology Subordinated | Home care provider 198 <0.1 – |

Convertible Promissory Note
1,858 0.3 873
10X Genomics Single cell sequencing company 1,714 0.3 4,361
Capsule Series 1-D Preferred Digital pharmacy 824 0.1 1,305
Capsule Series E Preferred Digital pharmacy 509 0.1 807
1,333 0.2 2,112
Sana Biotechnology Gene editing technology 1,239 0.2 929
Rivian Automotive Electric vehicle manufacturer 1,078 0.2 1,560
Ginkgo Bioworks Bioengineering company developing micro organisms 930 0.1 2,946
that produce various proteins

| Blockstream Series B-1 Preferred | Bitcoin and digital asset infrastructure 163 <0.1 1,140 |
| --- | --- |
| Indigo Agriculture Class A Common | Agricultural technology company 130 <0.1 2,375 |
| Abiomed CVR | Manufacturer of heart pumps – – – |

Total investments 678,234 99.3
Net liquid assets† 4,970 0.7
Total assets* 683,204 100.0
Private

|  | Listed |  | company | Net liquid | Total |
| --- | --- | --- | --- | --- | --- |
|  | equities |  | investments | # assets † | assets * |
|  |  | % | % | % | % |
| 31 May 2024 | 65.2 34.1 0.7 100.0 |  |  |  |  |
| 31 May 2023 | 65.0 34.5 0.5 100.0 |  |  |  |  |

* Total assets less current liabilities, before deduction of borrowings. See Glossary of terms and alternative performance measures on pages 124 to 127.
† See Glossary of terms and alternative performance measures on pages 124 to 127.
# Includes holdings in ordinary shares, preference shares and convertible promissory notes.
Denotes private company investment.
Denotes listed investment previously held in the portfolio as a private company investment.
Past performance is not a guide to future performance.
44 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Business
## review
Business model Objective and policy
The Company’s investment objective is to produce
Business and status
long-term capital growth.
Baillie Gifford US Growth Trust plc is a public
The Company invests predominantly in equities of
company limited by shares and is incorporated in
companies which are incorporated or domiciled, or
England and Wales. The Company is an investment
which conduct a significant portion of their business,
company within the meaning of section 833 of the
in the United States and which the Company
Companies Act 2006 and carries on business as an
believes have the potential to grow substantially
investment trust. Investment trusts are UK public
faster than the average company over the long
listed companies and their shares are traded on the
term. Such investment is typically direct, but may
London Stock Exchange. They invest
be indirect, including through investment in funds.
in a portfolio of assets in order to spread risk.
The Company has a fixed share capital although, The maximum direct investment in any one company
subject to shareholder approval, it may purchase or fund is limited to 10% of the Company’s total
its own shares or issue shares. The price of the assets measured at the time of investment.
Company’s shares is determined, like other
The portfolio consists of direct holdings in listed
listed shares, by supply and demand.
securities and unlisted securities in up to a combined
The Company has been approved as an investment maximum of 90 companies or funds, typically with
trust by HM Revenue & Customs subject to the 30 or more listed security holdings. The maximum
Company continuing to meet the eligibility amount which may be invested directly in unlisted
conditions. The Directors are of the opinion securities shall not exceed 50% of the total assets
that the Company has continued to conduct of the Company, measured at the time of investment.
its affairs so as to enable it to comply with the
The Company will at all times be invested in several
ongoing requirements of section 1158 of the
sectors. While there are no specific limits placed
Corporation Tax Act 2010 and the Investment Trust
on exposure to any one sector, the Company will
(Approved Company) (Tax) Regulations 2011.
at all times invest and manage the portfolio in a
The Company is an Alternative Investment manner consistent with spreading investment risk.
Fund for the purposes of the UK Alternative
With prior approval of the Board, the Company
Investment Fund Managers Regulations.
may use derivatives for the purposes of efficient
portfolio management (in order to reduce,
Purpose
transfer or eliminate investment risk in the
Baillie Gifford US Growth aims to deliver above
Company’s portfolio). Derivative instruments
average long-term returns for shareholders by
in which the Company may invest may include
keeping fees and costs low and harnessing the
foreign exchange forwards, exchange-listed
long-term growth potential of companies.
and over-the-counter options, futures, options
on futures, swaps and similar instruments. The
Board, however, currently does not expect to
enter into derivative or hedging transactions to
mitigate against currency or interest rate risk.
45
Strategic report
The Board intends to employ gearing in the Liquidity policy
normal course of events. The Company may in
The Board recognises the need to address any
aggregate borrow amounts equalling up to 30%
sustained and significant imbalance of buyers and
of the net asset value of the listed securities
sellers which might otherwise lead to shares trading
held by the Company, calculated at the time
at a material discount or premium to net asset value
of drawdown, although the Board expects that
per share. While it has not adopted any formal
borrowings will typically represent an amount in
discount or premium targets which would dictate
the range of 10% to 20% of the net asset value
the point at which the Company would seek to
of the listed securities held by the Company.
purchase shares or issue further shares, the Board is
committed to utilising its share purchase and share
While it is intended that the Company will be fully
issuance authorities where appropriate in such a way
invested in normal market conditions, the Company
as to mitigate the effects of any such imbalance. In
may hold cash on deposit or invest on a temporary
considering whether buy-back or issuance might be
basis in a range of cash equivalent instruments.
appropriate in any particular set of circumstances, the
The Board does not expect that the Company will
Board will take into account, inter alia: the prevailing
hold cash or cash equivalent instruments, but there
market conditions; whether the discount is substantial
is no restriction on the amount of cash or cash
relative to the Company’s peers; the degree of net
equivalent instruments that the Company may hold.
asset value accretion that will result from the buy-
Culture and values back or issuance; the cash resources readily available
to the Company; the immediate pipeline of investment
In the context of a company with no employees,
opportunities open to the Company; the level of the
culture and values are expressed by the Company’s
Company’s existing borrowings; and the working
Directors and the service providers with whom
capital requirements of the Company. The Board will
shareholders and other stakeholders interact, and
continue to monitor the discount and the application
through the relationships between the Board and
of the liquidity policy and will amend the approach to
those service providers, including the Managers.
discount management in response to the prevailing
As noted in more detail in the section 172 statement
market conditions and other factors noted above.
on pages 53 to 56, the Board seeks to engage
with its Managers and other service providers in a The Board will keep shareholders appraised, on
collaborative and collegiate manner, and to maintain a regular and ongoing basis, of the approach
the highest standards of business conduct. which it has adopted in implementing this
liquidity policy, principally through commentary
Dividend policy
in its Annual and Interim reports.
The Company’s priority is to produce capital growth
Share buy-backs – at the Annual General Meeting
over the long term. The Company therefore has
held on 18 September 2023 the Company was
no dividend target and will not seek to provide
granted a general authority to make purchases
shareholders with a particular level of distribution.
of up to 45,742,539 shares, being approximately
However, the Company intends to comply with
14.99% of the issued ordinary share capital as
the requirements for maintaining investment trust
at 4 August 2023. This authority expires at the
status for the purposes of section 1158 of the UK
forthcoming Annual General Meeting. In exercising
Corporation Tax Act 2010 regarding distributable
the Company’s power to buy back shares, the
income. The Company will therefore distribute as a
Board has complete discretion as to the timing,
final dividend amounts such that it does not retain,
price and volume of shares so purchased. If the
in respect of an accounting period, an amount
Company does purchase its own shares it may hold
greater than 15% of its income (as calculated for
them in treasury rather than purchase them for
UK tax purposes) for that period. As the revenue
cancellation. Shares may only be sold from treasury
account is again running at a deficit, the Board is
at a price which, after costs, is not less than the
recommending that no final dividend be paid.
net asset value per share at the relevant time.
All share repurchases are conducted in accordance
with the Companies Act 2006 and the UK Listing
Rules applicable to closed-ended investment funds
from time to time and are announced to the market
via a Regulatory Information System on the same
or the following business day.
46 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
7,925,000 were bought back during the year under Borrowings
review. At 31 May 2024 10,131,300 shares were
Borrowings are typically invested in securities when
held in treasury. Between 1 June 2024 and 16
it is considered that investment grounds merit the
August 2024 1,950,000 shares were bought back.
Company taking a geared position to securities.
The Directors are seeking shareholders’ approval Gearing levels, and the extent of equity gearing, are
at the Annual General Meeting to renew the discussed by the Board and Managers at every Board
authority to purchase up to 14.99% of the ordinary meeting. The Managers are tasked with ensuring
shares in issue as at 16 August 2024 (being the that gearing is managed efficiently and within the
latest practicable date prior to the publication of parameters set by the Board and any loan covenants.
this document) or, if less, up to 14.99% of the
Facility Facility
ordinary shares in issue (excluding treasury shares)
amount type Lender Maturing Drawings
on the date on which the authority is granted,
$25 Revolving ING Bank N.V. 31 July 2026 Fully
such authority to expire at the date of the Annual
million credit drawn
General Meeting in 2025. Such purchases will only
be made at a discount to the prevailing net asset

|  | $25 | Revolving | The Royal | 18 October | Fully |
| --- | --- | --- | --- | --- | --- |
| value. Any such shares which are bought back | million | credit | Bank of | 2026 | drawn |
| may be held in treasury and may subsequently |  |  | Scotland |  |  |

International
then either be sold for cash or cancelled.
Limited
Share issuance – the Directors will again be seeking
authorities at the forthcoming Annual General
Performance
Meeting for issuance and disapplication of pre-
At each Board meeting, the Directors consider a
emption rights to sell any shares held in treasury
number of performance measures to assess the
and allot new shares at a premium to the net asset
Company’s success in achieving its objectives.
value per share with debt valued at fair value.
These authorities will expire at the conclusion of
Key performance indicators
the 2025 Annual General Meeting or on the expiry
The key performance indicators (‘KPIs’) used
of 15 months from the passing of the resolutions,
to measure the progress and performance
whichever is earlier. Should shareholder approval
of the Company over time are established
be granted it will allow the Directors to issue new
industry measures and are as follows:
ordinary shares at a premium to net asset value
or C shares convertible into ordinary shares, in ș the movement in the net asset value per ordinary
order to satisfy investor demand over the year share;
should the Company be in a position to do so.
ș the movement in the share price;
No new ordinary shares will be issued at a price
ș performance compared to the comparative
which (after costs and expenses) is less than the
index;
net asset value per existing ordinary share at the
time of the issue of the new shares, unless the new ș the premium/discount of the share price to the
shares are first offered pro-rata to shareholders net asset value per share; and
on a pre-emptive basis. C shares will be issued at
ș the ongoing charges ratio.
a price of £1 per C share. As mentioned above,
An explanation of these measures can be found in
the Company has the authority to raise further
the Glossary of terms and alternative performance
funds through the issue of C shares rather than
measures on pages 124 to 127.
ordinary shares. C shares are designed to overcome
the potential disadvantages that may arise out
The KPIs for the year to 31 May 2024 and since
of a fixed price issue of further shares for cash.
inception, 28 March 2018, are shown on pages
These disadvantages relate primarily to the effect
20 to 25.
that an injection of substantial uninvested cash
In addition to the above, the Board considers peer
may have on the net asset value per ordinary
group comparative performance.
share performance of an otherwise fully invested
portfolio (commonly referred to as ‘cash drag’).
During the year to 31 May 2024 the Company
issued no shares. Between 1 June 2024 and
16 August 2024 no shares were issued.
47
Strategic report
Value assessment
Baillie Gifford & Co Limited undertakes regular value assessments of its products. Following the
assessment in 2024, it was concluded that the Company was expected to provide fair value for a
reasonably foreseeable period.
Principal and emerging risks
As explained on pages 70 and 71 there is an ongoing process for identifying, evaluating and managing the
risks faced by the Company on a regular basis. The Directors have carried out a robust assessment of the
principal and emerging risks facing the Company, including those that would threaten its business model,
future performance, regulatory compliance, solvency or liquidity. There have been no material changes to
the principal risks during the year. A description of these risks and how they are being managed or mitigated
is set out below.
The Board considers the heightened macroeconomic and geopolitical concerns to be factors which
exacerbate existing risks, rather than discrete risks, within the context of an investment trust.
Their impact is considered within the relevant risks.

| Financial | What is the risk? | How is it managed? | Current assessment of risk |
| --- | --- | --- | --- |
| risk | The Company’s assets consist | The Board has, in particular, | This risk is considered to |
|  | mainly of listed securities and | considered the impact of | be high but unchanged |
|  | its principal financial risks are | heightened market volatility | as a result of heightened |
|  | therefore market related and | during recent months due to | macroeconomic and |
|  | include market risk (comprising | macroeconomic factors such as | geopolitical concerns |
|  | currency risk, interest rate | higher inflation, interest | which continue to create |
|  | risk and other price risk), | rates and geopolitical concerns. | a challenging environment |
|  | liquidity risk and credit risk. | To mitigate this risk the Board | for businesses, but with |
|  | An explanation of those risks | considers at each meeting various | some signs that interest rate |
|  | and how they are managed | portfolio metrics including | pressures, for example, may |
|  | is contained in note 17 to the | individual stock performance and | be starting to recede. |
|  | Financial Statements on pages | weightings, the top and bottom |  |
|  | 104 to 111. | contributors to performance, |  |

purchases and sales of
investments and relative sector
weightings against the
comparative index. The portfolio
managers provide their rationale
for stock selection decisions. A
comprehensive strategy meeting
is held annually to facilitate
challenge of the Company’s
strategy. The value of the
Company’s investment portfolio
would be affected by any impact,
positively or negatively, on sterling
but such impact would be partially
offset by the effect of exchange
rate movements on the Company’s
dollar denominated borrowings.
Decreasing RiskIncreasing Risk No Change
48 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Private What is the risk? How is it managed? Current assessment of risk
company The Company’s liquidity risk To mitigate this risk, the Board There has been no significant
could be increased by its considers the private company change to the number of
investment
investment in private company securities in the context of the private company investments
risk

| securities. These assets may | overall investment strategy and | during the period. At 31 |
| --- | --- | --- |
| be more difficult to buy or | provides guidance to the Managers | May 2024, private company |
| sell, so changes in their prices | on the maximum exposure to | investments comprised |
| may be greater than for listed | private company securities. The | 34.1% of total assets. |
| investments. | investment policy limits the amount |  |

which may be invested in private
company securities to 50% of
the total assets of the Company in
aggregate, measured at the time
of investment.
Investment What is the risk? How is it managed? Current assessment of risk
strategy risk Pursuit of an investment To mitigate this risk, the Board This risk is considered to
strategy to fulfil the Company’s regularly reviews and monitors be stable as there are signs
objective which the market the Company’s objective and that the market’s appetite for
perceives to be unattractive or investment policy and strategy, growth stocks, typically held
inappropriate, or the ineffective the investment portfolio and by the Company, is recovering
implementation of an attractive its performance, the level of following the recent period of
or appropriate strategy, may discount/premium to net asset heightened macroeconomic
lead to reduced returns for value at which the shares trade and geopolitical concerns.
shareholders and, as a result, and movements in the share
a decreased demand for the register and raises any matters
Company’s shares. This may of concern with the Managers.
lead to the Company’s shares
trading at a wide discount to
their net asset value.
Environmental What is the risk? How is it managed? Current assessment of risk
social and Perceived problems on This is mitigated by the Managers’ The Managers continue
environmental, social and strong ESG stewardship and to embed analysis of ESG
governance
governance (‘ESG’) matters engagement policies which are factors within the investment
risk

| in an investee company | available to view on the Managers’ | process. Although climate |
| --- | --- | --- |
| could lead to that company’s | website, bailliegifford.com, and | activists have recently |
| shares being less attractive to | which have been reviewed and | targeted the Managers’ |
| investors, adversely affecting | endorsed by the Company, and | sponsorship of cultural |
| its share price, in addition | which have been fully integrated | events, media coverage |
| to potential valuation issues | into the investment process as | has been balanced and |
| arising from any direct impact | well as the extensive up-front | has largely recognised |
| of the failure to address | and ongoing due diligence which | that the objective is not |
| the ESG weakness on the | the Managers undertake on each | to seek perfection but to |
| operations or management | investee company. Due diligence | focus on materiality and |
| of the investee company | includes assessment of the risks | the direction of travel, with |
| (for example a failure to | inherent in climate change as well | the understanding that |
| identify a pathway to Net | as ongoing positive engagement | engagement can encourage |
| Zero or poor employment | on ESG-related issues (see pages | responsibility and meaningful |
| practices). Repeated failure | 17 to 19). | change. |

by the Managers to identify
ESG weaknesses in investee
companies could lead to the
Company’s own shares being
less attractive to investors,
adversely affecting its own
share price.
Decreasing RiskIncreasing Risk No Change
49
Strategic report

| Discount | What is the risk? | How is it managed? | Current assessment of risk |
| --- | --- | --- | --- |
| risk | The discount/premium at | To manage this risk, the | The Company’s discount |
|  | which the Company’s shares | Board monitors the level of | narrowed during the year. |
|  | trade relative to its net asset | discount/premium at which the | Over the year to 31 May 2024 |
|  | value can change. The risk | shares trade and the Company | the Company bought back |
|  | of a wide discount is that | has authority to buy back its | 7,925,000 shares to be |
|  | it may undermine investor | existing shares, when deemed | held in treasury. The Board |
|  | confidence in the Company and | by the Board to be in the best | continues to monitor closely |
|  | shareholders selling their shares | interests of the Company and | the discount and the impact |
|  | will get less than the net asset | its shareholders. The liquidity | of the current liquidity policy |
|  | value of those shares. | policy is set out on page 46. | being applied. |

Regulatory What is the risk? How is it managed? Current assessment of risk
risk Failure to comply with To mitigate this risk, All control procedures are
applicable legal and regulatory Baillie Gifford’s Business Risk, working effectively. There
requirements such as the Internal Audit and Compliance have been no material
tax rules for investment trust departments provide regular regulatory changes that
companies, the UK Listing reports to the Audit Committee impacted the Company
Rules and the Companies Act on Baillie Gifford’s monitoring during the year.
could lead to suspension of the programmes. Major regulatory
Company’s Stock Exchange change could impose
listing, financial penalties, a disproportionate compliance
qualified audit report or the burdens on the Company. In such
Company being subject to tax circumstances representation is
on capital gains. made to ensure that the special
circumstances of investment
trusts are recognised. Shareholder
documents and announcements,
including the Company’s published
Interim and Annual Report and
Financial Statements, are subject
to stringent review processes and
procedures are in place to ensure
adherence to the Transparency
Directive and the Market Abuse
Directive with reference to inside
information.
Custody and What is the risk? How is it managed? Current assessment of risk
Depositary Safe custody of the Company’s To mitigate this risk, the Audit All control procedures are
assets may be compromised Committee receives six-monthly working effectively.
risk
through control failures by the reports from the Depositary
Depositary, including breaches confirming safe custody of the
of cyber security. Company’s assets held by the
Custodian. Cash and portfolio
holdings are independently
reconciled to the Custodian’s
records by the Managers who
also agree uncertificated private
portfolio holdings to confirmations
from investee companies. The
Custodian’s assured internal
controls reports are reviewed
by Baillie Gifford’s Business Risk
department and a summary
of the key points is reported
to the Audit Committee and
any concerns investigated.
Decreasing RiskIncreasing Risk No Change
50 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Operational What is the risk? How is it managed? Current assessment of risk
risk Failure of Baillie Gifford’s To mitigate this risk, Baillie Gifford All control procedures
systems or those of other has a comprehensive business are working effectively.
third party service providers continuity plan which facilitates The other key third party
could lead to an inability to continued operation of the service providers have not
provide accurate reporting business in the event of a service experienced significant
and monitoring or a disruption. The Audit Committee operational difficulties
misappropriation of assets. reviews Baillie Gifford’s Report affecting their respective
on Internal Controls and reports services to the Company.
by other key third party providers
are reviewed by Baillie Gifford
on behalf of the Board and a
summary of the key points is
reported to the Audit Committee
and any concerns investigated.
Cyber What is the risk? How is it managed? Current assessment of risk
security risk A cyber attack on Baillie Gifford’s To mitigate this risk, the Audit This risk is seen as increasing
network or that of a third party Committee reviews reports on due to recent indications
service provider could impact Internal Controls published that the continuation of
the confidentiality, integrity or by Baillie Gifford and other geopolitical tensions could
availability of data and systems. third party service providers. lead to cyber attacks.
Baillie Gifford’s Business Risk Emerging technologies,
department reports to the Audit including AI, could potentially
Committee on the effectiveness increase information security
of information security controls risks.
in place at Baillie Gifford and its
business continuity framework.
Cyber security due diligence
is performed by Baillie Gifford
on third party service providers
which includes a review of crisis
management and business
continuity frameworks.
Decreasing RiskIncreasing Risk No Change
51
Strategic report

| Leverage risk | What is the risk? | How is it managed? | Current assessment of risk |
| --- | --- | --- | --- |
|  | The Company may borrow | To mitigate this risk, all borrowings | No significant change in |
|  | money for investment purposes. | require the prior approval of | risk level. The Company |
|  | If the investments fall in value, | the Board and leverage levels | refinanced its existing loan |
|  | any borrowings will magnify | are discussed by the Board and | facilities with revolving credit |
|  | the impact of this loss. If | Managers at every meeting. | facilities during the period. |
|  | borrowing facilities are not | Covenant levels are monitored |  |
|  | renewed, the Company may | regularly. The majority of the |  |
|  | have to sell investments | Company’s investments are in |  |
|  | to repay borrowings. The | quoted securities that are readily |  |
|  | Company can also make use of | realisable. Further information |  |
|  | derivative contracts. The use | on leverage can be found on |  |
|  | of such contracts may have a | page 119 and the Glossary of |  |
|  | gearing effect so as to enhance, | terms and alternative performance |  |
|  | or worsen, returns relative to | measures on pages 124 to 127. |  |

the amount invested in this way.
Political and What is the risk? How is it managed? Current assessment of risk
associated The Board is of the view that Political developments are closely This risk is increasing as
political change in areas in monitored and considered by the governments and consumers
economic risk
which the Company invests or Board. The Board has particular around the world continue
may invest may have financial regard to macroeconomic and to assess the impact of
consequences for the Company. geopolitical tensions, and heightened geopolitical
monitors portfolio diversification. tensions and conflicts
as well as challenging
macroeconomic conditions.
Emerging risk As explained on pages 70 and 71 the Board has regular discussions on principal risks and uncertainties,
including any risks which are not an immediate threat but could arise in the longer term. The Board considers
that the key emerging risks arise from the interconnectedness of global economies and the related exposure
of the investment portfolio to external and emerging threats such as the societal and financial implications of
escalating geopolitical tensions, cyber security risks including developing AI and quantum computing
capabilities and new infectious diseases or similar public health threats. This is mitigated by the Managers’
close links to the investee companies and their ability to ask questions on contingency plans. The Managers
believe the impact of such events may be to slow growth rather than to invalidate the investment rationale
over the long term.
Decreasing RiskIncreasing Risk No Change
52 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Viability statement Based on the Company’s processes for monitoring
operating costs, share price discount/premium,
Having regard to provision 31 of the UK Corporate
the Managers’ compliance with the investment
Governance Code, the Directors have assessed
objective, asset allocation, the portfolio risk
the prospects of the Company over a five year
profile, leverage, counterparty exposure, liquidity
period. The Directors continue to consider
risk and financial controls, the Directors have
this period to be appropriate, as it is reflective
concluded that there is a reasonable expectation
of the longer-term investment strategy of the
that the Company will be able to continue in
Company, and to be a period during which, in the
operation and meet its liabilities as they fall
absence of any adverse change to the regulatory
due over the next five years as a minimum.
environment and to the favourable tax treatment
afforded to UK investment trusts, they do not
Promoting the success of the Company
expect there to be any significant change to the

| current principal risks facing the Company nor to | (section 172 statement) |
| --- | --- |
| the adequacy of the mitigating controls in place. | Under section 172 of the Companies Act 2006, |
| Furthermore, the Directors do not reasonably | the directors of a company must act in the way |
| envisage any change in strategy or objectives | they consider, in good faith, would be most likely |
| or any events that would prevent the Company | to promote the success of the company for the |
| from continuing to operate over that period. | benefit of its members as a whole, and in doing |

so have regard (amongst other matters and to the
In considering the viability of the Company, the
extent applicable) to: a) the likely consequences
Directors have conducted a robust assessment
of any decision in the long term, b) the interests
of each of the Company’s principal and emerging
of the company’s employees, c) the need to
risks and uncertainties as detailed on pages 70
foster the company’s business relationships with
and 71 and in particular the impact of market risk
suppliers, customers and others, d) the impact of
where a significant fall in American equity markets
the company’s operations on the community and
would adversely impact the value of the Company’s
the environment, e) the desirability of the company
investment portfolio. The Directors have also
maintaining a reputation for high standards of
considered the Company’s leverage and liquidity
business conduct and f) the need to act fairly
in the context of the unsecured floating rate loan
as between members of the company.
facilities which expire in July and October 2026, the
income and expenditure projections and the fact that In this context and having regard to Baillie Gifford
the Company’s investments comprise mainly readily US Growth being an externally-managed investment
realisable quoted equity securities which can be sold company with no employees, the Board considers
to meet funding requirements if necessary. Specific that the Company’s key stakeholders are its
leverage and liquidity stress testing was conducted existing and potential new shareholders, its
during the year, including consideration of the externally-appointed Managers (Baillie Gifford)
risk of further market deterioration. The leverage and other professional service providers (corporate
stress testing identified the impact on leverage in broker, registrar, Auditor, Custodian and Depositary),
scenarios where gross assets fall by 25% and 50%, lenders, portfolio companies, AIC/industry
reflecting a range of market conditions that may peers, investment platforms, wider society
adversely impact the portfolio. The liquidity stress and the environment.
testing identified the reduction in the value of assets
The Board considers that the interests of the
that can be liquidated within one month that would
Company’s key stakeholders are aligned, in terms
result in the value of those assets falling below the
of wishing to see the Company deliver sustainable
value of the borrowings. The stress testing did not
long-term growth, in line with the Company’s
indicate any matters of concern. In addition, as
stated objective and strategy, and meet the highest
substantially all of the essential services required by
standards of legal, regulatory, and commercial
the Company are outsourced to third party service
conduct, with the differences between stakeholders
providers, this allows key service providers to be
being merely a matter of emphasis on those elements.
replaced at relatively short notice where necessary.
The Board’s methods for assessing the Company’s
progress in the context of its stakeholders’ interests
are set out on the following pages.
53
Strategic report
Stakeholder Why we engage How we engage and what we do
Shareholders Shareholders are, collectively, the Company’s The Board places great importance on communication
owners: providing them with a return for their with shareholders. The Annual General Meeting provides
investment in accordance with the Company’s an opportunity for the Board and Managers to present to
investment policy and objective is the reason shareholders on the Company’s performance, future plans
for its existence. and prospects. It also allows shareholders the opportunity to
meet with the Board and Managers and raise questions and
concerns. The Chair is available to meet with shareholders as
appropriate. The Managers meet regularly with shareholders
and their representatives, reporting their views back
to the Board. Directors also attend certain shareholder
presentations, in order to gauge shareholder sentiment first
hand. Shareholders may also communicate with members of
the Board at any time by writing to them at the Company’s
registered office or to the Company’s broker. These
communication opportunities help inform the Board when
considering how best to promote the success of the Company
for the benefit of all shareholders over the long term.
Baillie Gifford – The Company’s Board has delegated the The Board seeks to engage with its Managers, in a
Managers and management of the Company’s portfolio, collaborative and collegiate manner, encouraging open and
Secretaries and the administration of the Company’s constructive discussion and debate, while also ensuring that
operations including fulfilment of regulatory appropriate and regular challenge is brought and evaluation
and taxation reporting requirements, to conducted. This approach aims to enhance service levels
Baillie Gifford. Baillie Gifford is therefore and strengthen relationships with the Managers, with a view
responsible for the substantial activities of to ensuring the interests of the Company’s shareholders
the Company and has the most immediate are best served, by keeping cost levels proportionate and
influence on its conduct towards the other competitive, and by maintaining the highest standards of
stakeholders, subject to the oversight and business conduct.
strategic direction provided by the Board.
Portfolio companies As all of the Company’s operations are The Board is cognisant of the need to consider the impact

| conducted by third party service providers, | of the Company’s investment strategy and policy on wider |
| --- | --- |
| it is the companies held in its investment | society and the environment. The Board considers that its |
| portfolio which have the primary real-world | oversight of environmental, social and governance (‘ESG’) |
| impact in terms of social and environmental | matters is an important part of its responsibility to all |
| change, both positively and negatively, as | stakeholders. The Board’s review of the Managers includes |
| well as generating, through their commercial | an assessment of their ESG approach and its application in |
| success, the investment growth sought by | making investment decisions. The Board regularly reviews |
| the Company’s shareholders. The investee | Governance Engagement reports, which document the |
| companies have an interest in understanding | Managers’ interactions with investee companies on ESG |
| their shareholders’ investment rationale in | matters (see pages 14 to 19). |

order to assure themselves that long-term
business strategies will be supported.
Broker The Company’s broker provides an interface The Company’s broker regularly attends Board meetings,
between the Company’s Board and its and provides reports to those meetings, in order to keep the
institutional shareholders. Board apprised of shareholder and wider market sentiment
regarding the Company. They also arrange forums for
shareholders to meet the Chair, or other Directors, outwith
the normal general meeting cycle.
Registrar The Company’s registrar provides an The Company Secretaries liaise with the registrar to
interface with those shareholders who ensure the frequency and accuracy of communications
hold the Company’s shares directly. to shareholders is appropriate, and monitor shareholder
correspondence to ensure that the level of service provided
by the registrar is acceptable. The Managers’ risk function
reviews the registrars’ internal controls report and reports on
the outcome of this review to the Board.
54 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Stakeholder Why we engage How we engage and what we do
Auditor The Company’s Auditor has a responsibility The Company’s Auditor meets with the Audit Committee
to provide an opinion on the Financial Chair and the Board, in the absence of the Managers where
Statements as set out in the Auditor’s report deemed necessary, and the Managers undertake to provide
to the members on pages 83 to 89. all information requested by the Auditor in connection with
the Company’s annual audit promptly and to ensure that it is
complete and accurate in all respects.

| Depositary | The Depositary is responsible for the | The Depositary provides the Audit Committee with a report |
| --- | --- | --- |
| and Custodian | safekeeping of the Company’s financial | on its monitoring activities. The Board and Managers seek to |
|  | instruments, as set out in more detail on | engage with the Depositary and Custodian in a collaborative |
|  | page 62. | and collegiate manner, encouraging open and constructive |

discussion and debate, while also ensuring that appropriate
and regular challenge is brought and evaluation conducted.
This approach aims to enhance service levels and strengthen
relationships with the Depositary and Custodian, with a view
to ensuring the interests of the Company’s shareholders are
best served by keeping cost levels proportionate and
competitive, and by maintaining the highest standards of
business conduct.
Lenders Lenders such as banks providing fixed The Company’s legal advisers review all legal agreements
or revolving credit facilities provide the in connection with the Company’s debt arrangements
Company’s gearing as described on page 47 and advise the Board on the appropriateness of the terms
and have an interest in the Company’s ongoing and covenants therein. The Managers and Secretaries
financial health and viability. ensure that the frequency and accuracy of reporting on,
for example, covenant certification is appropriate and
that correspondence from the lenders receives a prompt
response.
AIC/industry peers The Association of Investment Companies The Company is a member of the AIC, and the Directors
(‘AIC’) and the Company’s investment and/or the Managers and Secretaries (as appropriate)
trust industry peers have an interest in the participate in technical reviews, requests for feedback on
Company’s conduct and performance, proposed legislation or regulatory developments, corporate
as adverse market sentiment towards governance discussions and/or training.
one investment trust can affect attitudes
towards the wider industry.
Investment platforms Investment platforms provide an interface The Managers liaise with the various investment platforms on
with shareholders who invest in the strategies for improving communications with the Company’s
Company indirectly. shareholders who hold their shares via these platforms. An
annual timetable of key dates is published on the Company’s
website, for the ease of reference of such shareholders.
Wider society and No entity, corporate or otherwise, can exist The Board’s and Managers’ interactions with the various
the environment without having an influence on the society stakeholders as noted above form the principal forms of
in which it operates or utilising the planet’s direct engagement with wider society and in respect of the
resources. Through its third-party relationships, environment (commercial, financial and in terms of planetary
as noted above, the Company seeks to be health and resources).
a positive influence and, in circumstances
where that is not possible, to mitigate its
negative impacts insofar as is possible.
55
Strategic report
The Board recognises the importance of keeping Board representation
the interests of the Company and its stakeholders,
At 31 May 2024 the Board comprises five Directors,
in aggregate, firmly front of mind in its key decision
three male and two female. The Company has no
making. The Company Secretaries are available at all
employees. The Board’s policy and disclosures on
times to the Board to ensure that suitable consideration
diversity are set out on page 69.
is given to the range of factors to which the Directors
should have regard. In addition to ensuring that the
Environmental, social and governance policy
Company’s stated investment objective was being
Details of the Company’s policy on socially responsible
pursued, key decisions and actions during the year
investment can be found under ‘Corporate governance
which required the Directors to have regard to
and stewardship’ on page 72 and the Managers’
applicable section 172 factors included:
approach to stewardship and examples of portfolio
ș the buying back of 7,925,000 of the Company’s
company engagement are set out on pages 14 to 19.
own shares into treasury at a discount to net asset
The Company considers that it does not fall within
value, for subsequent reissue, in order to ensure
the scope of the Modern Slavery Act 2015 and it
the Company’s shareholders found liquidity for
is not, therefore, obliged to make a slavery and
their shares when natural market demand was
human trafficking statement. In any event, the
insufficient, and on terms that enhance net asset
Company considers its supply chains to be of low
value for remaining shareholders; and
risk as its suppliers are typically professional
ș refinancing the expiring revolving credit facilities
advisers. A statement by the Managers under the
from ING Bank N.V. with a three-year US$25
Act has been published on the Managers’ website
million unsecured revolving credit facility from
at bailliegifford.com.
ING Bank N.V. and a three-year US$25 million
unsecured revolving credit facility from The
Future developments of the Company
Royal Bank of Scotland International Limited,
The outlook for the Company for the next year is set
for the purpose of investing in exciting growth
out in the Chair’s statement on pages 7 and 8 and in
opportunities, which the Board believes will
the Managers’ review on pages 9 to 12.
enhance long-term returns for shareholders.
The Strategic report which includes pages 7 to 56
Employees, human rights and community was approved by the Board on 21 August 2024.
issues
The Board recognises the requirement to provide
Tom Burnet
information about employees, human rights and
Chair
community issues. The Company has no employees.
All its Directors are non-executive and all its functions
are outsourced. There are, therefore, no disclosures
to be made in respect of employees, human rights
and community issues.
56 Annual Report and Financial Statements 2024
## Governance
## report
This Governance report, which
includes pages 58 to 81 outlines
the Board’s approach to the
governance of your Company.
We believe that good governance
builds better outcomes and we
are committed to high standards
of corporate governance and
transparency.
Governance report

# Directors and management

![img-7.jpeg](img-7.jpeg)

**Tom Burnet**
Chair
Appointed 2018

Tom Burnet was appointed a Director and Chair on 5 March 2018 and is also Chair of the Nomination Committee. He is chair of Kainos Group plc, a London listed IT services business, and a non-executive director of CT Private Equity Trust PLC. Tom is also chair of two privately owned technology businesses. Previously, Tom was managing director of Serco's Defence Services division. He started his career as an Army Officer serving in the Black Watch (R.H.R.), having graduated with an MBA from the University of Edinburgh.

![img-8.jpeg](img-8.jpeg)

**Sue Inglis**
Director
Appointed 2018

Sue Inglis was appointed a Director on 5 March 2018 and is the Senior Independent Director. She has a wealth of experience from more than 30 years advising listed investment companies and financial institutions. Before embarking on a non-executive career, her executive roles included managing director – Corporate Finance in the Investment Companies teams at Cantor Fitzgerald Europe (2012–2018) and Canaccord Genuity (2009–2012). Sue is a qualified lawyer, and was a partner and head of the funds and financial services group at Shepherd & Wedderburn, a leading Scottish law firm. In 1999 she was a founding partner of Intelli Corporate Finance, an advisory boutique firm focusing on the asset management and investment company sectors, which was acquired by Canaccord Genuity in 2009. Sue is currently a non-executive director of CT Global Managed Portfolio Trust PLC and Seraphim Space Investment Trust PLC.

![img-9.jpeg](img-9.jpeg)

**Graham Paterson**
Director
Appointed 2018

Graham Paterson was appointed a Director on 5 March 2018 and is Chair of the Audit Committee. He is an investment and financial services professional with over 20 years' experience in the private equity industry. A chartered accountant, Graham was one of the founding partners of SL Capital Partners LLP (formerly Standard Life Investments (Private Equity) Ltd), where he was a partner and board member until 2010. During his 13 years at SL Capital, he was one of the managers of Standard Life Private Equity Trust plc and was a member of the advisory boards to a number of leading private equity fund managers. In 2013, Graham co-founded TopQ Software Ltd, a technology company which develops software for the private equity industry. TopQ Software was acquired by eVestment Inc (now part of NASDAQ Inc) in 2015, where Graham was a director of the private markets data and analytics business until early 2018. Graham is currently Senior Independent Director of The Income & Growth VCT plc and a non-executive director of Invesco Perpetual UK Smaller Companies Investment Trust plc and Diaceutics PLC.

58 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Chris van der Kuyl was appointed a Director on 1 June 2021. He is one of
Scotland’s leading entrepreneurs working across the technology, media,
gaming and entertainment sectors. Chris is most notably co-founder
and chair of multiple award-winning games developer 4J Studios, best
known for developing Minecraft for Microsoft, Sony and Nintendo games
consoles. He and fellow co-founder, Paddy Burns, launched Chroma
Ventures, the investment arm of 4J Studios, in 2021. Chris is also chair
Chris van der Kuyl of Puny Astronaut, Broker Insights, Stormcloud Games and Ace Aquatec
Director
and sits on the boards of Blippar, Ant Workshop, Parsley Box Plc and
Appointed 2021 Chroma Developments. Alongside his commercial roles, he was the
founding chair of Entrepreneurial Scotland and is currently a member
of multiple advisory and local charity boards.
Rachael Palmer was appointed a Director on 1 June 2021. She is an
experienced strategy, marketing and business development professional
with extensive experience working within the technology sector.
Most recently, Rachael led Google’s VC and Startup Partnerships for
the Europe, Middle East and Africa region. Before Google, Rachael
consulted to numerous start-ups and led marketing and business
development efforts for EY’s world famous Entrepreneur of the Year
Rachael Palmer Program. Rachael has also held positions at American Express and
Director
Microsoft where she held various product, marketing and business
Appointed 2021 development roles. Rachael received her MBA from The Wharton School
and her BSE in Computer Science & Engineering from the University
of Pennsylvania.
All the Directors above and on the prior page served on the Board
throughout the year. All Directors are non-executive and, in the opinion
of the Board, are independent of the Managers. All Directors are
members of the Nomination and Audit Committees.
59
Governance report

## Portfolio managers

![img-10.jpeg](img-10.jpeg)

Gary is a partner and US Equity Growth investment manager. Gary joined Baillie Gifford in 2003 and spent time working in the Japanese, UK and European Equity teams before moving to the US Equity Team in 2008. Gary is a generalist investor but retains a special interest in the healthcare sector, dating back to his undergraduate degree. He graduated MBiochem in Biochemistry from Oxford University in 2003.

**Gary Robinson**  
Portfolio manager  
Appointed 2018

![img-11.jpeg](img-11.jpeg)

Kirsty is a portfolio manager in the US Equity Growth team. Kirsty joined Baillie Gifford in 2012 and began her career on the US Equity team, moving on to spend several years in the small and large cap global equities departments, before returning to the US Equity team. She graduated MA (Hons) in Economics in 2011 and MSc in Carbon Management in 2012, both from the University of Edinburgh.

**Kirsty Gibson**  
Portfolio manager  
Appointed 2021

### Managers and secretaries

The Company has appointed Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, as its Alternative Investment Fund Manager and Company Secretaries. Baillie Gifford & Co Limited has delegated portfolio management services to Baillie Gifford & Co. Dealing activity and transaction reporting have been further sub-delegated to Baillie Gifford Overseas Limited and Baillie Gifford Asia (Hong Kong) Limited. Baillie Gifford & Co is an investment management firm formed in 1927 out of the legal firm Baillie & Gifford, WS, which had been involved in investment management since 1908.

Baillie Gifford is one of the largest investment trust managers in the UK and currently manages thirteen closed-ended investment companies. Baillie Gifford also manages open-ended investment companies, together with investment portfolios on behalf of pension funds, charities and other institutional clients, both in the UK and overseas. Funds under the management or advice of Baillie Gifford totalled around £217.8 billion. Based in Edinburgh, it is one of the leading privately owned investment management firms in the UK, with 58 partners and a staff of around 1,700.

Baillie Gifford & Co Limited and Baillie Gifford & Co are both authorised and regulated by the Financial Conduct Authority.

60 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Directors’
## report
The Directors present their Corporate governance
report together with the Financial
The Corporate governance report is set out on pages
Statements of the Company for
66 to 72 and forms part of this report.
the year to 31 May 2024.
Managers and Company Secretaries
Baillie Gifford & Co Limited, a wholly owned
subsidiary of Baillie Gifford & Co, has been
appointed as the Company’s Alternative Investment
Fund Manager (‘AIFM’) and Company Secretaries.
Baillie Gifford & Co Limited has delegated portfolio
management services to Baillie Gifford & Co. Dealing
activity and transaction reporting have been further
sub-delegated to Baillie Gifford Overseas Limited and
Baillie Gifford Asia (Hong Kong) Limited.
The Investment Management Agreement between
the AIFM and the Company sets out the matters over
which the Managers have authority in accordance
with the policies and directions of, and subject to
restrictions imposed by, the Board. The Investment
Management Agreement is terminable on not less
than six months’ notice. Compensation fees would
only be payable in respect of the notice period if
termination by the Company were to occur within
a shorter notice period.
The annual management fee is 0.70% on the first
£100 million of net assets, 0.55% on the next
£900 million of net assets and 0.50% on the
remaining net assets. Management fees are
calculated and payable quarterly. The Board is of
the view that calculating the fee with reference to
performance would be unlikely to exert a positive
influence on performance.
The Board as a whole fulfils the functions of the
Management Engagement Committee. The Board
considers the Company’s investment management
and secretarial arrangements on a continuing basis
and a formal review is conducted at least annually.
61
Governance report
The Board considers, amongst others, the following Directors
topics in its review:
The names and biographical details of the Board
ș the quality of the personnel assigned to handle members who served on the Board as at the year
the Company’s affairs; end and up to the date the Financial Statements
were signed can be found on pages 58 and 59.
ș the investment process and the results achieved
to date; Each Director shall retire from office at each
Annual General Meeting and offer themselves
ș the administrative services provided by the
for re-election.
Secretaries; and
Following formal performance evaluation, the
ș the marketing effort undertaken by the Managers.
Board concluded that the performance of the
Following the most recent review, it is the opinion Directors continues to be effective and each remains
of the Directors that the continuing appointment of committed to the Company. Their contribution to the
Baillie Gifford & Co Limited as AIFM and Company Board is greatly valued and the Board recommends
Secretaries and the delegation of the investment their re-election to shareholders.
management services to Baillie Gifford & Co, and
the further sub-delegation of dealing activity and Directors’ indemnity and insurance
transaction reporting to Baillie Gifford Overseas The Company has entered into qualifying third party
Limited and Baillie Gifford Asia (Hong Kong) deeds of indemnity in favour of each of its Directors.
Limited, on the terms agreed, is in the interests The deeds, which were in force during the year
of the Company and the shareholders as a whole to 31 May 2024 and up to the date of approval of
due to the strength of the investment management this report, cover any liabilities that may arise to a
team, the Managers’ commitment to the investment third party, other than the Company, for negligence,
trust sector, the quality of the secretarial and default or breach of trust or duty. The Directors
administrative functions and the marketing efforts are not indemnified in respect of liabilities to the
undertaken by the Managers. Company, any regulatory or criminal fines, any costs
incurred in connection with criminal proceedings in
Depositary which the Director is convicted or civil proceedings
brought by the Company in which judgement is
In accordance with the Alternative Investment
given against him or her. In addition, the indemnity
Fund Managers Directive, the AIFM must appoint a
does not apply to any liability to the extent that it is
Depositary to the Company. The Bank of New York
recovered from another person.
Mellon (International) Limited has been appointed
as the Company’s Depository. The Company maintains Directors’ and Officers’
liability insurance.
The Depositary’s responsibilities include cash
monitoring, safe keeping of the Company’s financial
Conflicts of interest
instruments, verifying ownership and maintaining
a record of other assets and monitoring the Each Director submits a list of potential conflicts of
Company’s compliance with investment limits and interest to the Nomination Committee on an annual
leverage requirements. The custody function is basis. The Committee considers these carefully,
also undertaken by The Bank of New York Mellon taking into account the circumstances surrounding
(International) Limited (the ‘Custodian’). them, and makes a recommendation to the Board
on whether or not the potential conflicts should be
authorised. Board authorisation is for a period of
one year.
Having considered the lists of potential conflicts
there were no situations which gave rise to a direct
or indirect interest of a Director which conflicted
with the interests of the Company.
62 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

## Share capital

### Capital structure

The Company's capital structure (excluding treasury shares) as at 31 May 2024 consisted of 297,228,700 ordinary shares of 1p each (see note 12 to the Financial Statements on page 102). At 31 May 2024, 10,131,300 shares were held in treasury. There are no restrictions concerning the holding or transfer of the Company's ordinary shares and there are no special rights attached to any of the shares.

### Dividends

The ordinary shares carry a right to receive dividends. Interim dividends are determined by the Directors, whereas any proposed final dividend is subject to shareholder approval. The Company's objective is to produce capital growth and the policy is only to distribute, by way of a final dividend, the minimum permissible to maintain investment trust status. No dividends were declared during, or in respect of, the period.

### Capital entitlement

On a winding up, after meeting the liabilities of the Company, the surplus assets will be paid to ordinary shareholders in proportion to their shareholdings.

### Voting

Each ordinary shareholder present in person or by proxy is entitled to one vote on a show of hands and, on a poll, to one vote for every share held.

Information on the deadlines for proxy appointments for the forthcoming AGM can be found on pages 116 and 117.

### Major interests disclosed in the Company's shares

|  Name | Ordinary 1p shares held at 31 May 2024 | % of issue at 31 May 2024  |
| --- | --- | --- |
|  Saba Capital Management, L.P. (indirect) | 39,339,754 | 13.2  |
|  Brewin Dolphin Limited (indirect) | 27,039,346 | 9.1  |
|  Quilter plc (indirect) | 14,967,518 | 5.0  |

Subsequent to the year end on 12 June 2024 the Company received notification that Quilter plc held 14,812,038 shares, being 4.98% of the shares in issue. On 19 June 2024 the Company received

notification Saba Capital Management, L.P. held 41,894,682 shares, being 14.1% of the shares in issue. The Company received further notification on 13 August 2024 that Saba Capital Management, L.P. held 44,308,785, being 15.0% of the shares in issue. There have been no further notifications of major interests in the Company's shares intimated up to 16 August 2024.

### Analysis of shareholders at 31 May

|   | 2024 Number of shares held | 2024 % | 2023 Number of shares held | 2023 %  |
| --- | --- | --- | --- | --- |
|  Institutions | 36,077,259 | 12.1 | 45,557,960 | 14.9  |
|  Intermediaries | 218,868,169 | 73.6 | 240,643,562 | 78.9  |
|  Individuals | 432,785 | 0.2 | 1,552,388 | 0.5  |
|  Marketmakers | 41,850,487 | 14.1 | 17,399,790 | 5.7  |
|   | **297,228,700** | **100.0** | **305,153,700** | **100.0**  |

## Annual General Meeting

### Issuance of shares

At the last Annual General Meeting, the Directors were granted shareholders' approval for a general authority to allot shares and also an authority to issue shares or sell shares held in treasury on a non pre-emptive basis (without first offering such shares to existing shareholders pro rata to their existing holdings). No shares were issued during the year (2023 – no shares were issued).

Both authorities expire at the forthcoming Annual General Meeting and the Directors are seeking shareholders' approval to renew them for a further year, as detailed below.

Resolution 10 in the Notice of Annual General Meeting seeks a general authority in substitution to the Company's existing authorities for the Directors to issue ordinary shares or C shares up to an aggregate nominal amount of £984,262.33. This amount represents one-third of the Company's total ordinary share capital in issue (excluding treasury shares) at 16 August 2024 and meets institutional guidelines. This authority would be in substitution for the existing authority and will continue until the conclusion of the Annual General Meeting to be held in 2025 or on the expiry of 15 months from the passing of the resolution, if earlier.

63
Governance report

Resolution 11, which is proposed as a special resolution, seeks authority for the Directors to allot equity securities or sell treasury shares on a non pre-emptive basis for cash up to an aggregate nominal amount of £295,278.70 (representing 10% of the issued ordinary share capital of the Company excluding treasury shares as at 16 August 2024). This authority would be in substitution for the existing authority and will continue until the conclusion of the Annual General Meeting to be held in 2025 or on the expiry of 15 months from the passing of the resolution, if earlier.

The Directors consider that the authorities proposed to be granted by Resolutions 10 and 11 continue to be advantageous when the Company's shares trade at a premium to net asset value and the level of natural liquidity in the market is unable to meet demand.

Such authorities will only be used to issue ordinary shares or sell ordinary shares from treasury at a premium to net asset value and only when the Directors believe that it would be in the best interests of the Company to do so. The Directors believe that the ability to buyback shares at a discount and re-sell them or issue new ordinary shares at a premium are useful tools in smoothing supply and demand.

12,081,300 shares were held in treasury as at 16 August 2024.

#### **Market purchases of shares by the Company**

At the last Annual General Meeting the Company was granted authority to purchase up to 45,742,539 ordinary shares (equivalent to approximately 14.99% of the ordinary shares in issue (excluding treasury shares) as at 14 August 2023). This authority expires at the forthcoming Annual General Meeting. 7,925,000 shares were bought back during the year under review and 10,131,300 shares are held in treasury at 31 May 2024. Between 1 June 2024 and 16 August 2024 a further 1,950,000 shares were bought back.

Share buy-backs may be made principally:

i. to enhance net asset value for continuing shareholders by purchasing shares at a discount to the prevailing net asset value; and
ii. to address any imbalance between the supply of and the demand for the Company's shares that results in a discount of the quoted market price to the published net asset value per share.

The Company may hold bought back shares in treasury and then:

i. sell such shares (or any of them) for cash (or its equivalent under the Companies Act 2006); or
ii. cancel the shares (or any of them).

Shares will only be re-sold from treasury at a premium to net asset value per ordinary share.

Treasury shares do not receive distributions and the Company is not entitled to exercise voting rights attaching to them.

The Directors are seeking shareholders' approval at the Annual General Meeting to renew the authority to purchase up to 44,262,277 ordinary shares in issue (excluding treasury shares) as at 16 August 2024, being the latest practicable date prior to the publication of this document (or, if less, the number representing approximately 14.99% of the Company's ordinary shares in issue (excluding treasury shares) at the date of passing of the resolution, such authority to expire at the Annual General Meeting of the Company to be held in 2025.

In accordance with the UK Listing Rules, the maximum price (excluding expenses) that may be paid on the exercise of the authority must not exceed the higher of:

i. 5% above the average closing price on the London Stock Exchange of an ordinary share over the five business days immediately preceding the date of purchase; and
ii. an amount equal to the higher of the price of the last independent trade of an ordinary share and the highest current independent bid for an ordinary share on the trading venue where the purchase is carried out.

The minimum price (exclusive of expenses) that may be paid will be the nominal value of an ordinary share. Purchases of shares will be made within guidelines established, from time to time, by the Board. Your attention is drawn to Resolution 12 in the Notice of Annual General Meeting.

#### **Recommendation**

The Directors consider each resolution being proposed at the Annual General Meeting to be in the best interests of the Company and its shareholders as a whole and they unanimously recommend that all shareholders vote in favour of them, as they intend to do where possible in respect of their own beneficial shareholdings.

64 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Financial instruments Greenhouse Gas Emissions and Streamlined
The Company’s financial instruments comprise Energy and Carbon Report (‘SECR’)
its investment portfolio, cash balances, bank All of the Company’s activities are outsourced
borrowings and debtors and creditors that arise to third parties. The Company therefore has no
directly from its operations such as sales and greenhouse gas emissions to report from its
purchases awaiting settlement and accrued income. operations, nor does it have responsibility for any
The financial risk management objectives and other emissions producing sources under the
policies arising from its financial instruments and
Companies Act 2006 (Strategic report and Directors’
the exposure of the Company to risk are disclosed
reports) Regulations 2013. For the reasons set
in note 17 to the Financial Statements on pages 104
out above, the Company considers itself to be a
to 111.
low energy user and, therefore, is not required to
disclose energy and carbon information under the
Articles of Association SECR regulations.
The Company’s Articles of Association may only be
amended by special resolution at a general meeting Bribery Act
of shareholders.
The Company has a zero tolerance policy towards
bribery and is committed to carrying out business
Disclosure of information to Auditor fairly, honestly and openly. The Managers also adopt
The Directors confirm that so far as each of a zero tolerance approach and have policies and
the Directors is aware there is no relevant audit procedures in place to prevent bribery.
information of which the Company’s Auditor is
unaware and the Directors have taken all the steps Criminal Finances Act 2017
that they ought to have taken as Directors in order
The Company has a commitment to zero tolerance
to make themselves aware of any relevant audit
towards the criminal facilitation of tax evasion.
information and to establish that the Company’s
Auditor is aware of that information.
On behalf of the Board
Independent Auditor Tom Burnet
Chair
The Auditor, Ernst & Young LLP, is willing to
21 August 2024
continue in office and, in accordance with section
489 and section 491(1) of the Companies Act
2006, resolutions concerning Ernst & Young LLP’s
reappointment and remuneration will be submitted
to the Annual General Meeting.
Post balance sheet events
The Directors confirm that there have been no post
Balance Sheet events which require adjustment of
in, the Financial Statements or notes thereto up to
21 August 2024.
65
Governance report
## Corporate
## governance report
The Board is committed to Compliance
achieving and demonstrating
The Board confirms that the Company has complied throughout the
high standards of corporate
year under review with the relevant provisions of the Code (with the
governance. The Association of
exception of the membership of the Audit Committee noted below) and
Investment Companies (‘AIC’)
the recommendations of the AIC Code. The Code includes provisions
Code of Corporate Governance
relating to the role of the chief executive, executive directors’
(‘AIC Code’) provides a framework
remuneration and the need for an internal audit function. Given that
of best practice for investment
the Company is an externally managed investment trust, the Board
companies and can be found
considers these provisions are not relevant to the Company. The
at theaic.co.uk. The Financial
need for an internal audit function specific to the Company has been
Reporting Council (‘FRC’) has
addressed on page 73. Although the AIC Code permits the Chair of
confirmed that AIC members who
the Board to be a member of the Audit Committee, the Code does not.
report against the AIC Code, as is
The Board believes it is appropriate for Mr TJW Burnet to be a member
the case with the Company, will
of the Audit Committee due to the small size of the Board and his
be meeting their obligations in
knowledge, experience and professional expertise being a significant
relation to the 2018 UK Corporate
benefit to the Committee. Mr TJW Burnet was and continues to be
Governance Code (the UK ‘Code’),
considered independent.
which can be found at frc.org.uk.
The Board
The Board has overall responsibility for the Company’s affairs. It has a
number of matters formally reserved for its approval including strategy,
investment policy, currency hedging, gearing, treasury matters,
dividend and corporate governance policy. A separate strategy session
is held annually. The Board also reviews the Financial Statements,
investment transactions, revenue budgets and performance of the
Company. Full and timely information is provided to the Board to enable
the Board to function effectively and to allow Directors to discharge
their responsibilities.
At 31 May 2024 the Board comprised five Directors all of whom are
non-executive.
The Chair, Mr TJW Burnet, is responsible for organising the business of
the Board, ensuring its effectiveness and setting its agenda.
The executive responsibilities for investment management have been
delegated to the Company’s Alternative Investment Fund Manager
(‘AIFM’), Baillie Gifford & Co Limited, and, in the context of a Board
comprising entirely non-executive Directors, there is no chief executive
officer. The Senior Independent Director is Ms SP Inglis.
The Directors believe that the Board has a balance of skills and
experience which enable it to provide effective strategic leadership and
proper governance of the Company. Information about the Directors,
including their relevant experience, can be found on pages 58 and 59.
66 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Board of Directors
Comprises independent
non-executive directors*
Chair: Tom Burnet
Senior Independent Director:
Sue Inglis
Audit Nomination
Committee Committee
Chair: Graham Paterson Chair: Tom Burnet
Purpose: The primary purpose of the Purpose: The main purpose of the
Company’s Audit Committee is to provide Nomination Committee is to oversee Board
oversight of the financial reporting process, recruitment and succession planning as
the audit process, the Company’s system well as Board appraisals including
of internal controls and compliance with identifying training needs.
laws and regulations.
Third-party service providers
appointed by the Board
Alternative Investment Fund Managers and Company Secretaries:
Baillie Gifford & Co Limited (wholly owned
subsidiary of Baillie Gifford & Co)
Dealing activity and transaction reporting:
Baillie Gifford Overseas Limited and
Baillie Gifford Asia (Hong Kong) Limited
Portfolio management:
Baillie Gifford & Co
The Bank of Computershare Panmure Liberum
Ernst & Young
New York Mellon Investor Services Limited
LLP
(International) Limited PLC
Company broker
Auditor
Depositary and Custodian Registrar
* The independent non-executive directors are made up of Tom Burnet, Sue Inglis, Chris van der Kuyl, Rachael Palmer and Graham Paterson.
Further details on their experience and contribution to the Board can be found on pages 58 and 59.
67
Governance report
There is an agreed procedure for Directors to seek Following formal performance evaluation the
independent professional advice if necessary at the Board considers that each Director continues to
Company’s expense. No such advice was sought in be independent in character and judgement and
the year to 31 May 2024 or 31 May 2023. their skills and experience are a significant benefit
to the Board.
Appointments to the Board
Meetings
The terms and conditions of Directors’ appointments
are set out in formal letters of appointment which are There is an annual cycle of Board meetings which
available for inspection on request. is designed to address, in a systematic way, overall
strategy, review of investment policy, investment
Under the provisions of the Company’s Articles
performance, marketing, revenue budgets, dividend
of Association, a Director appointed during the
policy and communication with shareholders. The
period is required to retire and seek election by
Board considers that it meets sufficiently regularly
shareholders at the next Annual General Meeting.
to discharge its duties effectively. The following
In accordance with the Code, all Directors will retire
table shows the attendance record for the Board and
from office at each Annual General Meeting and,
Committee meetings held during the year, excluding
if appropriate, offer themselves for re-election.
ancillary and sub-committee meetings. The Annual
The reasons why the Board supports the Directors General Meeting was attended by all the Directors
re-election are set out on page 62. with the exception of Mr van der Kuyl.
Directors are not entitled to any termination
Directors’ attendance at meetings
payments in relation to their appointment.
Audit Nomination
Board Committee Committee
Chair and Directors’ tenure
The Nomination Committee has considered the Number of meetings 4 4 1
question of tenure for Directors and has concluded
TJW Burnet 4 4 1
that there should not be a set maximum time
SP Inglis 4 4 1
limit for a Director or Chair to serve on the Board.
GD Paterson 4 4 1
The Nomination Committee keeps under review
CRD van der Kuyl 3 4 1
the balance of skills, knowledge, experience,
performance and length of service of the Directors RL Palmer 4 4 1
ensuring the Board has the right combination of
skills and preservation of knowledge and experience
Nomination Committee
balanced with the appointment of new Directors
The Nomination Committee consists of the whole
bringing in fresh ideas and perspective.
Board due to its relatively modest size. The Chair
of the Board is Chair of the Committee. The
Independence of Directors
Committee meets on an annual basis and at such
All of the Directors are considered by the Board to other times as may be required. The Committee has
be independent of the Managers and free of any written terms of reference which include reviewing
business or other relationship which could interfere the composition of the Board, identifying and
with the exercise of their independent judgement. nominating new candidates for appointment to
the Board, Board appraisal, Board independence,
The Directors recognise the importance of
succession planning and training. The Committee
succession planning for company boards and
also considers whether Directors should be
reviews the Board composition annually. The
recommended for re-election by shareholders. The
Board is of the view that length of service will not
Committee is responsible for considering Directors’
necessarily compromise the independence or
potential conflicts of interest and for making
contribution of Directors of an investment trust
recommendations to the Board on whether or not
company, where continuity and experience can be
the potential conflicts should be authorised.
a benefit to the Board.
The Committee’s terms of reference are available
on request from the Company and on the Company
website: bgusgrowthtrust.com.
68 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Board diversity As an externally managed investment company with
no chief executive officer (CEO) or chief financial
Diversity policy
officer (CFO), the Board considers the Chairs of
Appointments to the Board are made on merit with the Audit Committee and Nomination Committee
due regard for the benefits of diversity including to be senior roles in addition to the roles of Senior
gender, social and ethnic backgrounds and cognitive Independent Director and Board Chair identified as
and personal strengths. The priority in appointing such by the FCA.
new Directors is to identify the candidate with the
best range of skills and experience to complement Board composition
existing Directors, with a view to ensuring that the In order to fulfil its obligations, the Board recognises
Board remains well placed to help the Company the importance of having a range of skilled and
achieve its investment and governance objectives. experienced Directors, balancing the benefits of
length of service and knowledge of the Company
The following disclosures are provided in respect
with the desirability of ensuring regular refreshment
of the UK Listing Rules targets that: i) 40% of a
of the Board.
board should be women; ii) at least one senior role
should be held by a woman; and iii) at least one The Board reviewed the composition of the Board
board member should be from a non-white ethnic during the year in consideration of succession
background, as defined by the Office of National planning and developing a diverse pipeline.
Statistics (ONS) criteria.
In line with the AIC Corporate Governance Code
The breakdown of gender diversity and ethnic principle that ‘a successful company is led by
background on the Board is shown below. an effective Board, whose role is to promote the
long-term sustainable success of the company,
generating value for shareholders and contributing
% of the Senior
Gender Number Board roles to wider society’ the Board will be undertaking a
recruitment process in the coming years to allow
Men 3 60% 1 *
time for an appropriate transition period. The
Women 2 40% 1
intention of the Board is that Director retirements
5 100% will be staggered, ensuring the experience and
* The Board Chair, being a senior position in accordance with the UK diversity of the Board is maintained and effective
Listing Rules. The Board also considers the Nomination Committee succession planning occurs.
and Audit Committee Chairs to be senior positions. The Nomination
Committee Chair is also the Board Chair. The Audit Committee Chair
is a man.
Performance evaluation
An appraisal of the Chair, each Director and a
% of the Senior
performance evaluation and review of the Board
Ethnic background Number Board roles
as a whole and its Committees was carried out during
White British or 4 80% 2 *
the year. After completing an evaluation questionnaire
Other White (including
the results were discussed and reviewed by the
minority white groups)
Board. The appraisal of the Chair was led by Ms SP
Black/African/ 1 20% –
Inglis, the Senior Independent Director.
Caribbean/Black British
The appraisals and evaluations considered,
5 100%
amongst other criteria, the balance of skills of the
* The Board Chair and SID, being senior positions in accordance with the
Board, training and development requirements, the
UK Listing Rules. The Board also considers the Nomination Committee
and Audit Committee Chairs to be senior positions. The Nomination contribution of individual Directors and the overall
Committee Chair is also the Board Chair. The Audit Committee Chair’s
effectiveness of the Board and its Committees.
ethnic background is White.
Following this process it was concluded that the
performance of each Director, the Chair, the Board
As at 31 May 2024, the Board complied with
and its Committees continues to be effective and
the UK Listing Rule target with respect to ethnic
the Chair and each of the other Directors remains
background and the 40% target for women. The
committed to the Company.
Board also meets the UK Listing Rules target for a
woman holding a senior role on the Board (Ms SP
Inglis is the Senior Independent Director).
69
Governance report
A review of the Chair’s and the other Directors’ The practical measures in relation to the design,
commitments was carried out and the Nomination implementation and maintenance of control policies
Committee is satisfied that they are capable of and procedures to safeguard the Company’s
devoting sufficient time to the Company. There assets and to manage its affairs properly, including
were no significant changes to the Chair’s other the maintenance of effective operational and
commitments during the year. compliance controls, have been delegated to the
Managers and Secretaries.
The Company became a constituent of the FTSE
350 Index in January 2024. The Board intends that The Board oversees the functions delegated to the
an independent external agency will be engaged Managers and Secretaries and the controls managed
to carry out the evaluation following the third by the AIFM in accordance with the UK Alternative
anniversary of the Company’s addition to the Investment Fund Managers Regulations (as detailed
FTSE 350 Index. below). Baillie Gifford & Co’s Internal Audit and
Compliance Departments and the AIFM’s permanent
Induction and training risk function provide the Audit Committee with
regular reports on their monitoring programmes.
New Directors are provided with an induction
The reporting procedures for these departments
programme which is tailored to the particular
are defined and formalised within a service level
circumstances of the appointee. Regular briefings
agreement. Baillie Gifford & Co conducts an annual
were provided during the year on industry and
review of its system of internal controls which is
regulatory matters. Directors receive other relevant
documented within an internal controls report which
training as necessary.
complies with ISAE 3402 – Assurance Reports on
Internal Controls of Service Organisations made
Remuneration
available to Third Parties. This report is independently
As all the Directors are non-executive, there is
reviewed by Baillie Gifford & Co’s auditor and a copy
no requirement for a separate Remuneration
is submitted to the Audit Committee.
Committee. Directors’ fees are considered by the
A report identifying the material risks faced by the
Board as a whole within the limits approved
Company and the key controls employed to manage
by shareholders. The Company’s policy on
these risks is reviewed by the Audit Committee.
remuneration is set out in the Directors’
Remuneration report on page 77. These procedures ensure that consideration is
given regularly to the nature and extent of risks
Audit Committee facing the Company and that they are being
actively monitored. Where changes in risk have
The report of the Audit Committee is set out on
been identified during the year they also provide
pages 73 to 75.
a mechanism to assess whether further action is
required to manage these risks.
Internal controls and risk management
The Board confirms that these procedures have
The Directors acknowledge their responsibility
been in place throughout the Company’s financial
for the Company’s risk management and
year and continue to be in place up to the date of
internal controls systems and for reviewing their
approval of this report.
effectiveness. The systems are designed to manage
rather than eliminate the risk of failure to achieve
To comply with the UK Alternative Investment Fund
business objectives and can only provide reasonable
Managers Regulations, The Bank of New York
but not absolute assurance against material
Mellon (International) Limited acts as the Company’s
misstatement or loss.
Depositary and Baillie Gifford & Co Limited as its
AIFM.
The Board confirms that there is a continuing
process for identifying, evaluating and managing
The Depositary’s responsibilities include cash
the significant risks faced by the Company in
monitoring, safe keeping of the Company’s financial
accordance with the FRC ‘Guidance on Risk
instruments, verifying ownership and maintaining a
Management, Internal Control and Related Financial
record of other assets and monitoring the Company’s
and Business Reporting’. No significant weaknesses
compliance with investment limits and leverage
were identified in the year under review and up to
requirements. The Depositary is liable for the loss of
the date of this report.
financial instruments held in custody. The Depositary
will ensure that any delegate segregates the assets
70 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
of the Company. The Company’s Depositary also The Company’s assets, the majority of which are
acts as the Company’s Custodian. The Custodian investments in quoted securities which are readily
prepares reports on its key controls and safeguards realisable, exceed its liabilities significantly. All
which are independently reviewed by its appointed borrowings require the prior approval of the Board.
auditor. The reports are reviewed by Baillie Gifford’s Gearing levels and compliance with borrowing
Business Risk Department and a summary of the key covenants are reviewed by the Board on a regular
points is reported to the Audit Committee and any basis. As at 31 May 2024, the Company had a net
concerns are investigated. current liability of £34.3 million primarily as a result
of the two US$25 million revolving credit facilities.
The Depositary provides the Audit Committee with a
The Company has continued to comply with the
report on its monitoring activities.
investment trust status requirements of section 1158
The AIFM has established a permanent risk of the Corporation Tax Act 2010 and the Investment
management function to ensure that effective risk Trust (Approved Company) (Tax) Regulations 2011.
management policies and procedures are in place
Accordingly, the Financial Statements have been
and to monitor compliance with risk limits. The AIFM
prepared on the going concern basis as it is the
has a risk management policy which covers the risks
Directors’ opinion, having assessed the principal
associated with the management of the portfolio,
and emerging risks and other matters set out in
and the adequacy and effectiveness of this policy
the viability statement on page 53, which assesses
is reviewed and approved at least annually. This
the prospects of the Company over a period of five
review includes the risk management processes and
years, that the Company will continue in operational
systems and limits for each risk area.
existence for a period of at least twelve months from
The risk limits, which are set by the AIFM and the date of approval of the Financial Statements.
approved by the Board, take into account the
objectives, strategy and risk profile of the portfolio.
Relations with shareholders
These limits, including leverage (see page 119) are
The Board places great importance on
monitored and the sensitivity of the portfolio to key
communication with shareholders. The Company’s
risks is undertaken periodically as appropriate to
Managers meet regularly with shareholders and
ascertain the impact of changes in key variables
their representatives and report shareholders’ views
in the portfolio. Exceptions from limits monitoring
to the Board. The Chair is available to meet with
and stress testing undertaken by Baillie Gifford’s
shareholders as appropriate. Shareholders wishing
Business Risk Department are escalated to the AIFM
to communicate with any member of the Board may
and reported to the Board along with any remedial
do so by writing to them at the Company’s registered
measures being taken. No exceptions occurred
office or through the Company’s broker, Panmure
during the year.
Liberum Limited (see contact details on page 129).
The Company’s Annual General Meeting provides
Going concern
a forum for communication with all shareholders.
In accordance with the Financial Reporting Council’s
The level of proxies lodged for each resolution
guidance on going concern and liquidity risk, the
will be announced at the Meeting and is published
Directors have undertaken a rigorous review of the
on the Company website bgusgrowthtrust.com
Company’s ability to continue as a going concern.
subsequent to the meeting.
The Company’s principal risks are market related
The notice period for the Annual General Meeting
and include market risk, liquidity risk and credit
is at least twenty working days.
risk. An explanation of these risks and how they are
managed is set out on pages 48 to 52 and contained Shareholders and potential investors may obtain
in note 17 to the Financial Statements on pages 104 up-to-date information on the Company at
to 111. bgusgrowthtrust.com.
The Board has considered in particular, the impact of
heightened market volatility due to macroeconomic
and geopolitical concerns, but does not believe the
Company’s going concern status is affected.
71
Governance report
Corporate governance and stewardship comparisons company-to-company and year-on-
year. Based on the most recent analysis, as at 31
The Company has given discretionary voting powers
May 2024 the carbon intensity of Baillie Gifford
to Baillie Gifford & Co. The Managers vote against
US Growth Trust’s portfolio was 89.4% lower than
resolutions they consider may damage shareholders’
the Company’s benchmark (S&P 500 Index). This
rights or economic interests and report their actions
analysis estimate is based on the 64% of the value
to the Board.
of the Company’s portfolio which reports on carbon
The Company believes that it is in the shareholders’
emissions and other carbon-related characteristics
interests to consider environmental, social and
and Scope 1&2 Weighted Average Carbon Intensity
governance (‘ESG’) factors, including climate
(WACI) by Revenue. Carbon intensity measures the
change, when selecting and retaining investments
carbon efficiency of the portfolio per unit of output
and has asked the Managers to take these issues
and assesses the portfolio’s exposure to carbon-
into account as long as the investment objectives
intensive companies.
are not compromised. The Managers do not exclude
Baillie Gifford’s Task Force on Climate-Related
companies from their investment universe purely
Financial Disclosures (‘TCFD’) Climate report
on the grounds of ESG factors but adopt a positive
is available on the Managers’ website at
engagement approach whereby matters
bailliegifford.com. A TCFD climate report for
are discussed with management with the aim of
Baillie Gifford US Growth is available on the
improving the relevant policies and management
Company website at bgusgrowthtrust.com.
systems and enabling the Managers to consider
how ESG factors could impact long term investment The Managers, Baillie Gifford & Co, are signatories
returns. The Managers’ statement of compliance to the Principles for Responsible Investment, the
with the UK Stewardship Code can be found on Net Zero Asset Managers initiative and the Carbon
the Managers’ website at bailliegifford.com. The Disclosure Project and are also members of the
Managers’ policy has been reviewed and endorsed Asian Corporate Governance Association and the
by the Board. Baillie Gifford & Co has considered the International Corporate Governance Network.
Sustainable Finance Disclosure Regulation (‘SFDR’)
and further details can be found on page 121.
On behalf of the Board
Tom Burnet
Climate change
Chair
The Board recognises that climate change poses
21 August 2024
a serious threat to our environment, our society
and economies and companies around the globe.
Addressing the underlying causes is likely to result
in companies that are high emitters of carbon facing
greater societal and regulatory scrutiny and higher
costs to account for the true environmental impact
of their activities. The Managers pursuit of long-term
growth opportunities typically involves investment
in entrepreneurial, disruptive and technology-driven
businesses. These companies are often capital-light
with a low carbon footprint.
The Managers’ utilise data sourced from a third
party provider to map the carbon footprint of the
equity portfolio, using the information to prioritise
engagement and understand what higher emitting
companies are doing to manage climate risk better.
Best practice in this area is evolving rapidly, and
it is therefore challenging to establish reliable
72 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Audit
## Committee report

| The Audit Committee consists of all the independent | ș the Company’s accounting policies and |  |
| --- | --- | --- |
| Directors. The 2019 AIC Code of Corporate |  | practices and the implementation of the |
| Governance permits the Chair of the Board to be a |  | Managers’ valuation policy for investments |
| member of the Audit Committee. The Board believes |  | in unlisted (private) companies; |

that Mr TJW Burnet’s knowledge, experience and
ș the regulatory changes impacting the Company;
professional expertise is a significant benefit to
the Committee. The members of the Committee ș the fairness, balance and understandability of
consider that they have the requisite financial the Annual Report and Financial Statements and
skills and experience to fulfil the responsibilities whether it provided the information necessary
of the Committee. Mr GD Paterson, Chair of the for shareholders to assess the Company’s
Committee, is a Chartered Accountant. performance, business model and strategy;
The Committee’s authority and duties are clearly ș the effectiveness of the Company’s
defined within its written terms of reference internal control environment;
which are available on request from the Company
ș the appointment, remuneration and terms of
Secretaries and at bgusgrowthtrust.com. The terms
engagement of the external Auditor;
of reference are reviewed annually.
ș the policy on the engagement of the external
The Committee’s effectiveness is reviewed on an
Auditor to supply non-audit services;
annual basis as part of the Board’s performance
ș the independence and objectivity of the
evaluation process.
external Auditor and the effectiveness of
At least once a year, where deemed necessary,
the audit process;
the Committee meets with the external Auditor
ș the need for the Company to have
without any representative of the Managers being
its own internal audit function;
present.
ș internal controls reports received from the
Main activities of the Committee Managers and other service providers; and
The Committee met twice during the year, and the
ș the arrangements in place within Baillie Gifford
external Auditor, Ernst & Young LLP, attended both
& Co whereby its staff may, in confidence,
meetings. Baillie Gifford & Co’s Internal Audit and
raise concerns about possible improprieties in
Compliance Departments and the AIFM’s permanent
matters of financial reporting or other matters.
risk function provided reports on their monitoring
programmes for these meetings. In addition, the
Internal audit
external Auditor met with the Audit Committee Chair
The Committee continues to believe that the
on an ad hoc basis to discuss matters pertinent to
compliance and internal controls systems and the
the Committee as they arose.
internal audit function in place within the Managers
The matters considered, monitored and reviewed
provide sufficient assurance that a sound system
by the Committee during the course of the year
of internal control, which safeguards shareholders’
included the following:
investment and the Company’s assets, is maintained.
An internal audit function, specific to the Company,
ș the results announcements and the
is therefore considered unnecessary.
Annual and Interim Reports;
73
Governance report
Financial reporting from the Managers on the cash position and cash
flow projections of the Company, the liquidity of
The Committee considers that the most significant
its investment portfolio, compliance with debt
area of risk likely to impact the Financial Statements
covenants, availability of borrowing facilities and
is the existence, ownership and valuation of
the Company’s ability to meet its obligations as they
investments as they represent 99.3% of total assets.
fall due. The Committee also reviewed the viability
statement on page 53 and statement on going
Unlisted (private company) investments
concern on page 71. Following this assessment,
The Committee reviewed the Managers’ valuation
the Committee recommended to the Board the
approach for investments in unquoted companies
appropriateness of the going concern basis in
(as described on pages 34, 95 and 96) and approved
preparing the Financial Statements and confirmed
the valuations of the unlisted investments following
the accuracy of the viability statement and
a detailed review of the valuation of each investment
statement on going concern.
and relevant challenge where appropriate.
The Managers and Auditor confirmed to the
The Auditor agreed the holdings in certificated form
Committee that they were not aware of any material
to confirmations from the Company’s Custodian and
misstatements in the context of the Financial
holdings of uncertificated unlisted investments to
Statements as a whole and that the Financial
confirmations from the relevant investee companies.
Statements are in accordance with applicable
law and accounting standards.
Listed investments
The majority of the investments are in quoted
Internal controls and risk management
securities and market prices are readily available
from independent external pricing sources. The The Committee reviewed the effectiveness of the
Committee reviewed Baillie Gifford’s report on Company’s risk management and internal controls
Internal Controls which details the controls in place systems as described on pages 70 and 71. No
regarding the recording and pricing of investments. significant weaknesses were identified in the year
under review.
The Managers agreed the prices of all the
listed investments at 31 May 2024 to external
External Auditor
price sources and the holdings were agreed to
To fulfil its responsibility regarding the independence
confirmations from the Company’s Custodian or
of the external Auditor, the Committee reviewed:
Transfer Agent.
ș the Auditor’s audit strategy for the year to
FRC Audit Quality Review
31 May 2024 which included a report from
The Financial Reporting Council (‘FRC’) reviewed the Auditor describing their arrangements to
the audit of the Company’s Financial Statements manage Auditor independence and received
for the year to 31 May 2023. The audit for the year confirmation of their independence; and
to 31 May 2023 was performed by KPMG LLP.
ș the extent of non-audit services provided by

| The FRC assessed the audit as good. A good quality | the external Auditor. There were no non-audit |
| --- | --- |
| assessment indicates that no key or other findings | fees paid to the external Auditor in the year |
| were identified. | to 31 May 2024 or the year to 31 May 2023. |

To assess the effectiveness of the external Auditor,
Other matters
the Committee reviewed and considered:
The Committee reviewed the Managers’ report on
Internal Controls which details the controls in place ș the Auditor’s fulfilment of the agreed audit plan;
regarding completeness and accurate recording of
ș the Audit Quality Inspection report on
investment income. The accounting treatment of any
Ernst & Young LLP issued by the FRC’s
special dividends received or receivable during the
Audit Quality Review team (‘AQRT’); and
year is reviewed by the Managers as they arise.
ș detailed discussion with audit personnel to
The Committee considered the factors that might
challenge audit processes and deliverables.
affect the Company’s viability over a period of five
years and its ability to continue as a going concern
for at least twelve months from the date of signing
of the Financial Statements, together with reports
74 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Non-audit service requests are considered on a case In recognition of underlying audit rotation
by case basis. requirements, the Committee intends to undertake
a further tender process no later than the year to
To fulfil its responsibility for oversight of
31 May 2033.
the external audit process the Committee
considered and reviewed:
Regulatory compliance
ș the Auditor’s engagement letter;
The Committee confirms that the Company is in
ș the Auditor’s proposed audit strategy; compliance with the requirements of the Statutory
Audit Services for Large Companies Market
ș the audit fee; and
Investigation (Mandatory Use of Competitive Tender
ș a report from the Auditor on the
Processes and Audit Committee Responsibilities)
conclusion of the audit.
Order 2014, which relates to the frequency and
governance of tenders for the appointment of
Ernst & Young LLP was appointed as the Company’s
the external Auditor and the setting of policy
Auditor, by the Directors, in October 2023. The
on the provision of non-audit services.
audit partner responsible for the audit is to be
rotated at least every five years in accordance with
professional and regulatory standards in order to Accountability and audit
protect independence and objectivity and to provide The respective responsibilities of the Directors
fresh challenge to the business. Mr Ahmer Huda, and the Auditor in connection with the Financial
the current audit partner, will continue as audit Statements are set out on pages 80 and 81.
partner until the conclusion of the 2028 audit. Ernst
& Young LLP has confirmed that it believes it is
independent within the meaning of regulatory and On behalf of the Board
professional requirements and that the objectivity Graham Paterson
of the audit partner and staff is not impaired. Audit Committee Chair
21 August 2024
Having carried out the review described above,
the Committee is satisfied that the Auditor
has remained independent and effective
for the purposes of this year’s audit.
There are no contractual obligations restricting
the Committee’s choice of external Auditor.
Audit tender
The Committee acknowledges its responsibility
to monitor and, at suitable junctures, to test the
external audit market in order to ensure that
the provision of external audit services to the
Company remains of a high quality as well as cost
proportionate, by reference to developing industry
practice and expectations. The Committee is
aware that the scope, complexity and associated
cost of external audit engagements continues to
increase across the market, driven by a number of
factors including growing regulatory expectations,
new auditing standards, the significant volume
of work required to deliver a high-quality audit
and a challenging audit labour market.
Following the audit tender process conducted
during the year to 31 May 2023, the Board
unanimously decided to appoint Ernst & Young
LLP as Auditor with effect from the audit of the
Financial Statements for the year to 31 May 2024.
75
Governance report

# Directors' remuneration report

**This report has been prepared in accordance with the requirements of the Companies Act 2006.**

## **Statement by the Chair**

The Directors' remuneration policy is subject to shareholder approval every three years or sooner if an alteration to the policy is proposed. The remuneration policy, which is set out below, was last approved at the Annual General Meeting in September 2022 and no changes to the policy are proposed. An ordinary resolution for the approval of the remuneration policy will be put to the members at the Annual General Meeting in September 2025.

For the year to 31 May 2024 the Directors' remuneration was set at £30,755 per annum for each Director other than the Chair, who received an additional £11,665 per annum, Chair of the Audit Committee, who received an additional £7,000 per annum, and the Senior Independent Director who received an additional £1,590 per annum.

The Board reviewed the level of fees during the year and agreed that, with effect from 1 June 2024 the fee for the Chair would increase to £43,777, the Directors' fees would increase to £31,739, the additional fee for the Chair of the Audit Committee would increase to £7,224 and the additional fee for the Senior Independent Director would increase to £1,641. The fees were last increased on 1 June 2023.

76 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

| Directors’ remuneration policy | Limits on Directors’ remuneration |
| --- | --- |
| The Board is composed wholly of non-executive | The fees for the non-executive Directors are |
| Directors, none of whom has a service contract with | payable monthly in arrears and are determined |
| the Company. There is no separate remuneration | within the limit set out in the Company’s Articles of |
| committee and the Board as a whole considers | Association which is currently £300,000 per annum |
| changes to Directors’ fees from time to time. | in aggregate. Any change to this limit requires |

shareholder approval.
The Board’s policy is that the remuneration of
Directors should be set at a reasonable level that is The basic and additional fees payable to Directors
commensurate with the duties and responsibilities in respect of the year ended 31 May 2024 and the
of the role and consistent with the requirement fees payable in respect of the year ending 31 May
to attract and retain Directors of the appropriate 2025 are set out in the table below. The fees payable
quality and experience. The Board believes that to the Directors in the subsequent financial periods
the fees paid to the Directors should reflect the will be determined following an annual review of the
experience of the Board as a whole, be fair and Directors’ fees.
should take account of the level of fees paid by
Expected Fees for
comparable investment trusts. Any views expressed
fees for the year
by shareholders on the fees being paid to Directors

|  | the year | ended |
| --- | --- | --- |
| will be taken into consideration by the Board when | ending 31 | 31 May |
|  | May 2025 | 2024 |

reviewing the Board’s policy on remuneration. Baillie
£ £
Gifford & Co Limited, the Company Secretaries,
Chair’s fee 43,777 42,420
provides comparative information when the Board
considers the level of Directors’ fees. Non-executive Director fee 31,739 30,755
Additional fee for 7,224 7,000
Directors are not eligible for any other remuneration
Audit Committee Chair
or benefits apart from the reimbursement of
Additional fee for the 1,641 1,590
allowable expenses. There are no performance
Senior Independent Director
conditions relating to Directors’ fees and there
Total aggregate annual fees that can 300,000 300,000
are no long-term incentive schemes or pension
be paid to the Directors in any year
schemes. There is no notice period and no
under the Directors’ remuneration
compensation is payable on loss of office.
policy, as set out in the Company’s
Articles of Association
77
Governance report
Directors’ remuneration for the year (audited)
The Directors who served during the year received the following remuneration in the form of fees and
taxable benefits. This represents the entire remuneration paid to the Directors.
For the year ended 31 May 2024 For the year ended 31 May 2023
Taxable Taxable
Fees benefits * Total Fees benefits * Total
Name £ £ £ £ £ £
TJW Burnet (Chair) 42,420 – 42,420 40,400 – 40,400
GD Paterson (Audit Committee Chair) 37,755 – 37,755 34,340 – 34,340
SP Inglis (Senior Independent Director) 32,345 – 32,345 30,805 77 30,882
CRD van der Kuyl 30,755 – 30,755 29,290 157 29,447
RL Palmer 30,755 4,782 35,537 29,290 6,288 35,578
174,030 4,782 178,812 164,125 6,522 170,647
* Comprises expenses incurred by Directors in the course of travel to attend Board and Committee meetings held at the offices of Baillie Gifford & Co
Limited, the Company’s Secretaries. These amounts have been grossed up for income tax. The taxable benefits in the prior year were grossed up for
income tax and national insurance. The total taxable benefits payable to Directors for the year ended 31 May 2023 would have been £6,039 if prepared
on the same basis as the current year.
Annual report on remuneration Directors’ interests (audited)
An ordinary resolution for the approval of this report The Directors at the financial year end, and their
will be put to the members at the forthcoming interests in the Company, were as shown below.
Annual General Meeting. There have been no changes intimated in the
Directors’ interests up to 16 August 2024.
The law requires the Company’s Auditor to audit
certain of the disclosures provided in this report.

|  |  |  |  | Ordinary 1p | Ordinary 1p |
| --- | --- | --- | --- | --- | --- |
| Where disclosures have been audited, they are |  |  | Nature | shares held at | shares held at |
|  | Name | of interest |  | 31 May 2024 | 31 May 2023 |

indicated as such. The Auditor’s opinion is included
in Ernst & Young LLP’s report on pages 83 to 89.
TJW Burnet Beneficial 126,040 126,040
SP Inglis Beneficial 50,000 50,000
GD Paterson Beneficial 80,000 80,000
CRD van der Kuyl Beneficial 285,314 285,314
RL Palmer n/a – –
Annual percentage change in remuneration
This represents the annual percentage change in the total remuneration paid to the Directors.

|  | % change | % change |  | % change | % change |  |
| --- | --- | --- | --- | --- | --- | --- |
|  | from 2023 | from 2022 |  | from 2021 | from 2020 |  |
| Name | to 2024 |  | to 2023 | to 2022 |  | to 2021 |

TJW Burnet 5.0 1.0 15.9 –
SP Inglis 4.7 1.3 24.5 # –
GD Paterson 9.9 1.0 17.2 –

| CRD van der Kuyl (appointed 1 June 2021) 4.4 1.5 – | * | n/a |
| --- | --- | --- |
| RL Palmer (appointed 1 June 2021) (0.1) 11.7 – | * | n/a |
| * These percentage movements reflect the Directors’ appointments in the period. |  |  |
| # When the Board reviewed the level of fees during the year to 31 May 2021 an additional fee of £1,500 for the Senior Independent Director was |  |  |

introduced for the first time. In addition to this, Director fees were increased from £24,500 to £29,000 due to the increase in private company holdings.
78 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

| Statement of voting at Annual General Meeting | Company performance |
| --- | --- |
| At the Annual General Meeting held on | The following graph compares, for the period from |
| 16 September 2022 of the proxy votes received | 23 March 2018, launch date and first trade date, to |
| in respect of the Directors’ remuneration policy, | 31 May 2024, the share price total return (assuming |
| 99.77% were in favour, 0.20% were against | all dividends are reinvested) to the Company’s |
| and votes withheld were 0.03%. At the Annual | ordinary shareholders compared to the total |
| General Meeting held on 18 September 2023, | shareholder return on a notional investment made |
| of the proxy votes received in respect of the | up of shares in the component parts of the FTSE |
| Directors’ remuneration report, 99.66% were | All-Share Index. This index was chosen for |
| in favour, 0.28% were against and votes withheld | comparison purposes as it is a widely used |
| were 0.06%. | measure of performance for UK listed companies. |

Comparative index provided for information
Relative importance of spend on pay
purposes only.
As the Company has no employees, the Directors

| do not consider it appropriate to present a table | Performance graph |  |
| --- | --- | --- |
| comparing remuneration paid to employees with | The Company’s share price, FTSE All-Share Index |  |
| distributions to shareholders. The Directors’ | and comparative index | * |
| remuneration for the year and the expected fees | (figures have been rebased to 100 at 23 March 2018) |  |

for the year to 31 May 2025 are set out on page 77.
The table below shows the actual expenditure during
the year in relation to Directors’ remuneration and 350
distributions to shareholders.
300
2024 2023 Change 250
£’000 £’000 %
200
Directors’ 179 171 4.7
150
remuneration
100
Share buy-backs 14,550 – n/a
50
2024202320222021202020192018
Directors’ service details
BG US Growth share price
Date of Due date for *
Name appointment re-election
Source: LSEG/Baillie Gifford and relevant underlying index providers. See
TJW Burnet 5 March 2018 AGM in 2024
disclaimer on page 120.
SP Inglis 5 March 2018 AGM in 2024 All figures are total returns (see Glossary of terms and alternative
performance measures on pages 124 to 127).
CRD van der Kuyl 1 June 2021 AGM in 2024
*S&P 500 Index total return (in sterling terms). See disclaimer on page 120.
RL Palmer 1 June 2021 AGM in 2024
GD Paterson 5 March 2018 AGM in 2024
Past performance is not a guide to future
performance.
Approval
The Directors’ remuneration report on pages
76 to 79 was approved by the Board of Directors
and signed on its behalf on 21 August 2024.
Tom Burnet
400
Chair
79
Comparative index FTSE All-Share Index
Governance report
## Statement of
## Directors’ responsibilities
The Directors are responsible for preparing the The Directors are responsible for keeping adequate
Annual Report and the Financial Statements in accounting records that are sufficient to show and
accordance with applicable law and regulations. explain the Company’s transactions and disclose
with reasonable accuracy at any time the financial
Company law requires the Directors to prepare
position of the Company and enable them to
financial statements for each financial year. Under
ensure that its financial statements comply with the
that law they have elected to prepare the Financial
Companies Act 2006. They are responsible for such
Statements in accordance with applicable law and
internal controls as they determine are necessary to
United Kingdom Accounting Standards including
enable the preparation of financial statements that
FRS 102 ‘The Financial Reporting Standard
are free from material misstatement, whether due
applicable in the UK and Republic of Ireland’.
to fraud or error, and have general responsibility for
Under company law the Directors must not approve taking such steps as are reasonably open to them to
the Financial Statements unless they are satisfied safeguard the assets of the Company and to prevent
that they give a true and fair view of the state of and detect fraud and other irregularities.
affairs of the Company and of the profit or
Under applicable laws and regulations, the Directors
loss of the Company for that period. In preparing the
are also responsible for preparing a Strategic
Financial Statements, the Directors are required to:
report, Directors’ report, a Directors’ remuneration
ș select suitable accounting policies and then report and a Corporate governance statement that
apply them consistently; complies with that law and those regulations.
ș make judgements and accounting estimates that The Directors have delegated responsibility to the
are reasonable and prudent; Managers for the maintenance and integrity of the
corporate and financial information included on the
ș state whether applicable United Kingdom
Company website. Legislation in the United Kingdom
Accounting Standards have been followed,
governing the preparation and dissemination of
subject to any material departures disclosed and
financial statements may differ from legislation in
explained in the Financial Statements;
other jurisdictions.
ș assess the Company’s ability to continue as a
going concern, disclosing, as applicable, matters
related to going concern; and
ș use the going concern basis of accounting
unless they either intend to liquidate the
company or to cease operations, or have no
realistic alternative but to do so.
80 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Responsibility statement of the Directors in
respect of the Annual Financial Report
We confirm that, to the best of our knowledge:
ș the Financial Statements, which have been
prepared in accordance with applicable law and
United Kingdom Accounting Standards (United
Kingdom Generally Accepted Accounting
Practice) including FRS 102 ‘The Financial
Reporting Standard applicable in the UK and
Republic of Ireland’, give a true and fair view of
the assets, liabilities, financial position and net
return of the Company;
ș the Annual Report and Financial Statements
taken as a whole is fair, balanced and
understandable and provide the information
necessary for shareholders to assess the
Company’s performance, business model and
strategy; and
ș the Strategic report and Directors’ report
include a fair review of the development and
performance of the business and the position of
the Company, together with a description of the
principal risks and uncertainties that it faces.
On behalf of the Board
Tom Burnet
21 August 2024
81
## Financial
## report
The Financial Statements for the
year to 31 May 2024 are set out
on pages 90 to 111 and have been
prepared in accordance with
FRS 102 ‘The Financial Reporting
Standard applicable in the UK
and Republic of Ireland’.
Baillie Gifford US Growth Trust plc
## Independent
## Auditor’s report
to the members of Baillie Gifford US Growth Trust plc
Opinion The non-audit services prohibited by the FRC’s
Ethical Standard were not provided to the Company
We have audited the financial statements of Baillie
and we remain independent of the Company in
Gifford US Growth Trust plc (the ‘Company) for the
conducting the audit.
year ended 31 May 2024 which comprise the Income
Statement, Balance Sheet, Statement of Changes
Conclusions relating to going concern
in Equity, Cash Flow Statement, and the related
notes 1 to 17, including the principal accounting In auditing the financial statements, we have
policies. The financial reporting framework that concluded that the Directors’ use of the going
has been applied in their preparation is applicable concern basis of accounting in the preparation of the
law and United Kingdom Accounting Standards financial statements is appropriate. Our evaluation of
including FRS 102 ‘The Financial Reporting Standard the Directors’ assessment of the Company’s ability
applicable in the UK and Republic of Ireland’ (United to continue to adopt the going concern basis of
Kingdom Generally Accepted Accounting Practice). accounting included:
In our opinion, the financial statements: ș Confirming our understanding of the Company’s
going concern assessment process by engaging
ș give a true and fair view of the Company’s affairs
with the Directors and the Company Secretary
as at 31 May 2024 and of its profit for the year
to determine if all key factors were considered
then ended;
in their assessment. We considered whether

| ș have been properly prepared in accordance with |  |  | the factors taken account of in the Directors’ |
| --- | --- | --- | --- |
|  | United Kingdom Generally Accepted Accounting |  | assessment addressed those matters which we |
|  | Practice; and |  | considered important. |
| ș have been prepared in accordance with the |  | ș Inspecting the Directors’ assessment of going |  |
|  | requirements of the Companies Act 2006. |  | concern, including the revenue forecast, for |

the period to 21 August 2025 which is at least
Basis for opinion 12 months from the date the financial statements
were authorised for issue. The Company has
We conducted our audit in accordance with
concluded that it is able to continue to meet its
International Standards on Auditing (UK) (ISAs
financial obligations as they fall due.
(UK)) and applicable law. Our responsibilities
under those standards are further described in the
ș Reviewing the factors and assumptions applied
Auditor’s responsibilities for the audit of the financial
to the Company’s forecast, liquidity review and
statements section of our report. We believe that the
covenant compliance assessment as prepared
audit evidence we have obtained is sufficient and
by the Company Secretary. We considered
appropriate to provide a basis for our opinion.
the appropriateness of the methods, used to
calculate the revenue forecast and the liquidity
Independence assessment and determined, through testing
We are independent of the Company in accordance of the methodology and calculations, that the
with the ethical requirements that are relevant to our methods, inputs and assumptions utilised were
audit of the financial statements in the UK, including appropriate to be able to make an assessment for
the FRC’s Ethical Standard as applied to public the Company.
interest entities, and we have fulfilled our other
ethical responsibilities in accordance with these
requirements.
83
Financial report
ș Assessing the risk of breaching the debt An overview of the scope of our audit
covenants as a result of a reduction in the value
Tailoring the scope
of the Company’s portfolio. We calculated and
reviewed the Company’s compliance with debt Our assessment of audit risk, our evaluation of
covenants throughout the year, validated the materiality and our allocation of performance
inputs used to the underlying information and materiality determine our audit scope for the
we performed reverse stress testing in order to Company. This enables us to form an opinion on
identify what factors would lead to the Company the financial statements. We take into account
breaching the financial covenants. size, risk profile, the organisation of the Company
and effectiveness of controls, the potential impact
ș Considering the mitigating factors that are
of climate change and changes in the business
within the control of the Company. We reviewed
environment when assessing the level of work to be
the Company’s assessment of the liquidity of
performed. All audit work was performed directly
investments held and evaluated the Company’s
by the audit engagement team which included our
ability to sell those investments in order to cover
valuation specialists.
working capital requirements should revenue
decline significantly.
Climate change
ș Reviewing the Company’s going concern
There has been increasing interest from stakeholders
disclosures included in the annual report to assess
as to how climate change will impact companies.
whether the disclosures were appropriate and in
The Company has determined that climate problems
conformity with the reporting standards.
may impact investee company valuations and in turn
the Company’s own share price. This is explained
Based on the work we have performed, we have
on page 49 in the principal and emerging risks
not identified any material uncertainties relating to
section, which form part of the “Other information”,
events or conditions that, individually or collectively,
rather than the audited financial statements. Our
may cast significant doubt on the Company’s ability
procedures on these disclosures therefore consisted
to continue as a going concern for a period to
solely of considering whether they are materially
21 August 2025, which is at least 12 months from
consistent with the financial statements, or our
the approval of these financial statements on
knowledge obtained in the course of the audit or
21 August 2024.
otherwise appear to be materially misstated.
In relation to the Company’s reporting on how it has
Our audit effort in considering climate change
applied the UK Corporate Governance Code,
was focused on the adequacy of the Company’s
we have nothing material to add or draw attention
disclosures in the financial statements as set out in
to in relation to the Directors’ statement in the
Note 1a and conclusion that there was no further
financial statements about whether the Directors
impact of climate change to be taken into account as
considered it appropriate to adopt the going concern
the investments are valued based on market pricing
basis of accounting.
as required by FRS 102. Unquoted investments
Our responsibilities and the responsibilities of the
are valued with reference to recent transaction
Directors with respect to going concern are described
prices, market approaches using comparable
in the relevant sections of this report. However,
trading multiples and benchmark performance and
because not all future events or conditions can be
therefore are reflective of market participants views.
predicted, this statement is not a guarantee as to the
We also challenged the Directors’ considerations of
Company’s ability to continue as a going concern.
climate change in their assessment of viability and
associated disclosures.
Overview of our audit approach
Key audit matters ș Risk of incorrect valuation or ownership
of the investment portfolio
ș Risk of incomplete or inaccurate revenue
recognition, including the classification
of special dividends as revenue or
capital in the Income Statement
Materiality ș Overall materiality of £6.44m which
represents 1% of shareholders’ funds
84 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Key audit matters
Key audit matters are those matters that, in our professional judgement, were of most significance in our
audit of the financial statements of the current period and include the most significant assessed risks of
material misstatement (whether or not due to fraud) that we identified. These matters included those which
had the greatest effect on: the overall audit strategy; the allocation of resources in the audit; and directing
the efforts of the engagement team. These matters were addressed in the context of our audit of the
financial statements as a whole, and in our opinion thereon, and we do not provide a separate opinion
on these matters.
Key observations
communicated to
Risk Our response to the risk the Audit Committee
Incorrect valuation or ownership We performed the following procedures: The results of
of the investment portfolio our procedures
We obtained an understanding of Baillie Gifford’s processes and
(as described on page 74 in the identified no material
controls surrounding legal title and pricing of quoted and unquoted
report of the Audit Committee and misstatement in
investments by performing walkthrough procedures in which we
as per the accounting policy set relation to the risk of
evaluated the design of controls.
out on page 95). incorrect valuation
For all quoted investments in the portfolio, we compared the market
or ownership of the
The valuation of the investment
prices and exchange rates applied to an independent pricing
investment portfolio.
portfolio at 31 May 2024 was
vendor and recalculated the investment valuations as at the year-
£678.23m (2023: £605.91m)
end.
consisting of quoted investments
We reviewed the prices for all quoted investments in the portfolio
with an aggregate value of £447.04m
near the year end of the Company to identify any stale prices.
(2023: £396.27m) and unquoted
Our testing of quoted investments did not identify any prices
investments with an aggregate value
for which there was no active market.
of £231.19m (2023: £209.64m).
For the unquoted investments held as at 31 May 2024 the audit
The valuation of the assets held in
team, with the assistance of our valuation specialists, reviewed and
the investment portfolio is the key
challenged a sample of the the valuations. This included:
driver of the Company’s net asset
ș Reviewing the valuation papers prepared by the valuation group
value and total return. Incorrect
to gain an understanding of, and comment on, the valuation
investment pricing or a failure to
methodologies and assumptions.
maintain proper legal title to the
investments held by the Company ș We have assessed the competence, capability and objectivity
could have a significant impact on of the valuations group.
the portfolio valuation and the return
ș Discussing the unquoted valuations with the valuations group
generated for shareholders.
to understand their valuation approach and a follow up meeting
The fair value of quoted investments to challenge certain areas of their approach, documentation
is determined by reference to and valuation conclusions.
bid value or the last traded price
ș Assessing whether the valuations have been performed in line
depending on the convention of the
with the valuation approaches as set out in the International
exchange on which the investment
Private Equity and Venture Capital (‘IPEV’) guidelines and
is quoted.
FRS 102.
Unquoted investments are valued
ș Assessing the appropriateness of the data inputs (including
at fair value by the Directors
supporting evidence) and challenging the assumptions used
following a detailed review and
to support the valuations.
appropriate challenge of the
ș Assessing other facts and circumstances, such as market
valuations proposed by the Baillie
movement and comparative company information, that have an
Gifford private company valuations
impact on the fair market value of the investments and assessing
group (‘the valuation group’). The
whether managements, valuation is reasonable.
unquoted investment policy applies

| methodologies consistent with the | We recalculated the unrealised gains/(losses) on investments as at |
| --- | --- |
| International Private Equity and | the year-end using the book-cost reconciliation. |
| Venture Capital Valuation (‘IPEV’) | We compared the Company’s investment holdings at 31 May 2024 |
| guidelines and FRS 102. | to independent confirmations received directly from the Company’s |
| The valuation of unquoted | Custodian or from the investee company. |

investments, and the resultant
impact on the unrealised gains/
(losses), is the area requiring the
most significant judgement and
estimation in the preparation of the
financial statements and has been
classified as an area of fraud risk as
highlighted below on page 88.
85
Financial report
Key observations
communicated to
Risk Our response to the risk the Audit Committee
Incomplete or inaccurate revenue We have performed the following procedures: The results of
recognition, including the our procedures
We obtained an understanding of Baillie Gifford’s processes and
classification of special dividends identified no material
controls surrounding revenue recognition performing walkthrough
as revenue or capital items in the misstatement in
procedures.
Income Statement (per the Audit relation to the risk
For all dividends, we recalculated the income by multiplying the
Committee report set out on page of incomplete or
investment holdings at the ex-dividend date, traced from the
74 and the accounting policy set inaccurate revenue
accounting records, by the dividend per share, which was agreed
out on page 96). recognition.
to an independent data vendor. We agreed a sample to bank
The total revenue for the year
statements and, where applicable, we also agreed the exchange
to 31 May 2024 was £0.60m
rates to an external source.
(2023: £0.85m).
To test completeness of recorded income, we tested that dividends
There is a risk of incomplete or
had been recorded for a sample of investee companies with
inaccurate recognition of revenue
reference to investee company announcements obtained from
through the failure to recognise
an independent data vendor.
proper income entitlements or to
For all dividends accrued at the year end, we reviewed the
apply an appropriate accounting
investee company announcements to assess whether the dividend
treatment.
obligation arose prior to 31 May 2024. We agreed the dividend rate
When received, the Directors may
to corresponding announcements made by the investee company,
be required to exercise judgement
recalculated the dividend amount receivable and confirmed this
in determining whether income
was consistent with cash received as shown on post year end
receivable in the form of special
bank statements.
dividends should be classified
For all investments held during the year, we compared the type of
as ‘revenue’ or ‘capital’ in the
dividends paid with reference to an external data source to identify
Income Statement and has been
any which were ‘special’. We confirmed there were no special
classified as an area of fraud risk as
dividends in the accounting period.
highlighted below on page 88.
In the prior year, the predecessor did not include a key audit matter on revenue recognition or the valuation
of quoted assets but did include a key audit matter on unlisted investments. There have been no other
changes to the areas of audit focus raised in the above risk table.
Our application of materiality Performance materiality
We apply the concept of materiality in planning and The application of materiality at the individual
performing the audit, in evaluating the effect of account or balance level. It is set at an amount to
identified misstatements on the audit and in forming reduce to an appropriately low level the probability
our audit opinion. that the aggregate of uncorrected and undetected
misstatements exceeds materiality.
Materiality
On the basis of our risk assessments, together
The magnitude of an omission or misstatement that,
with our assessment of the Company’s overall
individually or in the aggregate, could reasonably
control environment, our judgement was that
be expected to influence the economic decisions
performance materiality was 75% of our
of the users of the financial statements. Materiality
planning materiality, namely £4.83m. We have set
provides a basis for determining the nature and
performance materiality at this percentage due to
extent of our audit procedures.
our experience of working in prior years with the
We determined materiality for the company to be key service providers that indicates a lower risk of
£6.44 million, which is 1% of shareholders’ funds. misstatements, both corrected and uncorrected.
We believe that shareholders’ funds provides us
Given the importance of the distinction between
with a materiality aligned to the key measure of the
revenue and capital for investment trusts, we have
Company’s performance.
applied a separate testing threshold for the revenue
column of the Income Statement of £0.32m, being
our reporting threshold.
86 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Reporting threshold Opinions on other matters prescribed by the
An amount below which identified misstatements Companies Act 2006
are considered as being clearly trivial.
In our opinion the part of the Directors’ remuneration
report to be audited has been properly prepared in
We agreed with the Audit Committee that we would
accordance with the Companies Act 2006.
report to them all uncorrected audit differences
in excess of £0.32m (2023 predecessor auditor:
In our opinion, based on the work undertaken in the
£0.31m) which is set at 5% of planning materiality,
course of the audit:
as well as differences below that threshold that, in
ș the information given in the Strategic report and
our view, warranted reporting on qualitative grounds.
the Directors’ report for the financial year for
We evaluate any uncorrected misstatements against
which the financial statements are prepared is
both the quantitative measures of materiality
consistent with the financial statements; and
discussed above and in light of other relevant
ș the Strategic report and Directors’ reports have
qualitative considerations in forming our opinion.
been prepared in accordance with applicable legal
requirements.
Other information
The other information comprises the information
Matters on which we are required to report
included in the annual report other than the financial
by exception
statements and our auditor’s report thereon. The
In the light of the knowledge and understanding
Directors are responsible for the other information
of the Company and its environment obtained in
contained within the annual report.
the course of the audit, we have not identified
Our opinion on the financial statements does not
material misstatements in the Strategic report
cover the other information and, except to the extent
or Directors’ report.
otherwise explicitly stated in this report, we do not
We have nothing to report in respect of the following
express any form of assurance conclusion thereon.
matters in relation to which the Companies Act 2006
Our responsibility is to read the other information
requires us to report to you if, in our opinion:
and, in doing so, consider whether the other
ș adequate accounting records have not been kept,
information is materially inconsistent with the
or returns adequate for our audit have not been
financial statements or our knowledge obtained in
received from branches not visited by us; or
the course of the audit or otherwise appears to be
materially misstated. If we identify such material ș the financial statements and the part of the
inconsistencies or apparent material misstatements, Directors’ remuneration report to be audited are
we are required to determine whether this gives not in agreement with the accounting records and
rise to a material misstatement in the financial returns; or
statements themselves. If, based on the work we
ș certain disclosures of Directors’ remuneration
have performed, we conclude that there is a material
specified by law are not made; or
misstatement of the other information, we are
required to report that fact. ș we have not received all the information and
explanations we require for our audit.
We have nothing to report in this regard.
Corporate governance statement
We have reviewed the Directors’ statement in
relation to going concern, longer-term viability and
that part of the Corporate governance statement
relating to the Company’s compliance with the
provisions of the UK Corporate Governance Code
specified for our review by the UK Listing Rules.
87
Financial report
Based on the work undertaken as part of our audit, Auditor’s responsibilities for the audit of the
we have concluded that each of the following
Financial Statements
elements of the Corporate Governance Statement is
Our objectives are to obtain reasonable assurance
materially consistent with the financial statements or
about whether the financial statements as a whole
our knowledge obtained during the audit:
are free from material misstatement, whether due to
ș Directors’ statement with regards to the fraud or error, and to issue an auditor’s report that
appropriateness of adopting the going concern includes our opinion. Reasonable assurance is a
basis of accounting and any material uncertainties high level of assurance, but is not a guarantee that
identified set out on page 71; an audit conducted in accordance with ISAs (UK)
will always detect a material misstatement when it
ș Directors’ explanation as to their assessment
exists. Misstatements can arise from fraud or error
of the Company’s prospects, the period this
and are considered material if, individually or in the
assessment covers and why the period is
aggregate, they could reasonably be expected to
appropriate set out on page 53;
influence the economic decisions of users taken on
ș Directors’ statement on whether they have a the basis of the financial statements.
reasonable expectation that the Company will
be able to continue in operation and meets its
Explanation as to what extent the audit
liabilities set out on page 71;
was considered capable of detecting
ș Directors’ statement on fair, balanced and irregularities, including fraud
understandable set out on pages 80 and 81;
Irregularities, including fraud, are instances of non-
compliance with laws and regulations. We design
ș Board’s confirmation that it has carried out a
procedures in line with our responsibilities, outlined
robust assessment of the emerging and principal
above, to detect irregularities, including fraud. The
risks set out on pages 48 to 52;
risk of not detecting a material misstatement due
ș the section of the annual report that describes
to fraud is higher than the risk of not detecting one
the review of effectiveness of risk management
resulting from error, as fraud may involve deliberate
and internal control systems set out on pages
concealment by, for example, forgery or intentional
70 and 71; and
misrepresentations, or through collusion. The extent
ș the section describing the work of the Audit to which our procedures are capable of detecting
Committee set out on page 73. irregularities, including fraud, is detailed below.
However, the primary responsibility for the
Responsibilities of Directors
prevention and detection of fraud rests with both
As explained more fully in the Directors’ those charged with governance of the Company
responsibilities statement set out on page 80, the and management.
Directors are responsible for the preparation of the
ș We obtained an understanding of the legal and
financial statements and for being satisfied that
regulatory frameworks that are applicable to the
they give a true and fair view, and for such internal
Company and determined that the most significant
controls as the Directors determine are necessary
are United Kingdom Generally Accepted
to enable the preparation of financial statements that
Accounting Practice, the Companies Act 2006,
are free from material misstatement, whether due to
the UK Listing Rules, UK Corporate Governance
fraud or error.
Code, the Association of Investment Companies’

| In preparing the financial statements, the Directors | Corporate Governance Code and Statement of |
| --- | --- |
| are responsible for assessing the Company’s | Recommended Practice, Section 1158 of the |
| ability to continue as a going concern, disclosing, | Corporation Tax Act 2010 and The Companies |
| as applicable, matters related to going concern | (Miscellaneous Reporting) Regulations 2018. |

and using the going concern basis of accounting
ș We understood how the Company is complying
unless the Directors either intend to liquidate the
with those frameworks through discussions with
Company or to cease operations, or have no realistic
the Audit Committee and Company Secretary and
alternative but to do so.
review of Board minutes.
88 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
ș We assessed the susceptibility of the Company’s Use of our report
financial statements to material misstatement,
This report is made solely to the Company’s
including how fraud might occur by considering
members, as a body, in accordance with Chapter 3
the key risks impacting the financial statements.
of Part 16 of the Companies Act 2006. Our audit
We identified a fraud risk with respect to the
work has been undertaken so that we might state
incomplete or inaccurate revenue recognition
to the Company’s members those matters we are
through incorrect classification of special
required to state to them in an auditor’s report and
dividends as revenue or capital items in the
for no other purpose. To the fullest extent permitted
Income Statement. We also identified a fraud
by law, we do not accept or assume responsibility to
risk with respect to the incorrect valuation of the
anyone other than the Company and the Company’s
unquoted investments and the resultant impact
members as a body, for our audit work, for this
on unrealised gains/(losses). Further discussion
report, or for the opinions we have formed.
of our approach is set out in the section on key
audit matters above which include our response
to the fraud risks and other areas of audit focus.
Ahmer Huda (Senior statutory auditor)
for and on behalf of Ernst & Young LLP,
ș Based on this understanding we designed our
Statutory Auditor
audit procedures to identify non-compliance
London
with such laws and regulations. Our procedures
21 August 2024
involved review of the reporting to the Directors
with respect to the application of the documented
policies and procedures and review of the financial
statements to ensure compliance with the
reporting requirements of the Company.
A further description of our responsibilities for
the audit of the financial statements is located
on the Financial Reporting Council’s website at
frc.org.uk/auditorsresponsibilities. This description
forms part of our auditor’s report.
Other matters we are required to address
Following the recommendation from the Audit
Committee, we were appointed by the Company to
audit the financial statements for the year ending 31
May 2024 and subsequent financial periods.
The period of total uninterrupted engagement
including previous renewals and reappointments is
1 year, covering the year ending 31 May 2024.
The audit opinion is consistent with the additional
report to the Audit Committee.
89
Financial report
## Income
## statement
For the year ended 31 May

|  | 2024 | 2024 | 2024 |  | 2023 | 2023 | 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  | Revenue | Capital | Total | Revenue |  | Capital | Total |
| Notes | £’000 | £’000 | £’000 |  | £’000 | £’000 | £’000 |

Gains/(losses) on investments 9 – 95,288 95,288 – (10,169) (10,169)
Currency gains/(losses) 15 – 878 878 – (700) (700)
Income 2 603 – 603 850 – 850
Investment management fee 3 (3,581) – (3,581) (3,345) – (3,345)
Other administrative expenses 4 (726) – (726) (670) – (670)
Net return before finance costs (3,704) 96,166 92,462 (3,165) (10,869) (14,034)
and taxation
Finance costs of borrowings 5 (2,528) – (2,528) (1,482) – (1,482)
Net return before taxation (6,232) 96,166 89,934 (4,647) (10,869) (15,516)
Tax on ordinary activities 6 (50) – (50) (71) – (71)
Net return after taxation (6,282) 96,166 89,884 (4,718) (10,869) (15,587)
Net return per ordinary share 7 (2.07p) 31.73p 29.66p (1.55p) (3.56p) (5.11p)
The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital return columns
are prepared under guidance published by the Association of Investment Companies.
All revenue and capital items in this statement derive from continuing operations.
A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.
The accompanying notes on pages 94 to 111 are an integral part of the Financial Statements.
90 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

# Balance sheet

As at 31 May

|   | Notes | 2024 £'000 | 2024 £'000 | 2023 £'000 | 2023 £'000  |
| --- | --- | --- | --- | --- | --- |
|  **Fixed assets**  |   |   |   |   |   |
|  Investments held at fair value through profit or loss | 9 |  | 678,234 |  | 605,908  |
|  **Current assets**  |   |   |   |   |   |
|  Debtors | 10 | 605 |  | 657 |   |
|  Cash and cash equivalents | 17 | 6,620 |  | 3,440 |   |
|   |  | 7,225 |  | 4,097 |   |
|  **Creditors**  |   |   |   |   |   |
|  Amounts falling due within one year | 11 | (41,526) |  | (41,406) |   |
|  **Net current liabilities** |  |  | (34,301) |  | (37,309)  |
|  **Net assets** |  |  | **643,933** |  | **568,599**  |
|  **Capital and reserves**  |   |   |   |   |   |
|  Share capital | 12 |  | 3,073 |  | 3,073  |
|  Share premium account | 13 |  | 250,827 |  | 250,827  |
|  Special distributable reserve | 13 |  | 168,942 |  | 168,942  |
|  Capital reserve | 13 |  | 247,547 |  | 165,931  |
|  Revenue reserve | 13 |  | (26,456) |  | (20,174)  |
|  **Total shareholders' funds** |  |  | **643,933** |  | **568,599**  |
|  **Net asset value per ordinary share*** | 14 |  | **216.65p** |  | **186.33p**  |

The Financial Statements of Baillie Gifford US Growth Trust plc (Company Registration number 11194060) were approved and authorised for issue by the Board and were signed on 21 August 2024.

Tom Burnet Chair

* Net asset value per ordinary share after deducting borrowings at book value. See Glossary of terms and alternative performance measures on pages 124 to 127.

The accompanying notes on pages 94 to 111 are an integral part of the Financial Statements.

91
Financial report
## Statement of
## changes in equity
For the year ended 31 May 2024

|  |  |  | Share |  | Special |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Share | premium |  | distributable |  | Capital | Revenue |  | Shareholders’ |  |
|  | capital | account |  |  | reserve | reserve | reserve |  |  | funds |
| Notes | £’000 |  | £’000 |  | £’000 | £’000 |  | £’000 |  | £’000 |

Shareholders’ funds at 1 June 2023 3,073 250,827 168,942 165,931 (20,174) 568,599
Ordinary shares bought back into treasury 13 – – – (14,550) – (14,550)
Net return after taxation – – – 96,166 (6,282) 89,884
Shareholders’ funds at 31 May 2024 3,073 250,827 168,942 247,547 (26,456) 643,933
For the year ended 31 May 2023

|  |  |  | Share |  | Special |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Share | premium |  | distributable |  | Capital | Revenue |  | Shareholders’ |  |
|  | capital | account |  |  | reserve | reserve | reserve |  |  | funds |
| Notes | £’000 |  | £’000 |  | £’000 | £’000 |  | £’000 |  | £’000 |

Shareholders’ funds at 1 June 2022 3,073 250,827 168,942 176,800 (15,456) 584,186
Ordinary shares bought back into treasury 13 – – – – – –
Net return after taxation – – – (10,869) (4,718) (15,587)
Shareholders’ funds at 31 May 2023 3,073 250,827 168,942 165,931 (20,174) 568,599
The accompanying notes on pages 94 to 111 are an integral part of the Financial Statements.
92 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

# Cash flow statement

For the year ended 31 May

|   | Notes | 2024 £'000 | 2024 £'000 | 2023 £'000 | 2023 £'000  |
| --- | --- | --- | --- | --- | --- |
|  **Cash flows from operating activities** |  |  |  |  |   |
|  Net return before taxation |  |  | 89,934 |  | (15,516)  |
|  *Adjustments to reconcile company profit before tax to net cash flow from operating activities* |  |  |  |  |   |
|  Net (gains)/losses on investments |  |  | (95,288) |  | 10,169  |
|  Currency (gains)/losses |  |  | (878) |  | 700  |
|  Finance costs of borrowings |  |  | 2,528 |  | 1,482  |
|  *Other capital movements* |  |  |  |  |   |
|  Overseas withholding tax incurred |  |  | (50) |  | (71)  |
|  Changes in debtors |  |  | 51 |  | (298)  |
|  Changes in creditors |  |  | 191 |  | (10)  |
|  **Cash from operations*** |  |  | (3,512) |  | (3,544)  |
|  Finance costs paid |  |  | (2,308) |  | (1,481)  |
|  **Net cash outflow from operating activities** |  |  | **(5,820)** |  | **(5,025)**  |
|  **Cash flows from investing activities** |  |  |  |  |   |
|  Acquisitions of investments |  | (95,852) |  | (63,894) |   |
|  Disposals of investments |  | 118,814 |  | 69,383 |   |
|  **Net cash inflow from investing activities** |  |  | **22,962** |  | **5,489**  |
|  **Cash flows from financing activities** |  |  |  |  |   |
|  Ordinary shares bought back into treasury and stamp duty thereon | 13 | (13,769) |  | - |   |
|  Bank loans drawn down |  | 20,577 |  | - |   |
|  Bank loans repaid |  | (20,577) |  | - |   |
|  **Net cash outflow from financing activities** |  |  | **(13,769)** |  | **-**  |
|  **Increase in cash and cash equivalents** |  |  | **3,373** |  | **464**  |
|  Exchange movements |  |  | (193) |  | (31)  |
|  Cash and cash equivalents at 1 June | 15 |  | 3,440 |  | 3,007  |
|  **Cash and cash equivalents at 31 May** | 15 |  | **6,620** |  | **3,440**  |

* Cash from operations includes dividends received of £331,000 (2023 – £472,000) and interest received of £35,000 (2023 – £154,000).

The accompanying notes on pages 94 to 111 are an integral part of the Financial Statements.

93
Financial report

# Notes to the Financial Statements

Baillie Gifford US Growth Trust plc was incorporated under the Companies Act 2006 in England and Wales as a public limited company with registered number 1194060. The Company is an investment company within the meaning of section 833 of the Companies Act 2006 and carries on business as an investment trust.

## 01 Principal accounting policies

The Financial Statements for the year to 31 May 2024 have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and on the basis of the accounting policies set out below which are unchanged from the prior year and have been applied consistently.

### a. Basis of accounting

All of the Company's operations are of a continuing nature and the Financial Statements are prepared on a going concern basis under the historical cost convention, modified to include the revaluation of fixed asset investments at fair value through profit or loss, and on the assumption that approval as an investment trust under section 1158 of the Corporation Tax Act 2010 and the Investment Trust (Approved Company) (Tax) Regulations 2011 will be retained. The Board has, in particular, considered the impact of heightened market volatility due to macroeconomic and geopolitical concerns but does not believe the Company's going concern status is affected. The Company's assets, the majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly. All borrowings require the prior approval of the Board. Gearing levels and compliance with borrowing covenants are reviewed by the Board on a regular basis. As at 31 May 2024 the Company had a net current liability of £34.3 million primarily as a result of the two US$25 million revolving credit facilities. The Company has continued to comply with the investment trust status requirements of section 1158 of the Corporation Tax Act 2010 and the Investment Trust (Approved Company) (Tax) Regulations 2011. Accordingly, the Financial Statements have been prepared on the going concern basis as it is the Directors' opinion, having assessed the principal and emerging risks and other matters set out in the viability statement on page 53 which assesses the prospects of the Company over a period of five years, that the Company will continue in operational existence for a period of at least twelve months from the date of approval of these Financial Statements.

The Financial Statements have been prepared in accordance with the Companies Act 2006, applicable UK Accounting Standards, the Association of Investment Companies ('AIC') Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued in November 2014 and updated in July 2022 with consequential amendments, except for certain financial information required by paragraph 82(c) regarding unquoted holdings with a value greater than 5% of the portfolio or included in the top 10, where information is not publicly available (see note 9 on page 101). In order to reflect better the activities of the Company and in accordance with guidance issued by the AIC, supplementary information which analyses the profit and loss account between items of a revenue and capital nature has been presented in the Income Statement.

Although the Company invests in US dollar investments, the Directors have determined the Company's functional currency to be sterling, as the Company's share capital is denominated in sterling, the entity is listed on a sterling stock exchange in the UK, the Company's shareholders are predominantly based in the UK and the Company and its Managers, who are subject to the UK's regulatory environment, are also UK based.

Financial assets and financial liabilities are recognised in the Company's Balance Sheet when it becomes a party to the contractual provisions of the instrument.

### b. Significant accounting estimates and judgements

The preparation of the Financial Statements requires the use of estimates, assumptions and judgements. These estimates, assumptions and judgements affect the reported amounts of assets and liabilities at the reporting date. While estimates are based on best judgement using information and financial data available, the actual outcome may differ from these estimates. The key sources of estimation and uncertainty relate to the fair valuation of the unlisted investments.

#### Judgements

The Directors consider that the preparation of the Financial Statements involves the following key judgements:

- (i) the determination of the functional currency of the Company as sterling (see rationale in 1a above); and

The key judgements in the fair valuation process are:

- (i) the Managers' determination of the appropriate application of the International Private Equity and Venture Capital Valuation ('IPEV') Guidelines 2022 to each unlisted investment;

94 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
(ii) the Directors’ consideration of whether each fair The key assumptions for the multiples approach are
value is appropriate following detailed review and that the selection of comparable companies provides a
challenge. The judgement applied in the selection of the reasonable basis for identifying relationships between
methodology used (see 1c below) for determining the fair enterprise value, revenue and growth to apply in the
value of each unlisted investment can have a significant determination of fair value. Other assumptions include the
impact upon the valuation; discount applied for reduced liquidity versus listed peers.
(iii) the selection of appropriate comparable companies Valuations are cross-checked for reasonableness to
in order to derive revenue multiples and meaningful alternative market-based approaches or benchmark index
relationships between enterprise value, revenue and movements as appropriate.
earnings growth. Comparable companies are chosen
c. Investments
on the basis of their business characteristics and growth
The Company’s investments are classified, recognised
patterns; and
and measured at fair value through profit or loss in
(iv) the selection of a revenue metric (either historical or accordance with sections 11 and 12 of FRS 102. Changes
forecast). in fair value of investments and gains and losses on
disposal are recognised as capital items in the Income
Estimates
Statement.
The key estimate in the Financial Statements is the
determination of the fair value of the unlisted investments Recognition and initial investment
by the Managers for consideration by the Directors. This Purchases and sales of investments are accounted for on
estimate is key as it significantly impacts the valuation of a trade date basis. Upon initial recognition investments
the unlisted investments at the Balance Sheet date. The in securities are recognised at fair value, which is
fair valuation process involves estimation using subjective transaction value. Expenses incidental to purchase and
inputs that are unobservable (i.e. for which market data is sale are written off to capital at the time of acquisition or
unavailable). The main estimates involved in the selection disposal. All investments are classified as valued at fair
of the valuation process inputs are: value through profit or loss upon initial recognition and
are measured at subsequent reporting dates at fair value.
(i) the application of an appropriate discount factor to
reflect the reduced liquidity of unlisted companies versus Measurement and valuation
their listed peers;
Listed investments
(ii) the estimation of the probability assigned to an The fair value of listed security investments is the last
exit being through an initial public offering (‘IPO’) or a traded price on recognised overseas exchanges.
company sale;
Unlisted investments
(iii) the selection of an appropriate industry benchmark
Unlisted investments are valued at fair value by the
index to assist with the valuation validation or the
Directors following a detailed review and appropriate
application of valuation adjustments, particularly in the
challenge of the valuations proposed by the Managers.
absence of established earnings or closely comparable
The Managers’ unlisted investment valuation policy
peers; and
applies techniques consistent with the IPEV Guidelines.
(iv) the calculation of valuation adjustments derived from
The techniques applied are predominantly market-based
milestone analysis (i.e. incorporating operational success
approaches. The market-based approaches available
against the plan/forecasts of the business into the
under the IPEV guidelines are set out below and are
valuation).
followed by an explanation of how they are applied to the
Fair value estimates are cross-checked to alternative Company’s unlisted portfolio:
estimation methods where possible to improve the
ș Multiples;
robustness of the estimates. As the valuation outcomes
may differ from the fair value estimates a price sensitivity ș Industry Valuation Benchmarks; and
analysis is provided in Other Price Risk Sensitivity in note
ș Available Market Prices.
17 on pages 106 to 109 to illustrate the effect on the
Financial Statements of an over or under estimation of The nature of the unlisted portfolio currently will influence
fair values. The risk of an over or under estimation of fair the valuation technique applied. The valuation approach
values is greater when methodologies are applied using recognises that, as stated in the IPEV Guidelines, the
more subjective inputs. price of a recent investment, if resulting from an orderly
transaction, generally represents fair value as at the
Assumptions
transaction date and may be an appropriate starting point
The determination of fair value by the Managers involves
for estimating fair value at subsequent measurement
key assumptions dependent upon the valuation technique
dates. However, consideration is given to the facts and
used. As explained in 1c below, the primary technique
circumstances as at the subsequent measurement date,
applied under the IPEV Guidelines is the multiples
including changes in the market or performance of the
approach. Where the multiples approach is used the
investee company. Milestone analysis is used where
valuation process recognises also, as stated in the
appropriate to incorporate the operational progress of
IPEV Guidelines, that the price of a recent investment
the investee company into the valuation. Additionally, the
may be an appropriate starting point for estimating fair
background to the transaction must be considered. As
value. The multiples approach involves subjective inputs
a result, various market-based techniques are employed
and therefore presents a greater risk of over or under
to assess the valuations particularly in those companies
estimation and particularly in the absence of a recent
with established revenues. Discounted cashflows are used
transaction.
where appropriate. An absence of relevant industry peers
may preclude the application of the industry valuation
95
Financial report
benchmarks technique and an absence of observable (ii) they relate directly to the buy-back/issuance of shares,
prices may preclude the available market prices approach. in which case they are added to the buy-back cost or
All valuations are cross-checked for reasonableness by deducted from the share issuance proceeds.
employing relevant alternative techniques.
h. Finance costs
The unlisted investments are valued according to a three
Finance costs are accounted for on an accruals basis
monthly cycle of measurement dates. The fair value of
and on an effective interest rate basis and are charged
the unlisted investments will be reviewed before the
through the revenue account.
next scheduled three monthly measurement date on the
i. Taxation
following occasions:
Current tax assets and liabilities are measured at the
(i) at the year end and half year end of the Company; and
amount expected to be recovered from or paid to taxation
(ii) where there is an indication of a change in fair value as authorities. The tax rates and tax laws used to compute
defined in the IPEV Guidelines (commonly referred to as the amount are those enacted or substantively enacted at
‘trigger’ events). the reporting date.
Gains and losses Deferred taxation is provided on an undiscounted basis
on all timing differences which have originated but not
Gains and losses on investments, including those
reversed by the Balance Sheet date, calculated at the
arising from foreign currency exchange differences, are
tax rates expected to apply when the timing differences
recognised in the Income Statement as capital items.
reverse, based on what has been enacted or substantially
The Managers monitor the investment portfolio on a fair
enacted, relevant to the benefit or liability. Deferred tax
value basis and use the fair value basis for investments
assets are recognised only to the extent that it is more
in making investment decisions and monitoring financial
likely than not that there will be taxable profits from which
performance.
underlying timing differences can be deducted.
d. Cash and cash equivalents
j. Foreign currencies
Cash and cash equivalents include cash in hand and
Transactions involving foreign currencies are converted
deposits repayable on demand. Deposits are repayable
at the rate ruling at the time of the transaction. Assets
on demand if they can be withdrawn at any time without
and liabilities in foreign currencies are translated at the
notice and without penalty or if they have a maturity or
closing rates of exchange at the Balance Sheet date.
period of notice of not more than one working day.
Any gain or loss arising from a change in exchange rate
subsequent to the date of the transaction is included as
e. Financial liabilities
an exchange gain or loss in the capital reserve or revenue
Bank loans are classified as loans and are measured at
reserve as appropriate. Foreign exchange movements on
amortised cost. They are initially recorded at the proceeds
investments are included in the Income Statement within
received net of direct costs.
gains or losses on investments.
f. Income
k. Special distributable reserve
(i) Income from equity investments is brought into account
The special distributable reserve can be used for the
on the date on which the investments are quoted ex-
repurchase of shares and may be distributed by way
dividend or, where no ex-dividend date is quoted, when
of dividend.
the Company’s right to receive payment is established.
l. Capital reserve
(ii) If scrip dividends are taken in lieu of dividends in cash,
Gains and losses on disposal of investments, changes
the net amount of the cash dividend declared is credited
in the fair value of investments held and realised and
to the revenue account. Any excess or shortfall in the
unrealised foreign exchange differences of a capital
value of the shares received over the amount of the cash
nature are dealt with in this reserve after being recognised
dividend foregone is recognised as capital.
in the Income Statement. Purchases of the Company’s
(iii) Special dividends are treated as repayments of capital own shares may be funded from this reserve
or income depending on the facts of each particular case.
m. Revenue reserve
(iv) Overseas dividends include the taxes deducted at
The revenue profit or loss for the year is taken to or from
source.
this reserve. The revenue reserve, when in surplus, may
(v) Interest receivable on bank deposits and underwriting be distributed by way of a dividend.
commission are recognised on an accruals basis.
n. Single segment reporting
g. Expenses The Company is engaged in a single segment of business,
All expenses are accounted for on an accruals basis. being investment business, consequently no business
Expenses are charged through the revenue column of the segmental analysis is provided.
Income Statement except where:
(i) they relate directly to the acquisition or disposal of an
investment (transaction costs), in which case they are
recognised as capital within losses/gains on investments;
and
96 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
02 Income
2024 2023
£’000 £’000
Income from investments
Overseas dividends 536 472
Overseas interest 32 224
568 696
Other income
Deposit interest 35 154
Total income 603 850
03 Investment management fee
2024 2023
£’000 £’000
Investment management fee 3,581 3,345
Details of the Investment Management Agreement are set out on page 61. The annual management fee is 0.70% on the first £100
million of net assets, 0.55% on the next £900 million of net assets and 0.50% on the remaining net assets. Management fees are
calculated and payable quarterly.
04 Other administrative expenses

|  | 2024 | 2023 |
| --- | --- | --- |
|  | £’000 | £’000 |
| Directors’ fees (see Directors’ remuneration report page 78) | 174 164 |  |

Auditor’s remuneration for audit services 158 135
General administrative expenses 198 179
Marketing * 110 84
Custody fees 12 10
Depositary fees 58 82
Registrar fees 16 16
726 670
* The Company is part of a marketing programme which includes all the investment trusts managed by the Managers. The marketing strategy has
an ongoing objective to stimulate demand for the Company’s shares. The cost of this marketing strategy is borne in partnership by the Company
and the Managers. The Managers match the Company’s marketing contribution and provide the resource to manage and run the programme.
There were no non-audit fees paid to the external auditor in the year to 31 May 2024 or 2023.
05 Finance costs of borrowings
2024 2023
£’000 £’000
Interest on bank loans (see note 11) 2,528 1,482
Finance costs include the initial arrangement fee and non-utilisation fees.
97
Financial report

## 06 Tax

|   | 2024 £'000 | 2023 £'000  |
| --- | --- | --- |
|  **Analysis of charge in year** |  |   |
|  Overseas withholding tax | 50 | 71  |
|  **Factors affecting the tax charge for the year** |  |   |
|  The tax charge for the year is higher than the standard rate of corporation tax in the UK of 25% (2023 – 20%). The differences are explained below: |  |   |
|  **Net return before taxation** | **89,934** | **(15,516)**  |
|  Net return before taxation multiplied by the standard rate of corporation tax in the UK of 25% (2023 – 20%) | 22,484 | (3,103)  |
|  Capital returns not taxable | (24,042) | 2,174  |
|  Overseas dividends not taxable | (134) | (95)  |
|  Current year management expenses and non-trade loan relationship deficit not utilised | 1,692 | 1,024  |
|  Overseas withholding tax incurred | 50 | 71  |
|  **Tax charge for the year** | **50** | **71**  |

As an investment trust, the Company's capital gains are not taxable in the United Kingdom.

### Factors that may affect future tax charges

At 31 May 2024 the Company had surplus management expenses and losses on non-trading loan relationships of £29,164,000 (2023 – £22,395,000). No deferred tax asset has been recognised in respect of these amounts because the Company is not expected to generate taxable income in a future period in excess of the deductible expenses of that future period and, accordingly, it is unlikely that the Company will be able to reduce future tax liabilities through the use of existing surplus expenses.

## 07 Net return per ordinary share

|   | 2024 Revenue | 2024 Capital | 2024 Total | 2023 Revenue | 2023 Capital | 2023 Total  |
| --- | --- | --- | --- | --- | --- | --- |
|  Net return after taxation | (2.07p) | 31.73p | 29.66p | (1.55p) | (3.56p) | (5.11p)  |

Revenue return per ordinary share is based on the net revenue loss after taxation of £6,282,000 (2023 – net revenue loss after taxation of £4,718,000) and on 303,075,968 (2023 – 305,153,700) ordinary shares, being the weighted average number of ordinary shares in issue (excluding treasury shares) during each period.

Capital return per ordinary share is based on the net capital profit for the financial period of £96,166,000 (2023 – net capital loss of £10,869,000) and on 303,075,968 (2023 – 305,153,700) ordinary shares, being the weighted average number of ordinary shares in issue (excluding treasury shares) during each period.

Total return per ordinary share is based on the total profit for the financial period of £89,884,000 (2023 – total loss of £15,587,000) and on 303,075,968 (2023 – 305,153,700) ordinary shares, being the weighted average number of ordinary shares in issue (excluding treasury shares) during each period.

There are no dilutive or potentially dilutive shares in issue.

## 08 Ordinary dividends

There are no dividends paid or proposed in respect of the financial year. There is no investment income available for distribution by way of dividend for the year to 31 May 2024 due to the revenue loss of £6,282,000 in the year (2023 – revenue loss of £4,718,000).

98 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

## 09 Fixed assets – investments

|  As at 31 May 2024 | Level 1 £'000 | Level 2 £'000 | Level 3 £'000 | Total £'000  |
| --- | --- | --- | --- | --- |
|  Listed equities | 447,044 | – | – | 447,044  |
|  Unlisted ordinary shares | – | – | 38,928 | 38,928  |
|  Unlisted preference shares* | – | – | 189,986 | 189,986  |
|  Unlisted convertible promissory notes | – | – | 2,276 | 2,276  |
|  Unlisted CVR† | – | – | – | –  |
|  **Total financial asset investments** | **447,044** | **–** | **231,190** | **678,234**  |

|  As at 31 May 2023 | Level 1 £'000 | Level 2 £'000 | Level 3 £'000 | Total £'000  |
| --- | --- | --- | --- | --- |
|  Listed equities | 396,272 | – | – | 396,272  |
|  Unlisted ordinary shares | – | – | 37,307 | 37,307  |
|  Unlisted preference shares* | – | – | 168,162 | 168,162  |
|  Unlisted convertible promissory notes | – | – | 4,167 | 4,167  |
|  Unlisted CVR† | – | – | – | –  |
|  **Total financial asset investments** | **396,272** | **–** | **209,636** | **605,908**  |

* The investments in preference shares are not classified as equity holdings as they include liquidation preference rights that determine the repayment (or multiple thereof) of the original investment in the event of a liquidation event such as a take-over.

† The Abiomed CVR (see 'Contingent value rights' on page 127 for details) had a fair value of nil at 31 May 2024 and 31 May 2023.

During the year to 31 May 2024 investments with a book cost of £5,725,000 (31 May 2023 – no investments) were transferred from Level 3 to Level 1 on becoming listed. Investments in securities are financial assets held at fair value through profit or loss. In accordance with FRS 102, the tables above provide an analysis of these investments based on the fair value hierarchy described below, which reflects the reliability and significance of the information used to measure their fair value.

### Fair value hierarchy

The fair value hierarchy used to analyse the fair values of financial assets is described below. The levels are determined by the lowest (that is the least reliable or least independently observable) level of input that is significant to the fair value measurement for the individual investment in its entirety as follows:

**Level 1** – using unadjusted quoted prices for identical instruments in an active market;

**Level 2** – using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

**Level 3** – using inputs that are unobservable (for which market data is unavailable).

The valuation techniques used by the Company are explained in the accounting policies on pages 95 and 96. A sensitivity analysis by valuation technique of the unlisted securities is given on pages 106 to 109.

99
Financial report
09 Fixed assets – investments (continued)

|  | Listed | Unlisted | 2024 | 2023 |
| --- | --- | --- | --- | --- |
| securities |  | securities* | Total | Total |
|  | £’000 | £’000 | £’000 | £’000 |

Cost of investments at start of year 376,349 203,001 579,350 608,422
Investment holding gains at start of year 19,923 6,635 26,558 13,165
Value of investments at start of year 396,272 209,636 605,908 621,587
Movements in year:
Purchases at cost 87,608 8,244 95,852 63,894
Sales – proceeds received (118,814) – (118,814) (69,383)
– realised losses on sales (15,089) (8,010) † (23,099) (23,583)
Gains on investments 91,342 27,045 118,387 13,393
Change in categorisation # 5,725 (5,725) – –
Value of investments at end of year 447,044 231,190 678,234 605,908
Cost of investments at end of year 335,779 197,510 533,289 579,350
Investment holding gains at end of year 111,265 33,680 144,945 26,558
Value of investments at end of year 447,044 231,190 678,234 605,908
* Includes holdings in ordinary shares, preference shares and convertible promissory notes.
† Loss arose from the investment in Convoy which was written off in the period subsequent to the company ceasing operations.
# During the year to 31 May 2024 investments with a book cost of £5,725,000 and fair value of £6,314,000 (31 May 2023 – no investments) were
transferred from Level 3 to Level 1 on becoming listed.
The Company received £118,814,000 from investments sold in the year (2023 – £69,383,000). The book cost of these
investments when they were purchased was £141,913,000 (2023 – £92,966,000). These investments have been revalued over
time and until they were sold any unrealised gains/losses were included in the fair value of the investments.
Transaction costs of £21,000 (2023 – £12,000) and £28,000 (2023 – £14,0000) were suffered on purchases and sales
respectively.
2024 2023
£’000 £’000
Net gains/(losses) on investments
Losses on sales* (23,099) (23,583)
Changes in investment holding gains 118,387 13,393
Provision for Stripe put right – 21
95,288 (10,169)
* Includes losses on Convoy which was written off in the period subsequent to the company ceasing operations. The holdings in Convoy had a book
cost of £8,010,000 when written off.
100 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
09 Fixed assets – investments (continued)
Significant holdings
Details of significant holdings are noted below in accordance with the disclosure requirements of paragraph 82 of the AIC
Statement of Recommended Practice ‘Financial Statements of Investment Trust Companies and Venture Capital Trusts’ (updated
in July 2022), in relation to unlisted investments included in the twenty largest holdings within the list of investments disclosed on
pages 41 to 44. As required, this disclosure includes turnover, pre-tax profits and net assets attributable to investors as reported
within the most recently audited financial statements of the investee companies, where possible.

| As at 31 May 2024 |  |  |  |  |  |  |  |  | Income |  |  | Pre-tax |  | Net assets |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Latest |  | Book | Market | recognised from |  |  |  |  | profit/ | attributable to |  |  |
|  |  |  | financial |  | cost | value |  | holding in the |  | Turnover |  | (loss) | shareholders |  |  |
|  |  | statements |  |  | £’000 | £’000 |  | period £’000 |  |  | £’000 | £’000 |  |  | £’000Name Business |
| Space | Rocket and |  |  | n/a 11,225 51,864 Nil Information not publicly available* |  |  |  |  |  |  |  |  |  |  |  |
| Exploration | spacecraft |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Technologies | company |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Stripe Online payment |  |  |  | n/a 25,463 32,007 Nil Information not publicly available* |  |  |  |  |  |  |  |  |  |  |  |

platform
Brex Corporate credit n/a 14,536 20,666 Nil Information not publicly available*
cards for start-ups
Zipline Drone-based n/a 6,131 14,779 Nil Information not publicly available*
medical delivery

| Faire | Online wholesale | n/a 17,699 13,085 Nil Information not publicly available* |
| --- | --- | --- |
| Wholesale | marketplace |  |
| Databricks Data and AI |  | n/a 10,140 12,082 Nil Information not publicly available* |

platform

| As at 31 May 2023 |  |  |  |  |  |  |  |  | Income |  |  | Pre-tax |  | Net assets |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Latest |  | Book | Market | recognised from |  |  |  |  | profit/ | attributable to |  |  |
|  |  |  | financial |  | cost | value |  | holding in the |  | Turnover |  | (loss) | shareholders |  |  |
|  |  | statements |  |  | £’000 | £’000 |  | period £’000 |  |  | £’000 | £’000 |  |  | £’000Name Business |
| Space | Rocket and |  |  | n/a 11,225 39,220 Nil Information not publicly available* |  |  |  |  |  |  |  |  |  |  |  |
| Exploration | spacecraft |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Technologies | company |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Stripe Online payment |  |  |  | n/a 25,463 25,681 Nil Information not publicly available* |  |  |  |  |  |  |  |  |  |  |  |

platform
Brex Corporate credit n/a 14,536 15,624 Nil Information not publicly available*
cards for start-ups
Zipline Drone-based n/a 6,131 14,548 Nil Information not publicly available*
medical delivery

| Faire | Online wholesale | n/a 17,699 13,449 Nil Information not publicly available* |
| --- | --- | --- |
| Wholesale | marketplace |  |
| Discord Communication |  | n/a 11,551 11,006 Nil Information not publicly available* |

software
* Confidentiality agreements prevent the disclosure of this information.
101
Financial report

## 10 Debtors

|   | 2024 £'000 | 2023 £'000  |
| --- | --- | --- |
|  **Amounts falling due within one year:** |  |   |
|  Income accrued (net of withholding taxes) | 427 | 472  |
|  Other debtors and prepayments | 178 | 185  |
|   | **605** | **657**  |

None of the above debtors are financial assets designated at fair value through profit or loss. The carrying amount of debtors is a reasonable approximation of fair value. There are no debtors that were past due or impaired at 31 May 2024 or 31 May 2023.

## 11 Creditors – amounts falling due within one year

|   | 2024 £'000 | 2023 £'000  |
| --- | --- | --- |
|  Bank loans | 39,271 | 40,342  |
|  Investment management fee | 923 | 819  |
|  Other creditors and accruals | 560 | 245  |
|  Buyback payable | 772 | –  |
|   | **41,526** | **41,406**  |

### Borrowing facilities

The US$25 million five-year revolving credit facility with ING Bank N.V., London Branch matured on 31 July 2023 and was refinanced with a new unsecured US$25 million three-year revolving credit facility from ING Bank N.V., London Branch on 26 July 2023. At 31 May 2024 there were drawings of US$25 million at an interest rate of 7.01% (2023 – US$25 million at an interest rate of 6.87%). The US$25 million three-year fixed rate facility with ING Bank N.V., London Branch matured on 23 October 2023 and was refinanced with a new unsecured US$25 million three-year revolving credit facility, from The Royal Bank of Scotland International Limited, on 18 October 2023. At 31 May 2024 there were drawings of US$25 million at an interest rate of 6.61% (2023 – US$25 million at an interest rate of 1.90%).

The main covenants relating to the loans are that borrowings should not exceed 30% of the Company's adjusted net asset value or adjusted portfolio value and the Company's minimum adjusted net asset value or adjusted portfolio value shall be £140 million. The adjusted net asset value and adjusted portfolio value calculations include the deduction of 100% of the value of any unlisted securities. There were no breaches in the loan covenants during the year to 31 May 2024 (31 May 2023 – none).

## 12 Share capital

|   | 2024 Number | 2024 £'000 | 2023 Number | 2023 £'000  |
| --- | --- | --- | --- | --- |
|  Allotted, called up and fully paid ordinary shares of 1p each | 297,228,700 | 2,972 | 305,153,700 | 3,051  |
|  Treasury shares of 1p each | 10,131,300 | 101 | 2,206,300 | 22  |
|   | **307,360,000** | **3,073** | **307,360,000** | **3,073**  |

In the year to 31 May 2024, the Company issued no shares (2023 – nil).

Over the period from 1 June 2024 to 16 August 2024 the Company has issued no shares.

The Company's authority to buy back shares up to a maximum of 14.99% of the Company's issued share capital was renewed at the Annual General Meeting held on 18 September 2023. In the year to 31 May 2024, 7,925,000 shares with a nominal value of £79,250 were bought back at a total cost of £14,550,000 and held in treasury (2023 – nil). At 31 May 2024 the Company had authority to buy back 37,817,539 ordinary shares.

Over the period from 1 June 2024 to 16 August 2024 the Company bought back 1,950,000 shares.

102 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
13 Capital and reserves

|  |  | Share |  | Special |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Share | premium |  | distributable |  | Capital | Revenue |  | Shareholders’ |  |
| capital | account |  |  | reserve | reserve | reserve |  |  | funds |
| £’000 |  | £’000 |  | £’000 | £’000 |  | £’000 |  | £’000 |

At 31 May 2023 3,073 250,827 168,942 165,931 (20,174) 568,599
Net loss on sales of investments – – – (23,099) – (23,099)
Changes in investment holding gains – – – 118,387 – 118,387
Exchange differences on bank loans – – – 1,071 – 1,071
Other exchange differences – – – (193) – (193)
Ordinary shares bought back – – – (14,550) – (14,550)
into treasury
Revenue return after taxation – – – – (6,282) (6,282)
At 31 May 2024 3,073 250,827 168,942 247,547 (26,456) 643,933

|  |  | Share |  | Special |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Share | premium |  | distributable |  | Capital | Revenue |  | Shareholders’ |  |
| capital | account |  |  | reserve | reserve | reserve |  |  | funds |
| £’000 |  | £’000 |  | £’000 | £’000 |  | £’000 |  | £’000 |

At 31 May 2022 3,073 250,827 168,942 176,800 (15,456) 584,186
Net loss on sales of investments – – – (23,583) – (23,583)
Changes in investment holding gains – – – 13,393 – 13,393
Provision for Stripe put right released – – – 21 – 21
Exchange differences on bank loans – – – (669) – (669)
Other exchange differences – – – (31) – (31)
Revenue return after taxation – – – – (4,718) (4,718)
At 31 May 2023 3,073 250,827 168,942 165,931 (20,174) 568,599
The capital reserve includes investment holding gains on fixed asset investments of £144,945,000 (2023 – gains of £26,558,000)
as disclosed in note 9.
The revenue reserve, the capital reserve (to the extent it constitutes realised profits) and the special distributable reserve may be
distributed by way of dividend.
The special distributable reserve and the capital reserve can be used for the repurchase of shares.
14 Net asset value per ordinary share
The net asset value per ordinary share and the net asset value attributable to the ordinary shareholders at the year end calculated
in accordance with the Articles of Association were as follows:
2024 2023
2024 2023 £’000 £’000
Shareholders’ funds 216.65p 186.33p 643,933 568,599
The movements during the period of the assets attributable to the ordinary shares are shown in note 13.
Net asset value per ordinary share is based on the net assets as shown above and on 297,228,700 (2023 – 305,153,700) ordinary
shares, being the number of ordinary shares in issue (excluding treasury shares) at 31 May 2024 and 31 May 2023 respectively.
103
Financial report
15 Analysis of change in net debt

| At 31 May |  |  |  | Exchange |  | At 31 May |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  | 2023 | Cash flows |  | movement |  |  | 2024 |
|  | £’000 |  | £’000 |  | £’000 |  | £’00 |

Cash and cash equivalents 3,440 3,373 (193) 6,620
Loans due within one year (40,342) – 1,071 (39,271)
(36,902) 3,373 878 (32,651)
16 Transactions with related parties and the Managers and Secretaries
The Directors’ fees and shareholdings are detailed in the Directors’ remuneration report on pages 76 to 79. No Director has a
contract of service with the Company. During the period no Director was interested in any contract or other matter requiring
disclosure under section 412 of the Companies Act 2006.
Baillie Gifford & Co Limited has been appointed as the Company’s Alternative Investment Fund Managers and Company
Secretaries. Details of the terms of the Investment Management Agreement are set out on page 61 and details of the fees during
the period and the balance outstanding at the period end are shown in notes 3 and 11 respectively.
17 Financial instruments
As an investment trust, the Company invests in listed and unlisted securities and makes other investments so as to achieve
its investment objective of maximising capital appreciation from a focussed and actively managed portfolio of investments
predominantly in listed and unlisted US companies. The Company may borrow money when the Board and Managers have
sufficient conviction that the assets funded by borrowed monies will generate a return in excess of the cost of borrowing.
In pursuing its investment objective, the Company is exposed to various types of risk that are associated with the financial
instruments and markets in which it invests.
These risks are categorised as market risk (comprising currency risk, interest rate risk and other price risk), liquidity risk and
credit risk. The Board monitors closely the Company’s exposures to these risks but does so in order to reduce the likelihood of
a permanent loss of capital rather than to minimise short-term volatility. Risk provides the potential for both losses and gains. In
assessing risk, the Board encourages the Managers to exploit the opportunities that risk affords.
The risk management policies and procedures outlined in this note have not changed significantly from the previous accounting
period.
Market risk
The fair value or future cash flows of a financial instrument or other investment held by the Company may fluctuate because of
changes in market prices. This market risk comprises three elements – currency risk, interest rate risk and other price risk. The
Board of Directors reviews and agrees policies for managing these risks and the Company’s Managers both assess the exposure
to market risk when making individual investment decisions and monitor the overall level of market risk across the investment
portfolio on an ongoing basis.
Details of the Company’s investment portfolio are shown in note 9. The Company may, from time to time, enter into derivative
transactions to hedge specific market, currency or interest rate risk. In the year to 31 May 2024 and the year to 31 May 2023
no such transactions were entered into. The Company’s Managers may not enter into derivative transactions without the prior
approval of the Board.
i. Currency risk
The Company’s assets, liabilities and income are principally denominated in US dollars. The Company’s functional currency and
presentational currency is sterling. Consequently, movements in the US dollar/sterling exchange rate will affect the sterling value
of those items.
The Managers monitor the Company’s US dollar exposure (and any other overseas currency exposure) and report to the Board on
a regular basis. The Managers assess the risk to the Company of the foreign currency exposure by considering the effect on the
Company’s net asset value and income of a movement in the rates of exchange to which the Company’s assets, liabilities, income
and expenses are exposed. However, the country in which a company is listed is not necessarily where it earns its profits. The
movement in exchange rates on overseas earnings may have a more significant impact upon a company’s valuation than a simple
translation of the currency in which the company is quoted.
US dollar borrowings can limit the Company’s exposure to anticipated future changes in exchange rates which might otherwise
adversely affect the value of the portfolio of investments.
104 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
17 Financial instruments (continued)
i. Currency risk (continued)
Exposure to currency risk through asset allocation, which is calculated by reference to the currency in which the asset or liability
is quoted, is shown below.

|  |  |  | Cash and |  | Bank | Other debtors |  |  | Net |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Investments |  | deposits |  | loans | and creditors* | exposure |  |  |
| At 31 May 2024 |  | £’000 |  | £’000 | £’000 | £’000 |  | £’000 |  |

US dollar 678,234 6,237 (39,271) 171 645,371
Total exposure to currency risk 678,234 6,237 (39,271) 171 645,371
Sterling – 383 – (1,821) (1,438)
678,234 6,620 (39,271) (1,650) 643,933

| * Includes non-monetary assets of £172,000. |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Cash and |  | Bank | Other debtors |  |  | Net |
|  | Investments |  | deposits |  | loans | and creditors* | exposure |  |  |
| At 31 May 2023 |  | £’000 |  | £’000 | £’000 | £’000 |  | £’000 |  |

US dollar 605,908 3,074 (40,342) (556) 568,084
Total exposure to currency risk 605,908 3,074 (40,342) (556) 568,084
Sterling – 366 – 149 515
605,908 3,440 (40,342) (407) 568,599
* Includes non-monetary assets of £172,000.
Currency risk sensitivity
At 31 May 2024, if sterling had strengthened by 5% against the US dollar, with all other variables held constant, total net assets
and total return would have decreased by £32,269,000 (2023 – £28,404,000). A 5% weakening of sterling against the US dollar,
with all other variables held constant, would have had an equal but opposite effect on the Financial Statement amounts. The
analysis is performed on the same basis as it was for 2023.
A change of 5% in foreign currency rates has been considered to be a reasonably plausible change.
ii. Interest rate risk
Interest rate movements may affect directly the level of income receivable on cash deposits and the interest payable on any variable
rate borrowings.
They may also impact upon the market value of investments as the effect of interest rate movements upon the earnings of a
company may have a significant impact upon the valuation of that company’s equity.
The possible effects on fair value and cash flows that could arise as a result of changes in interest rates are taken into account when
making investment decisions and when entering into borrowing agreements.
The Board reviews on a regular basis the amount of investments in cash.
The Company finances part of its activities through borrowings within approved levels. The amount of any such borrowings and the
approved levels are monitored and reviewed regularly by the Board.
The interest rate risk profile of the Company’s financial assets and liabilities at 31 May 2024 and 31 May 2023 are shown below.
Financial assets

|  |  |  |  | 2024 |  |  | 2024 |  |  |  |  | 2023 |  |  | 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | 2024 |  | Weighted |  |  | Weighted |  |  | 2023 |  | Weighted |  |  | Weighted |  |
| Fair value |  |  | average |  | average period |  |  | Fair value |  |  | average |  | average period |  |  |
|  | £’000 | interest rate |  |  | until maturity |  |  |  | £’000 | interest rate |  |  | until maturity |  |  |

Cash
US dollar 6,237 2.2% n/a 3,074 2.3% n/a
Sterling 383 1.0% n/a 366 1.1% n/a
6,620 3,440
The cash deposits generally comprise overnight call or short-term money market deposits and earn interest at floating rates based
on prevailing bank base rates. The table above does not include interest bearing investments because these investments have
fixed interest rates and therefore are not subject to interest rate sensitivity.
105
Financial report
17 Financial instruments (continued)
Financial liabilities

|  |  |  |  | 2024 | 2024 |  |  |  |  | 2023 | 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | 2024 |  | Weighted |  | Weighted |  | 2023 |  | Weighted |  | Weighted |
| Book value |  |  | average |  | average period | Book value |  |  | average |  | average period |
|  | £’000 | interest rate |  |  | until maturity* |  | £’000 | interest rate |  |  | until maturity* |

Bank loans
Floating rate – US$ denominated 39,271 6.8% 826 days 20,171 5.2% 61 days
Fixed rate – US$ denominated – – – 20,171 1.9% 145 days
39,271 40,342
* Based on expected maturity date. The three-year floating rate facilities are rolled forward on a three-monthly basis. The amount drawn down over
the term of the facilities is reviewed at every roll forward date.
Interest rate risk sensitivity
An increase of 100 basis points in interest rates, with all other variables held constant, would have decreased the Company’s
total net assets and total return for the year ended 31 May 2024 by £307,000 (2023 – decreased by £146,000). This is due to the
Company’s exposure to interest rates on its revolving floating rate bank loans and cash balances. A decrease of 100 basis points
would have had an equal but opposite effect.
iii. Other price risk
Changes in market prices other than those arising from interest rate risk or currency risk may also affect the value of the Company’s
net assets. The Board manages the market price risks inherent in the investment portfolio by ensuring full and timely access to
relevant information from the Managers. The Board meets regularly and at each meeting reviews investment performance, the
investment portfolio and the rationale for the current investment portfolio positioning to ensure consistency with the Company’s
objectives and investment policies. The portfolio does not seek to reproduce the comparative index. Investments are selected
based upon the merit of individual companies and therefore performance may well diverge from the comparative index.
Other price risk sensitivity
A full list of the Company’s investments is given on pages 41 to 44. In addition, an analysis of the investment portfolio by broad
industrial or commercial sector is shown on page 32.
69.4% (2023 – 69.7%) of the Company’s net assets are invested in quoted equities. A 5% increase in quoted equity valuations
at 31 May 2024 would have increased total assets and total return by £22,352,000 (2023 – £19,814,000). A decrease of 5%
would have had an equal but opposite effect.
35.9% (2023 – 36.7%) of the Company’s net assets are invested in private company investments. The fair valuation of the
private company investments is influenced by the estimates, assumptions and judgements made in the fair valuation process
(see 1b on pages 94 and 95).
106 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
17 Financial instruments (continued)
iii. Other price risk (continued)
Other price risk sensitivity (continued)
The private company sensitivity analysis below recognises that the valuation methodologies employed involve different levels
of subjectivity in their significant unobservable inputs and illustrates the sensitivity of the valuations to these inputs as it involves
more significant subjective estimation than the recent transaction method. The inputs have been flexed by +/-10%. The table also
provides the range of values for the key unobservable inputs.
As at
Significant unobservable inputs*
31 May 2024

|  | Fair value of | Key |  | Other |  |  | Weighted |  |  |  | Sensitivity to changes |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | investments | unobservable |  | unobservable |  |  | average |  | Sensitivity |  | in significant |
| Valuation technique | £’000 | inputs |  | inputs | † | Range |  | range# |  | % | unobservable inputs |
| Recent transaction | 119,699 n/a |  | ^ | a,b n/a n/a 10.0% If the recent |  |  |  |  |  |  |  |
| price |  |  |  |  |  |  |  |  |  |  | transaction price |

changed by +/- 10%,
the fair value would
change by £11,896,255
and -£11,593,406.

| Benchmark | 86,637 Selection of |  |  | a,b,c,f (26.0%) |  | (0.7%) 10.0% If input comparable |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| performance |  | comparable |  |  | – 15.8% |  | company performance |
|  |  | companies |  |  |  |  | changed by +/- 10%, |
|  |  | and relevant |  |  |  |  | the fair value would |
|  |  | indices | ‡ |  |  |  | change by £7,117,989 |

and -£6,908,997.

| Market approach | 24,854 EV/LTM |  |  | a,b,c,d | 1.6x – | 5.6x | 10.0% | If EV/LTM multiples |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| using comparable |  | revenue |  |  | 8.1x |  |  | changed by +/- 10%, |
| trading multiples |  | multiple | ¶ |  |  |  |  | the fair value would |

change by £1,878,772
and -£1,838,372.

| EV/NTM |  | a,b,c,d | 6.9x | 6.9x | 10.0% | If EV/NTM multiples |
| --- | --- | --- | --- | --- | --- | --- |
| revenue |  |  |  |  |  | changed by +/- 10%, |
| multiple | § |  |  |  |  | the fair value would |

change by £221,252
and -£221,232.
Illiquidity e (10.0%) (10.0%) 10.0% If the illiquidity discount
discount is changed by -/+ 10%,
the fair value would
change by £219,574
and -£191,262.

| Transaction | g | (49.7%) | (49.7%) | 10.0% | If a +/- 10% |
| --- | --- | --- | --- | --- | --- |
| implied |  |  |  |  | adjustment is applied |
| premiums and |  |  |  |  | to the calculated |
| discounts |  |  |  |  | premiums and |

discounts, the fair
value would change
by £133,781 and
-£120,733.
† See explanation of significant unobservable inputs on page 109 (sections ‘a’ to ‘g’ as relevant).
# Weighted average is calculated by reference to the fair value of holdings as at the respective year end. This therefore gives a clearer indication of
the typical multiple or adjustment being applied across the portfolio.
‡ See explanation for the selection of comparable companies on page 109, section ‘c’. The percentage movements reflect the movement in overall
company value for the basket of comparable companies relevant to each holding since the most recent transaction or since the last assessed.
¶ Enterprise value (EV) divided by the last twelve months (LTM) revenue.
§ Enterprise value (EV) divided by the next twelve months (NTM) forecast revenue.
^ Whilst a recent transaction price may be the most appropriate basis for a valuation, it will be corroborated by other techniques which factor in the
unobservable inputs noted in the above table. However, the transaction price itself is observable.
* Significant unobservable inputs
The unobservable inputs applicable to each broad category of valuation basis will vary dependent on the particular circumstances of each
unlisted company valuation. An explanation of each of the key unobservable inputs is provided below and includes an indication of the range in
value for each input, where relevant. The assumptions made in the production of the inputs are described in note 1b on pages 94 and 95.
107
Financial report
17 Financial instruments (continued)
As at Significant unobservable inputs*
31 May 2023

|  | Fair value of | Key |  | Other |  |  | Weighted |  |  |  | Sensitivity to |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | investments | unobservable |  | unobservable |  |  | average |  | Sensitivity |  | changes in significant |
| Valuation technique | £’000 | inputs |  | inputs | † | Range |  | range# |  | % | unobservable inputs |
| Recent transaction | 95,711 n/a |  | ^ | a,b n/a n/a n/a n/a |  |  |  |  |  |  |  |

price

| Benchmark | 83,399 Selection of |  |  | a,b,c,f (36.3%)– |  | (9.8%) 10.0% If input comparable |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| performance |  | comparable |  |  | 21.2% |  | company performance |
|  |  | companies |  |  |  |  | changed by +/-10%, |
|  |  | and relevant |  |  |  |  | the fair value would |
|  |  | indices | ‡ |  |  |  | change by £5,463,779 |

and -£5,331,196.

| Market approach | 30,526 EV/LTM |  |  | a,b,c,d 1.9x–6.9x 4.8x 10.0% If EV/LTM multiples |  |
| --- | --- | --- | --- | --- | --- |
| using comparable |  | revenue |  |  | changed by +/-10%, |
| trading multiples |  | multiple | ¶ |  | the fair value would |

change by £1,418,080
and -£1,390,974.

| EV/NTM |  | a,b,c,d 4.4x–4.9x 4.6x 10.0% If EV/NTM multiples |  |
| --- | --- | --- | --- |
| revenue |  |  | changed by +/-10%, |
| multiple | § |  | the fair value would |

change by £715,920
and -£715,110.
Illiquidity e (10.0%) (10.0%) 10.0% If the transaction
discount implied premium/
discount is changed
by -/+ 10%, the fair
value would change
by £241,009 and
-£237,884.
Transaction g n/a n/a n/a n/a
implied
premiums and
discounts**
† See explanation of significant unobservable inputs on page 109 (sections ‘a’ to ‘g’ as relevant).
# Weighted average is calculated by reference to the fair value of holdings as at the respective year end. This therefore gives a clearer indication of
the typical multiple or adjustment being applied across the portfolio.
‡ See explanation for the selection of comparable companies on page 109, section ‘c’. The percentage movements reflect the movement in overall
company value for the basket of comparable companies relevant to each holding since the most recent transaction or since the last assessed.
¶ Enterprise value (EV) divided by the last twelve months (LTM) revenue.
§ Enterprise value (EV) divided by the next twelve months (NTM) forecast revenue.
^ Whilst a recent transaction price may be the most appropriate basis for a valuation, it will be corroborated by other techniques which factor in the
unobservable inputs noted in the above table. However, the transaction price itself is observable.
** Due to fewer transactions in the last 12 months and to avoid stale valuations, there were no transaction implied premiums or discounts directly
impacting the valuations.
* Significant unobservable inputs
The unobservable inputs applicable to each broad category of valuation basis will vary dependent on the particular circumstances of each unlisted
company valuation. An explanation of each of the key unobservable inputs is provided below and includes an indication of the range in value for
each input, where relevant. The assumptions made in the production of the inputs are described in note 1(b) on pages 94 and 95.
108 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
17 Financial instruments (continued)
a. Application of valuation basis
Each investment is assessed independently, and the valuation basis applied will vary depending on the circumstances of each
investment. When an investment is pre-revenue, the focus of the valuation will be on assessing the recent transaction and the
achievement of key milestones since investment. Adjustments may also be made depending on the performance of comparable
benchmarks and companies. For those investments where a trading multiples approach can be taken, the methodology will
factor in revenue, earnings or net assets as appropriate for the investment, and where a suitable correlation can be identified
with the comparable companies then a regression analysis will be performed. Discounted cash flows will also be considered
where appropriate forecasts are available.
b. Probability estimation of liquidation events
The probability of a liquidation event such as a company sale, or alternatively an initial public offering (‘IPO’), is a key variable
input in the transaction-based and multiples-based valuation techniques. The probability of an IPO versus a company sale is
typically estimated from the outset to be 50:50 if there has been no indication by the company of pursuing either of these
routes. If the company has indicated an intention to IPO, the probability is increased accordingly to 75% and if an IPO has
become a certainty the probability is increased to 100%. Likewise, in a scenario where a company is pursuing a trade sale the
weightings will be adjusted accordingly in favour of a sale scenario. The Company typically invests in higher ranking preference
shares which carry more protection, and this can therefore influence the end valuation. Option pricing models are used to
corroborate the valuations where there has been more notable company underperformance to ensure that the economic reality
of the shares held by Baillie Gifford US Growth remain appropriate.
c. Selection of comparable companies
The selection of comparable companies is assessed individually for each investment at the point of investment, and the
relevance of the comparable companies is continually evaluated at each valuation. The key criteria used in selecting
appropriate comparable companies are the industry sector in which they operate, the geography of the company’s operations,
the respective revenue and earnings growth rates and the operating margins. Typically, between four and ten comparable
companies will be selected for each investment, depending on how many relevant comparable companies are identified.
The resultant revenue or earnings multiples or share price movements derived will vary depending on the companies selected
and the industries they operate in.
d. Estimated sustainable earnings
The selection of sustainable revenue or earnings will depend on whether the company is sustainably profitable or not, and
where it is not then revenues will be used in the valuation. The valuation approach will typically assess companies based on
the last twelve months of revenue or earnings, as they are the most recent available and therefore viewed as the most reliable.
Where a company has reliably forecasted earnings previously or there is a change in circumstance at the business which will
impact earnings going forward, then forward estimated revenue or earnings may be used instead.
e. Application of liquidity discount
The application of an illiquidity discount will be applied either through the calibration of a valuation against the most recent
transaction, or by application of a specific discount. The discount applied where a calibration (see ‘g’ below) is not appropriate
is typically 10%, reflecting that the majority of the investments held are substantial companies with some secondary market
activity.
f. Selection of appropriate benchmarks
The selection of appropriate benchmarks is assessed individually for each investment. The industry and geography of
each company are key inputs to the benchmark selection, with either one or two key indices or benchmarks being used for
comparison where applicable.
g. Transaction implied premium and discount
Where there is an implied company valuation available as a result of an external arm’s length transaction, the ongoing valuation
will be calibrated to this by deriving a company valuation with reference to the average multiple from a set of comparable
companies and comparing this to a transaction implied valuation, and could result in an implied premium or discount compared
to comparable companies at the point of transaction. This discount or premium will be considered in future valuations, and may
be reduced due to factors such as period of time since the transaction and company performance. Where a calibrated approach
is not appropriate, a discount for illiquidity will be applied as noted in ‘e’ above.
109
Financial report

## 17 Financial instruments (continued)

### Liquidity risk

This is the risk that the Company will encounter difficulty in meeting obligations associated with financial liabilities. 65.2% of the Company's total assets as at 31 May 2024 were investments in quoted securities that are readily realisable mitigating liquidity risk. The Board provides guidance to the Managers as to the maximum exposure to any one holding and to the maximum aggregate exposure to substantial holdings.

The Company has the power to take out borrowings, which give it access to additional funding when required. The Company's current borrowing facilities are detailed in note 11. Under the terms of the borrowing facility, borrowings are repayable on demand at their current carrying value.

### Credit risk

This is the risk that a failure of a counterparty to a transaction to discharge its obligations under that transaction could result in the Company suffering a loss.

This risk is managed as follows:

- (i) where the Managers make an investment in a bond or other security with credit risk, that credit risk is assessed and then compared to the prospective investment return of the security in question;
- (ii) the Depositary is liable for the loss of financial instruments held in custody. The Depositary will ensure that any delegate segregates the assets of the Company. The Managers monitor the Company's risk by reviewing the Custodian's internal control reports and reporting its findings to the Board;
- (iii) investment transactions are carried out with a large number of brokers whose creditworthiness is reviewed by the Managers. Transactions are ordinarily undertaken on a delivery versus payment basis whereby the Company's Custodian bank ensures that the counterparty to any transaction entered into by the Company has delivered on its obligations before any transfer of cash or securities away from the Company is completed;
- (iv) the creditworthiness of the counterparty to transactions involving derivatives, structured notes and other arrangements, wherein the creditworthiness of the entity acting as broker or counterparty to the transaction is likely to be of sustained interest, are subject to rigorous assessment by the Managers; and
- (v) cash is only held at banks that are regularly reviewed by the Managers. At 31 May 2024 and 31 May 2023 all cash deposits were held with the Custodian bank.

The Company owns a number of unquoted preference share securities. Some of these may have been classified as debt by the issuer. There are no material amounts past due in relation to these securities. As these instruments (alongside the ordinary share securities) have been recognised at fair value through profit and loss, the fair value takes into account credit, market and other price risk.

### Credit risk exposure

The maximum exposure to credit risk at 31 May was:

|   | 2024 £'000 | 2023 £'000  |
| --- | --- | --- |
|  Fixed interest investments | 2,276 | 4,167  |
|  Cash and short term deposits | 6,620 | 3,440  |
|  Debtors and prepayments | 605 | 657  |
|   | **9,501** | **8,264**  |

The maximum exposure to cash during the year to 31 May 2024 was £15,196,000 (31 May 2023 – £23,049,000) and the minimum was -£5,015,000 (31 May 2023 – £1,213,000). None of the Company's financial assets are past due or impaired.

110 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
17 Financial instruments (continued)
Fair value of financial assets and financial liabilities
The Directors are of the opinion that the financial assets and liabilities of the Company are stated at fair value in the Balance
Sheet with the exception of long-term borrowings. The fair values of the Company’s borrowings are shown below.

|  |  | 2024 |  | 2024 |  | 2023 |  | 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Book value |  | Fair value |  | Book value |  | Fair value |  |
|  |  | £’000 |  | £’000 |  | £’000 |  | £’000 |
| Floating rate multi-currency loan* |  | 39,271 39,271 20,171 20,171 |  |  |  |  |  |  |

Fixed rate multi-currency loan – – 20,171 19,733
39,271 39,271 40,342 39,904
* All short-term floating rate borrowings are stated at book cost which is considered to be equal to their fair value given the facilities are revolving
credit facilities.
Capital management
The capital of the Company is its share capital and reserves as set out in notes 12 and 13 together with its borrowings (see note
11). The objective of the Company is to invest predominantly in listed and unlisted US companies in order to achieve capital
growth. The Company’s investment policy is set out on pages 45 and 46. In pursuit of the Company’s objective, the Board has
a responsibility for ensuring the Company’s ability to continue as a going concern and details of the related risks and how they
are managed are set out on pages 48 to 53. The Company has the authority to issue and buy back its shares and changes to
the share capital during the period are set out in notes 12 and 13. The Company does not have any externally imposed capital
requirements other than the covenants on its loans which are detailed in note 11.
111
## Shareholder
## information
Baillie Gifford US Growth Trust plc
## Notice of
## Annual General Meeting
Primrose St
Sun St
Liverpool A10
Street
The Annual General Meeting of the Company will
Sun St Passage be held at the offices of Herbert Smith Freehills
Liverpool St
in London (Exchange House, Primrose Street,
London, EC2A 2EG) on Friday, 27 September 2024,
at 9.00am. You will find directions to the venue
by scanning the QR code above.
The Board encourages all shareholders to submit
proxy voting forms as soon as possible and, in any
event, by no later than 9.00am on 25 September
2024. Should shareholders have questions for the
Board or the Managers or any queries as to how to
vote, they are welcome as always to submit them by
email to trustenquiries@bailliegifford.com or call
0800 917 2112. Baillie Gifford may record your call.
113
Shareholder information

Notice is hereby given that the sixth Annual General Meeting of Baillie Gifford US Growth Trust plc (the 'Company') will be held at the offices of Herbert Smith Freehills in London (Exchange House, Primrose Street, London, EC2A 2EG) on Friday, 27 September 2024 at 9.00am for the purposes of considering and, if thought fit, passing the following resolutions, of which resolutions 1 to 10 will be proposed as ordinary resolutions and resolutions 11 and 12 will be proposed as special resolutions.

# Ordinary business

1. To receive and adopt the Annual Report and Financial Statements of the Company for the financial year ended 31 May 2024 together with the Reports of the Directors and of the Independent Auditor thereon.
2. To approve the Directors' Annual Report on Remuneration for the financial year ended 31 May 2024.
3. To re-elect Mr TJW Burnet as a Director of the Company.
4. To re-elect Ms SP Inglis as a Director of the Company.
5. To re-elect Mr GD Paterson as a Director of the Company.
6. To re-elect Mr CRD van der Kuyl as a Director of the Company.
7. To re-elect Ms RL Palmer as a Director of the Company.
8. To re-appoint Ernst & Young LLP as Independent Auditor of the Company to hold office until the conclusion of the next Annual General Meeting at which the Financial Statements are laid before the Company.
9. To authorise the Directors to determine the remuneration of the Independent Auditor of the Company.

10. That, in substitution to any existing authority but without prejudice to the exercise of any such authority prior to the date hereof, the Directors of the Company be and they are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot ordinary shares in the capital of the Company, or C shares convertible into ordinary shares, provided that such authority shall be limited to the allotment of ordinary shares and grant of rights in respect of ordinary shares with an aggregate nominal value of up to £984,262.33 (representing approximately one-third of the nominal value of the issued share capital excluding treasury shares as at 16 August 2024), such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, unless previously revoked, varied or extended by the Company in a general meeting, save that the Company may at any time prior to the expiry of this authority make an offer or enter into an agreement which would or might require ordinary shares or C shares to be allotted or granted after the expiry of such authority and the Directors shall be entitled to allot or grant ordinary shares or C shares in pursuance of such an offer or agreement as if such authority had not expired.
11. That, subject to the passing of Resolution 10 above, and in substitution to any existing authorities but without prejudice to the exercise of any such authority prior to the date hereof, the Directors of the Company be and they are hereby generally empowered, pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560(1) of the Act, and including ordinary shares and C shares)

114 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc

| for cash pursuant to the authority given by | (b) the minimum price (excluding expenses) |  |
| --- | --- | --- |
| Resolution 10 above and to sell treasury shares |  | which may be paid for each ordinary share |
| for cash as if section 561(1) of the Act did not |  | shall be the nominal value of that share; |

apply to any such allotment or sale, provided that
(c) the maximum price (excluding expenses)
this power:
which may be paid for any ordinary share
(a) expires at the conclusion of the next purchased pursuant to this authority shall not
Annual General Meeting of the Company be more than the higher of:
after the passing of this Resolution or on the
(i) 5% above the average closing price
expiry of 15 months from the passing of this
on the London Stock Exchange of an
Resolution, whichever is the earlier, save that
ordinary share over the five business
the Company may, before such expiry, make
days immediately preceding the day of
an offer or agreement which would or might
purchase; and
require equity securities to be allotted after
such expiry and the Directors may allot (ii) the higher of the price of the last
equity securities in pursuance of any such independent trade and the highest current
offer or agreement as if the power conferred independent bid for an ordinary share in
hereby had not expired; and the Company on the trading venues where
the market purchases by the Company
(b) shall be limited to the allotment of equity
pursuant to the authority conferred by this
securities or the sale of treasury shares up to
Resolution 12 will be carried out; and
an aggregate nominal value of £ 295,278.70

| (representing approximately 10% of the | (d) unless previously varied, revoked or renewed |  |
| --- | --- | --- |
| nominal value of the issued share capital |  | by the Company in a general meeting, the |
| excluding treasury shares of the Company as |  | authority hereby conferred shall expire at |
| at 16 August 2024). |  | the conclusion of the next Annual General |

Meeting, save that the Company may, prior to
12. That, in substitution for any existing authority
such expiry, enter into a contract to purchase
but without prejudice to the exercise of any such
ordinary shares under such authority which
authority prior to the date hereof, the Company
will or might be completed or executed wholly
be generally and unconditionally authorised, in
or partly after the expiration of such authority
accordance with section 701 of the Companies
and may make a purchase of ordinary shares
Act 2006 (the ‘Act’) to make market purchases
pursuant to any such contract or contracts.
(within the meaning of section 693(4) of the
Act) of fully paid ordinary shares of 1p each in
the capital of the Company (‘ordinary shares’)
By Order of the Board
(either for retention as treasury shares for future
Baillie Gifford & Co Limited
reissue, resale or transfer or for cancellation)
Managers and Secretaries
provided that:
28 August 2024
(a) the maximum aggregate number of ordinary
shares hereby authorised to be purchased
is 44,262,277, or, if less, the number
representing approximately 14.99% of the
issued ordinary share capital (excluding
treasury shares) of the Company as at the
date of the passing of this Resolution;
115
Shareholder information
Notes

| 01. As a member you are entitled to appoint a proxy |  | 04. In order for a proxy appointment or instruction |  |
| --- | --- | --- | --- |
|  | or proxies to exercise all or any of your rights |  | made using the CREST service to be |
|  | to attend, speak and vote at the AGM. A proxy |  | valid, the appropriate CREST message (a |
|  | need not be a member of the Company but |  | ‘CREST Proxy Instruction’) must be properly |
|  | must attend the AGM to represent you. You may |  | authenticated in accordance with Euroclear |

UK & International Limited’s specifications,
appoint more than one proxy provided each
and must contain the information required for
proxy is appointed to exercise rights attached to
such instruction, as described in the CREST
different shares. You can only appoint a proxy
Manual. The message, regardless of whether
using the procedure set out in these notes and
it constitutes the appointment of a proxy or
the notes to the proxy form. You may not use
is an amendment to the instruction given to a
any electronic address provided either in this
previously appointed proxy must, in order to
notice or any related documents (including
be valid, be transmitted so as to be received
the Financial Statements and proxy form) to
by the Company’s registrar (ID 3RA50) no
communicate with the Company for any purpose
later than 9.00am two days (excluding non-
other than those expressly stated.
working days) before the time of the meeting

| 02. A proxy form for use by shareholders at the |  | or any adjournment. For this purpose, the |
| --- | --- | --- |
|  | meeting is enclosed with this document. Proxies | time of receipt will be taken to be the time |
|  | must be lodged with the Company’s registrar, | (as determined by the timestamp applied to |
|  | Computershare Investor Services PLC, The | the message by the CREST Application Host) |

from which the Company’s registrar is able to
Pavilions, Bridgwater Road, Bristol BS99 6ZY or
retrieve the message by enquiry to CREST in
eproxyappointment.com, not less than two days
the manner prescribed by CREST. After this time
(excluding non-working days) before the time
any change of instructions to proxies appointed
appointed for the meeting together with any
through CREST should be communicated to the
power of attorney or other authority (if any)
appointee through other means.
under which it is signed. Completion of the
proxy form will not prevent a shareholder from 05. CREST members and, where applicable,
attending the meeting and voting in person. their CREST sponsors, or voting service
providers should note that Euroclear UK &
03. CREST members who wish to appoint a proxy
International Limited does not make available
or proxies through the CREST electronic proxy
special procedures in CREST for any particular
appointment service may do so by using the
message. Normal system timings and
procedures described in the CREST Manual
limitations will, therefore, apply in relation to
and/or by logging on to the website
the input of CREST Proxy Instructions. It is the
euroclear.com/CREST. CREST personal
responsibility of the CREST member concerned
members or other CREST sponsored members,
to take (or, if the CREST member is a CREST
and those CREST members who have appointed
personal member, or sponsored member, or
a voting service provider(s), should refer to their
has appointed a voting service provider(s),
CREST sponsor or voting service provider(s),
to procure that his or her CREST sponsor or
who will be able to take the appropriate action
voting service provider(s) take(s)) such action
on their behalf.
as shall be necessary to ensure that a message
is transmitted by means of the CREST system
by any particular time. In this connection,
CREST members and, where applicable, their
CREST sponsors or voting system providers are
referred, in particular, to those sections of the
CREST Manual concerning practical limitations
of the CREST system and timings.
06. The Company may treat as invalid a CREST
Proxy Instruction in the circumstances set out
in Regulation 35(5)(a) of the Uncertificated
Securities Regulations 2001.
116 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
07. The return of a completed proxy form or other 12. Any corporation which is a member can appoint
instrument of proxy will not prevent you attending one or more corporate representatives who
the AGM and voting in person if you wish. may exercise on its behalf all of its powers as
a member provided that they do not do so in
08. Pursuant to Regulation 41 of the Uncertificated
relation to the same shares.
Securities Regulations 2001 and section 311 of

| the Companies Act 2006 the Company specifies | 13. As at 16 August 2024 (being the last practicable |  |
| --- | --- | --- |
| that to be entitled to attend and vote at the |  | date prior to the publication of this notice) the |
| Annual General Meeting (and for the purpose of |  | Company’s issued share capital (excluding |
| the determination by the Company of the votes |  | treasury shares) consisted of 295,278,700 |
| they may cast), shareholders must be registered |  | ordinary shares of 1p each, carrying one vote |
| in the Register of Members of the Company no |  | each. Therefore, the total number of voting |
| later than 9.00am two days (excluding non- |  | rights in the Company as at 16 August 2024 |
| working days) prior to the commencement of the |  | were 295,278,700 votes. |

AGM or any adjourned meeting. Changes to the
14. Any person holding 3% or more of the total
Register of Members after the relevant deadline
voting rights of the Company who appoints a
shall be disregarded in determining the rights of
person other than the Chair of the meeting as
any person to attend and vote at the meeting.
his or her proxy will need to ensure that both

| 09. The members of the Company may require the |  | he/she and his/her proxy complies with their |
| --- | --- | --- |
|  | Company to publish, on its website, (without | respective disclosure obligations under the UK |
|  | payment) a statement (which is also passed | Disclosure Guidance and Transparency Rules. |

to the Auditor) setting out any matter relating
15. No Director has a contract of service with
to the audit of the Company’s Financial
the Company.
Statements, including the Auditor’s report and
the conduct of the audit. The Company will
be required to do so once it has received such
requests from either members representing
at least 5% of the total voting rights of the
Company or at least 100 members who have
a relevant right to vote and hold shares in the
Company on which there has been paid up an
average sum per member of at least £100. Such
requests must be made in writing and must state
your full name and address and be sent to the
Company at Calton Square, 1 Greenside Row,
Edinburgh EH1 3AN.
10. Information regarding the Annual General
Meeting, including information required by
section 311A of the Companies Act 2006,
is available from the Company website at
bgusgrowthtrust.com.
11. Members have the right to ask questions at the
meeting in accordance with section 319A of the
Companies Act 2006
117
Shareholder information
## Further shareholder
## information
Baillie Gifford US Growth Trust plc Key dates
(‘Baillie Gifford US Growth’) is an investment The Company pays the minimum permissible level of
trust. Investment trusts offer investors final dividend and no interim dividend. If a dividend
the following: was payable this would be due soon after the Annual
General Meeting.
ș participation in a diversified portfolio of shares;
ș constant supervision by experienced
Share register enquiries
professional managers; and
Computershare Investor Services PLC maintains
ș the Company is free from capital gains tax
the share register on behalf of the Company. In the
on capital profits realised within its portfolio,
event of queries regarding shares registered in your
although investors are still liable for capital gains
own name, please contact the registrar on
tax on profits when selling their investment.
0370 707 1711.
This helpline also offers an automated self-service
How to invest
functionality (available 24 hours a day, 7 days a
The Company’s shares are traded on the London
week) which allows you to:
Stock Exchange. They can be bought by placing an
ș hear the latest share price;
order with a stockbroker, or by asking a professional
adviser to do so. If you are interested in investing
ș confirm your current share holding balance; and
directly in Baillie Gifford US Growth Trust, you can
ș order change of address and stock transfer
do so online. There are a number of companies
forms.
offering real time online dealing services. Find
out more by visiting the investment trust pages at You can also check your holding on the registrar’s
bailliegifford.com. website at investorcentre.co.uk.
They also offer a free, secure share management
Sources of further information
website service which allows you to:
on the Company
ș view your share portfolio and see the latest
The ordinary shares of the Company are listed
market price of your shares;
on the London Stock Exchange and their price is
shown in the Financial Times. The price of shares ș calculate the total market price of each
can also be found on the Company website at shareholding;
bgusgrowthtrust.com, Trustnet at trustnet.co.uk and
ș view price histories and trading graphs;
on other financial websites. Company factsheets
ș change address details; and
are also available on the Baillie Gifford website
and are updated monthly. These are available from
ș use online dealing services.
Baillie Gifford on request.
To take advantage of this service, please log in at
investorcentre.co.uk and enter your Shareholder
Baillie Gifford US Growth share identifiers
Reference Number and Company Code (this
ISIN GB00BDFGHW41
information can be found on your share certificate).
Sedol BDFGHW4
Ticker USA
Legal Entity Identifier 213800UM1OUWXZPKE539
118 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Electronic proxy voting Leverage
If you hold stock in your own name you can choose The Company’s maximum and actual leverage levels
to vote by returning proxies electronically at (see Glossary of terms and alternative performance
eproxyappointment.com. measures on pages 124 to 127) at 31 May 2024 are
shown below:
If you have any questions about this service please

| contact Computershare on 0370 707 1711. |  | Gross | Commitment |  |
| --- | --- | --- | --- | --- |
|  |  | method |  | method |
| CREST proxy voting | Maximum limit 2.50:1 2.00:1 |  |  |  |
| If you are a user of the CREST system (including | Actual 1.06:1 1.06:1 |  |  |  |

a CREST Personal Member), you may appoint one
or more proxies or give an instruction to a proxy
by having an appropriate CREST message
Automatic exchange of information
transmitted. For further information please refer
In order to fulfil its obligations under UK tax
to the CREST Manual.
legislation relating to the automatic exchange of
Where this has been received in a country where
information, Baillie Gifford US Growth Trust plc is
the provision of such a service would be contrary to
required to collect and report certain information
local laws or regulations, this should be treated as
about certain shareholders.
information only.
The legislation will require investment trust
companies to provide personal information to
How to vote your shares
HMRC on certain investors who purchase shares in
As a shareholder you have a say on how the
investment trusts. As an affected company, Baillie
Company is run. The following link will take
Gifford US Growth Trust plc will have to provide
you through to The Association of Investment
information annually to the local tax authority on
Companies (AIC) website where there is information
the tax residencies of a number of non-UK based
on how to vote your shares if you hold them via one
certificated shareholders and corporate entities.
of the major platforms: theaic.co.uk/how-to-vote-
Shareholders, excluding those whose shares are
your-shares.
held in CREST, who come on to the share register
will be sent a certification form for the purposes of
Alternative Investment Fund Managers
collecting this information.
(AIFM) Regulations
For further information, please see HMRC’s
In accordance with the AIFM Regulations, Quick Guide: Automatic Exchange of Information
information in relation to the Company’s leverage – information for account holders gov.uk/
and the remuneration of the Company’s AIFM, government/publications/exchange-of-information-
Baillie Gifford & Co Limited, is required to be made accountholders.
available to investors.
Data protection
AIFM remuneration
The Company is committed to ensuring the
In accordance with the Regulations, the AIFM
confidentiality and security of any personal data
remuneration policy is available at bailliegifford.com
provided to it. Further details on how personal data
or on request (see contact details in the ‘Company
is held and processed on behalf of the Company
information’ section on page 129). The numerical
can be found in the privacy policy available on the
remuneration disclosures in respect of the AIFM’s
Company’s website bgusgrowthtrust.com.
reporting period are available at bailliegifford.com.
119
Shareholder information
## Third party
## data provider
## disclaimer
No third party data provider (‘Provider’) makes any any index to accurately represent the asset class
warranty, express or implied, as to the accuracy, or market sector that it purports to represent and
completeness or timeliness of the data contained neither S&P Dow Jones Indices LLC, Dow Jones
herewith nor as to the results to be obtained by Trademark Holdings LLC, their affiliates nor their
recipients of the data. third party licensors shall have any liability for any
errors, omissions, or interruptions of any index or the
No Provider shall in any way be liable to any
data included therein.
recipient of the data for any inaccuracies, errors
or omissions in the index data included in this
FTSE Index data
document, regardless of cause, or for any damages
(whether direct or indirect) resulting therefrom. London Stock Exchange Group plc and its group
No Provider has any obligation to update, modify undertakings (collectively, the ‘LSE Group’). ©
or amend the data or to otherwise notify a recipient LSE Group 2024. FTSE Russell is a trading name
thereof in the event that any matter stated herein of certain of the LSE Group companies. ‘FTSE®’
changes or subsequently becomes inaccurate. ‘Russell®’, ‘FTSE Russell®’, is/are a trade mark(s) of
the relevant LSE Group companies and is/are used
Without limiting the foregoing, no Provider shall have
by any other LSE Group company under license. All
any liability whatsoever to you, whether in contract
rights in the FTSE Russell indexes or data vest in the
(including under an indemnity), in tort (including
relevant LSE Group company which owns the index
negligence), under a warranty, under statute or
or the data. Neither LSE Group nor its licensors
otherwise, in respect of any loss or damage suffered
accept any liability for any errors or omissions in the
by you as a result of or in connection with any
indexes or data and no party may rely on any indexes
opinions, recommendations, forecasts, judgements
or data contained in this communication.
or any other conclusions, or any course of action
No further distribution of data from the LSE Group is
determined, by you or any third party, whether or
permitted without the relevant LSE Group company’s
not based on the content, information or materials
express written consent. The LSE Group does not
contained herein.
promote, sponsor or endorse the content of this
communication.
S&P Index Data
The S&P 500 Index (‘Index’) is a product of S&P Dow
Jones Indices LLC, a division of S&P Global, or its
affiliates (‘SPDJI’). Standard & Poor’s® and S&P®
are registered trademarks of Standard & Poor’s
Financial Services LLC, a division of S&P Global
(‘S&P’); Dow Jones® is a registered trademark of
Dow Jones Trademark Holdings LLC (‘Dow Jones’).
Neither S&P Dow Jones Indices LLC, Dow Jones
Trademark Holdings LLC, their affiliates nor their
third party licensors make any representation or
warranty, express or implied, as to the ability of
120 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Sustainable Finance
## Disclosure Regulation
## ('SFDR')
The EU Sustainable Finance Disclosure Regulation complexity and duration of an event or condition,
(‘SFDR’) does not have a direct impact in the UK prevailing market conditions and existence of any
due to Brexit. However, it applies to third-country mitigating factors.
products marketed in the EU. As Baillie Gifford
Whilst consideration is given to sustainability
US Growth is marketed in the EU by the AIFM,
matters, there are no restrictions on the investment
Baillie Gifford & Co Limited, via the National Private
universe of the Company, unless otherwise stated
Placement Regime (‘NPPR’) the following disclosures
within in its investment objective & policy. Baillie
have been provided to comply with the high-level
Gifford & Co can invest in any companies it believes
requirements of SFDR.
could create beneficial long-term returns for
The AIFM has adopted Baillie Gifford & Co’s investors. However, this might result in investments
stewardship principles and guidelines as its policy being made in companies that ultimately cause a
on integration of sustainability risks in investment negative outcome for the environment or society.
decisions.
More detail on the Managers’ approach to
Baillie Gifford & Co believes that a company sustainability can be found in the stewardship
cannot be financially sustainable in the long run if principles and guidelines document, available
its approach to business is fundamentally out of publicly on the Baillie Gifford website
line with changing societal expectations. It defines bailliegifford.com and by scanning the QR
‘sustainability’ as a deliberately broad concept which code below.
encapsulates a company’s purpose, values, business
The underlying investments do not take into account
model, culture and operating practices.
the EU criteria for environmentally sustainable
Baillie Gifford & Co’s approach to investment is economic activities established under the EU
based on identifying and holding high quality growth Taxonomy Regulation.
businesses that enjoy sustainable competitive
advantages in their marketplace. To do this it
looks beyond current financial performance,
undertaking proprietary research to build up an
in-depth knowledge of an individual company
and a view on its long-term prospects. This
includes the consideration of sustainability factors
(environmental, social and/or governance matters)
which it believes will positively or negatively
influence the financial returns of an investment.
The likely impact on the return of the portfolio
from a potential or actual material decline in the
value of investment due to the occurrence of an
environmental, social or governance event or
condition will vary and will depend on several factors
including but not limited to the type, extent,
121
Shareholder information
## Communicating
## with shareholders
Trust magazine Baillie Gifford US Growth web page at bgusgrowthtrust.com
Trust magazine Baillie Gifford US Growth on the Web
Trust is the Baillie Gifford investment trust magazine Up-to-date information about Baillie Gifford
which is published twice a year. It provides an insight US Growth can be found on the Company website
to Baillie Gifford’s investment approach by including at bgusgrowthtrust.com. You will find full details on
interviews with Baillie Gifford’s fund managers, as Baillie Gifford US Growth, including recent portfolio
well as containing investment trust news, investment information and performance figures.
features and articles about the trusts managed by
Baillie Gifford, including Baillie Gifford US Growth. Client Relations Team contact details
Trust plays an important role in helping to explain
You can contact the Baillie Gifford Client Relations
Baillie Gifford’s products so that readers can really
Team by telephone, email or post:
understand them.
Telephone: +44 (0)800 917 2112
You can subscribe to Trust magazine or view a digital
Your call may be recorded for training or monitoring
copy at bailliegifford.com/trust.
purposes.
Email: trustenquiries@bailliegifford.com
Suggestions and questions
Website: bailliegifford.com
Any suggestions on how communications with

| shareholders can be improved are welcomed, so | Baillie Gifford Client Relations Team |
| --- | --- |
| please contact the Baillie Gifford Client Relations | Calton Square |
| Team and give them your suggestions. They will also | 1 Greenside Row |
| be very happy to answer questions that you may | Edinburgh EH1 3AN |

have about Baillie Gifford US Growth.
Please note that Baillie Gifford is not permitted
to give financial advice. If you would like advice,
please ask an authorised intermediary.
122 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
A year of opportunity in US Growth The American Dream made real The Long View
by Kirsty Gibson by Ben James
Exploring the inefficiencies of At the heart of the American Articles by our US Equities Team
the US stock market and the Dream is the idea that anyone exploring what matters most to
unique opportunities it presents can start a business and change optimistic, long-term investors.
for growth. the world through ingenuity, hard
work and investment.
123
Shareholder information

# Glossary of terms and alternative performance measures ('APM')

An alternative performance measure ('APM') is a financial measure of historical or future financial performance, financial position or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. The APMs noted below are commonly used measures within the investment trust industry and serve to improve comparability between investment trusts.

## Total assets

This is the Company's definition of adjusted total assets, being the total value of all assets held less all liabilities (other than liabilities in the form of borrowings).

## Shareholders' funds and net asset value

Shareholders' funds is the value of all assets held less all liabilities, with borrowings deducted at book cost. Net asset value ('NAV') is the value of all assets held less all liabilities, with borrowings deducted at either fair value or book value as described below. Per share amounts are calculated by dividing the relevant figure by the number of ordinary shares in issue.

## Borrowings at book value

Borrowings are valued at adjusted net issue proceeds. The value of the borrowings at book is set out on page 111.

## Borrowings at fair value (APM)

Borrowings are valued at an estimate of their market worth. The value of the borrowings at fair is set out on page 111.

## Net asset value (reconciliation of NAV at book value to NAV at fair value)

|   | 2024 | 2023  |
| --- | --- | --- |
|  Net asset value per ordinary share (borrowings at book value) | 216.65p | 186.33p  |
|  Shareholders' funds (borrowings at book value) | £643,933,000 | £568,599,000  |
|  Add: book value of borrowings | £39,271,000 | £40,342,000  |
|  Less: fair value of borrowings | (£39,271,000) | (£39,904,000)  |
|  **Net asset value (borrowings at fair value)** | **£643,933,000** | **£569,037,000**  |
|  **Number of shares in issue** | **297,228,700** | **305,153,700**  |
|  **Net asset value per ordinary share (borrowings at fair value)** | **216.65p** | **186.48p**  |

## Net liquid assets

Net liquid assets comprise current assets less current liabilities (excluding borrowings).

124 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Discount/premium (APM)
As stock markets and share prices vary, an investment trust’s share price is rarely the same as its NAV. When
the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount
is calculated by subtracting the NAV per share from the share price and is usually expressed as a percentage
of the NAV per share. If the share price is higher than the NAV per share, it is said to be trading at a premium.
2024 2023
Net asset value per ordinary share a 216.65p 186.48p
(after deducting borrowings at fair value)
Share price b 192.40p 144.80p
Discount (borrowings at fair value) (b-a) ÷ a 11.2% 22.4%
2024 2023
Net asset value per ordinary share a 216.65p 186.33p
(after deducting borrowings at book value)
Share price b 192.40p 144.80p
Discount (borrowings at book value) (b-a) ÷ a 11.2% 22.3%
Total return (APM)
The total return is the return to shareholders after reinvesting any dividend on the date that the share price
goes ex-dividend. The Company does not pay a dividend, therefore, the total returns for the share price and
NAV per share at book and fair value are the same as the percentage movements in the share price and NAV
per share at book and fair value as detailed on page 20.
Ongoing charges (APM)
The total recurring expenses (excluding the Company’s cost of dealing in investments and borrowing costs)
incurred by the Company as a percentage of the average net asset value (with debt at fair value).

| 31 May | 31 May |
| --- | --- |
| 2024 | 2023 |
| £’000 | £’000 |

Investment management fee 3,581 3,345
Other administrative expenses 726 670
Total expenses a 4,307 4,015
Average net asset value b 616,958 578,722
Ongoing charges (a ÷ b expressed as a percentage) 0.70% 0.69%
125
Shareholder information
Turnover (APM)
Annual turnover is a measure of portfolio change or trading activity in a portfolio. Turnover is calculated
as the minimum of purchases and sales in a month, divided by the average market value of the portfolio,
summed to get rolling 12 month turnover data.
Gearing (APM)
At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow
money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders’
assets is called ‘gearing’. If the Company’s assets grow, the shareholders’ assets grow proportionately more
because the debt remains the same. But if the value of the Company’s assets falls, the situation is reversed.
Gearing can therefore enhance performance in rising markets but can adversely impact performance in
falling markets.
Gearing is the Company’s borrowings at book value less cash and cash equivalents (including any
outstanding trade settlements) expressed as a percentage of shareholders’ funds.

| 31 May | 31 May |
| --- | --- |
| 2024 | 2023 |
| £’000 | £’000 |

Borrowings (at book cost) £39,271 £40,342
Less: cash and cash equivalents (£6,620) (£3,440)
Adjusted borrowings (a) £32,651 £36,902
Shareholders’ funds (b) £643,933 £568,599
Gearing: (a) as a percentage of (b) 5% 6%
Gross gearing is the Company’s borrowings expressed as a percentage of shareholders’ funds.

| 31 May | 31 May |
| --- | --- |
| 2024 | 2023 |
| £’000 | £’000 |

Borrowings (at book cost) (a) £39,271 £40,342
Shareholders’ funds (b) £643,933 £568,599
Gross gearing: (a) as a percentage of (b) 6% 7%
126 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
Leverage (APM)
For the purposes of the Alternative Investment Fund Managers Regulations, leverage is any method
which increases the Company’s exposure, including the borrowing of cash and the use of derivatives. It is
expressed as a ratio between the Company’s exposure and its net asset value and can be calculated on a
gross and a commitment method. Under the gross method, exposure represents the sum of the Company’s
positions after the deduction of sterling cash balances, without taking into account any hedging and netting
arrangements. Under the commitment method, exposure is calculated without the deduction of sterling cash
balances and after certain hedging and netting positions are offset against each other.
Active share (APM)
Active share, a measure of how actively a portfolio is managed, is the percentage of the portfolio that
differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio
that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an
active share of zero indicates a portfolio that tracks the index.
Treasury shares
The Company has the authority to make market purchases of its ordinary shares for retention as treasury
shares for future reissue, resale, transfer or cancellation. Treasury shares do not receive distributions and
the Company is not entitled to exercise the voting rights attaching to them.
Private (unlisted) company
An unlisted or private company means a company whose shares are not available to the general public for
trading and are not listed on a stock exchange.
Contingent value rights
‘CVR’ after an instrument name indicates a security, usually arising from a corporate action such as a
takeover or merger, which represents a right to receive potential future value, should the continuing
company achieve certain milestones. The Abiomed CVR arose on Johnson & Johnson’s takeover of
Abiomed. The milestones relate to the performance of the technologies acquired through the takeover.
Any value attributed to this holding reflects both the amount of the future value potentially receivable
and the probability of the milestones being met within the time frames in the CVR agreement.
127
Shareholder information
128 Annual Report and Financial Statements 2024
Baillie Gifford US Growth Trust plc
## Company
## information
Directors Company details Registered office
Chair: TJW Burnet bgusgrowthtrust.com Baillie Gifford & Co Limited
SP Inglis

| CRD van der Kuyl | Company Registration No. 11194060 | 3 St Helen’s Place |
| --- | --- | --- |
| RL Palmer |  | London |
| GD Paterson | ISIN: GB00BDFGHW41 | EC3A 6AB |

Sedol: BDFGHW4
Ticker: USA
Legal Entity Identifier
213800UM1OUWXZPKE539
Alternative Investment Fund

| Further information | Managers and Secretaries | Registrar |
| --- | --- | --- |
| Baillie Gifford Client Relations Team | Baillie Gifford & Co Limited | Computershare Investor Services PLC |
| Calton Square | Calton Square | The Pavilions |
| 1 Greenside Row | 1 Greenside Row | Bridgwater Road |
| Edinburgh | Edinburgh | Bristol |
| EH1 3AN | EH1 3AN | BS99 6ZZ |
| T: +44 (0)800 917 2112 | T: +44 (0)131 275 2000 | T: +44 (0)370 707 1711 |
| trustenquiries@bailliegifford.com | bailliegifford.com |  |

Depositary Company broker Independent Auditor
The Bank of New York Mellon
Panmure Liberum Limited Ernst & Young LLP
(International) Limited
40 Gracechurch Street Atria One
160 Victoria Street
London 144 Morrison Street
London
EC3V 0BT Edinburgh
EC4V 4LA
EH3 8EX
129
## bgusgrowthtrust.com
Calton Square, 1 Greenside Row, Edinburgh EH1 3AN
Telephone +44 (0)131 275 2000